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Abstract 
The hair follicle is an important skin appendage that arises during development from 
complex reciprocal signalling between the epidermis and dermis.  The multiple epidermal 
layers of the hair follicle are known to be under the control of the mesenchymal 
component, the dermal papilla (DP), which has been described as the key regulator of hair 
follicle induction and maintenance.  The hair follicle has elicited interest as a model system 
for the investigation of tissue and organ regeneration due to its ability to regenerate 
completely throughout the life of a mammal.  This characteristic is attributed to the 
reservoir of stem cells within the hair follicle, which is modulated by the DP. 
Although it is known that the DP is central to regulation of the hair follicle, mediators of 
its signalling are incompletely understood.  Potential mediators of DP activity continue to 
emerge, two of which include the SoxF transcription factor, Sox18, and the transcription 
factor, STAT5.  Sox18 has been implicated in hair type specification by the DP; however, 
its expression and function remains unclear.  STAT5 has been shown in microarray 
analyses of the DP to be specifically expressed and upregulated, while studies involving 
STAT5 genetic knockouts display a hair phenotype.  More recently, STAT5 has been 
implicated in autoimmune conditions affecting the hair follicle such as alopecia areata. 
To investigate further the role of STAT5 in the DP, I have hypothesised that STAT5 
plays a key role in the DP’s hair follicle inductive properties and regulation of cycling. 
STAT5 activation in the DP was characterised through immunofluorescence staining of 
mouse back skin at various stages of hair follicle development and cycling.  Back skin was 
obtained from Topflash transgenic mice, a canonical Wnt reporter transgenic mouse 
driving luciferase expression, using β-catenin activity to monitor hair cycling via live 
bioluminescence imaging.  While embryonic skin did not display any activation of STAT5, 
during postnatal hair follicle development (P0-P19), the majority of phospho-STAT5 
positive DP were present within telogen phase, to a lesser extent within catagen and not at 
all during anagen.  Adult skin showed phospho-STAT5 activation beginning in late catagen 
and persisting through to early anagen.  Characterisation of SOCS2 by 
immunofluorescence, a downstream STAT5 transcriptional target, showed expression 
corresponding to the chronology of phospho-STAT5 activity. 
Hair regeneration assays were performed with DP cells using SKP culture with STAT5 
activity modified through adenovirus constructs.  SKPs derived from C57BL/6 neonates 
and STAT5lox/lox neonates were transduced with STAT5A/B constitutively-active and cre-
recombinase constructs, respectively.  These transduced SKPs were then used in patch 
assay experiments and DP formation was quantified using a green fluorescent protein 
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(GFP) reporter.  SKPs transduced with constitutively-active STAT5 were significantly 
better at forming hair follicle DP than control SKPs transduced with GFP alone.  SKPs with 
STAT5 deletion were less effective at forming hair follicle DP and the overall number of 
hair follicles produced was also reduced compared to control SKPs.  Comparison of 
STAT5-deleted and control SKPs revealed that a number of genes related to well-known 
anagen signalling pathways were downregulated in the STAT5-deleted condition. 
In vivo STAT5 inhibition was achieved by adopting a cre-lox breeding strategy where 
Sox18GCre/ER mice were crossed with STAT5A/Blox/lox mice in order to perform targeted 
deletion of STAT5 in the DP, inducible with tamoxifen.  It was found that mice with STAT5 
deletion in the DP using this strategy resulted in a delay of anagen entry in the second 
post-developmental anagen stage when compared to control group animals.  In addition, 
pharmacological inhibition of STAT5 attempted using ruxolitinib, a JAK1/2 inhibitor, was 
not found to have any effect on postnatal hair follicle development and cycling. 
I have also hypothesised that Sox18 plays an essential role in DP development and 
function in all murine hair follicle types.  Sox18 was found to be expressed within the DCs 
of all hair types during early development, and its loss of function resulted in the inhibition 
of DP formation and impaired development and cycling of all hair follicle types.  Hair 
regeneration assays performed using Sox18+/Op and wild-type SKPs provided confirmation 
that the hair follicle phenotype observed in Sox18 mutant mice was due to a mesenchymal 
defect. Comparison of Sox18+/Op and control SKPs by RNA microarray revealed 
downregulation of a number of DP signature genes, including those related to Wnt and 
FGF signalling, in Sox18+/Op SKPs. It was determined that Sox18 is required for DP 
function in all murine hair types and confirmed its suitability as a marker to target the DP. 
 In addition to the investigation of DP signalling, skin wound healing studies were 
performed examining the role of macrophages during the early stages of wound healing, 
and the potential for DP-derived cell populations to improve wound healing.  Using Col1α2-
luciferase mice, macrophages were determined to be important for the control of collagen 
transcription during the early stages of wound healing.  Depletion of macrophages was 
found to worsen wound closure and resulted in a reduced proportion of collagen within the 
wound.  Analysis of macrophage subpopulations found that the observed effects were 
likely due to a reduction in the proportion of macrophages expressing high levels of MHCII. 
Transplantation of SKPs was found to significantly improve wound closure, and this 
effect was augmented with the transduction of a STAT5B constitutively-active (STAT5B-
CA) construct.  It was found that wounds treated with STAT5B-CA SKPs had a reduced 
number of macrophages compared to control conditions. Gene expression analyses 
iii 
 
revealed that a number of pro-inflammatory genes were downregulated in STAT5B-CA 
SKPs, suggesting that their presence in the wound results in reduced inflammation. 
The overall findings of this study suggest that (i) STAT5 activation acts as a 
mesenchymal switch to improve hair inductive potential and induce natural anagen entry 
during the adult hair follicle cycle; (ii) Sox18 acts as a mesenchymal molecular switch 
necessary for the formation and function of the DP in all hair types; (iii) macrophages 
control Co1α2 transcription during the early stages of wound healing; and (iv) SKPs 
transduced with constitutively-active STAT5B reduce inflammation within the wound and 
improve wound healing. 
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1.1. The Hair Follicle 
The skin is the largest organ of the human body, serving to protect the body from 
dehydration and environmental insults.  Such insults include mechanical and chemical 
stressors, as well as microbial infection (Blanpain and Fuchs, 2009).  The skin is 
composed of three main layers: the epidermis, dermis and hypodermis; as well as 
appendages such as hair follicles, sebaceous glands and sweat glands. 
The epidermis is a stratified, squamous epithelium that is primarily composed of 
keratinocytes.  Epidermal keratinocytes originate from populations of epidermal stem cells 
that are continuously maintained and undergo terminal differentiation throughout life 
(Blanpain and Fuchs, 2006).  The dermis underlies the epidermis and is predominantly 
composed of fibroblasts that produce collagen, providing protection from mechanical 
stress.  The deepest layer of the skin is the hypodermis and is composed of lipid-secreting 
adipocytes (Rinn et al., 2008). 
Hair follicles are composed of both an epidermal and dermal component, with 
reciprocal signalling between the two layers pivotal for hair follicle induction and 
maintenance.  Hair follicles are not only of cosmetic importance, but are important in skin 
sensation, protect against environmental insults, and their associated structures provide 
essential lubrication for the skin.  In addition, hair follicles have been shown to serve as a 
source of stem cells that contribute to skin healing after wounding (Fuchs, 2007; Ito et al., 
2005a). 
Hair follicle induction and maintenance occurs through a complex interplay between 
the dermal component of mesenchymal origin known as the dermal papilla (DP), and the 
epidermal stem cell population found in an area known as the hair follicle bulge.  The hair 
follicle has a unique ability to regenerate completely and continually throughout the entire 
life of a mammal, and has therefore elicited substantial interest as a “mini-organ” to 
investigate stem cell modulation in tissue regeneration (Fuchs, 2007). 
Hair regeneration and cycling has been investigated for decades, yielding numerous 
proposed molecular pathways in mesenchymal-epidermal interactions. However, as more 
is discovered regarding the integral signalling pathways, new questions continually arise. 
 
1.1.1. Embryonic Hair Follicle Development 
 Hair follicle development in the embryo begins following the initial stages of epidermal 
differentiation (Blanpain and Fuchs, 2009; Schmidt-Ullrich and Paus, 2005).  Ectodermal 
cells are induced to adopt an epidermal fate as a result of a signalling cascade involving 
bone morphogenetic proteins (BMPs), growth factors comprising part of the transforming 
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growth factor beta (TGF-β) protein superfamily (Moreau and Leclerc, 2004).  Following 
formation of an undifferentiated epidermal layer, hair follicle induction begins with an 
exchange of signals both within and between epidermal keratinocytes and the underlying 
dermal fibroblasts of mesenchymal origin.  This is known to occur in the mouse at 
approximately embryonic day (E) 13.5 and consists of three consecutive waves, termed 
primary, secondary and tertiary, giving rise to the three types of murine hair follicles, 
guard, awl/auchene and zigzag, respectively (Fuchs, 2007; Millar, 2002; Schmidt-Ullrich 
and Paus, 2005).  The formation of a “hair placode” characterises the initial stages of hair 
follicle development, appearing as small invaginations of the epidermis (Aubin-
Houzelstein, 2012; Fuchs, 2007).  Hair follicle induction and development has been 
predominantly attributed to the Wingless-int (Wnt)/β-catenin and ectodysplasin 
(Eda)/ectodysplasin receptor (Edar)/nuclear factor κB (NF-κB) signalling pathways (Wang 
et al., 2012).  Until recently, it has been claimed that hair placode formation begins with a 
dermal signal to the epidermis, inducing a combination of signalling pathways that 
ultimately give rise to new hair follicles (Aubin-Houzelstein, 2012; Fuchs, 2007; Schmidt-
Ullrich and Paus, 2005). However, recent investigation of embryonic skin development in 
Wnt signalling reporter mice suggests otherwise (Chen et al., 2012). 
 Conditional deletion of Wntless (Wls), resulting in reduced expression of the Wnt 
ligand in the mouse epidermis, has been shown to suppress the expression of Wnt 
signalling target genes in the dermis, consequently preventing formation of hair follicles 
(Chen et al., 2012).  This suggests that induction of hair placode formation begins with an 
epidermal signal to the dermis, as opposed to the previously believed dermal signal 
initiation of hair follicle induction.  Consequently, following the secretion of epidermal Wnt 
ligands, canonical Wnt/β-catenin signalling is activated in the underlying dermis. This 
results in the translocation of cytoplasmic/plasma membrane β-catenin to the nucleus to 
form binding complexes with the transcription factor (TCF)/lymphoid enhancer-binding 
factor 1 (Lef1) DNA-binding proteins, resulting in upregulation of target genes (Fuchs, 
2007; Schmidt-Ullrich and Paus, 2005).  For the primary hair wave, this occurs at E13.5 in 
mice and signals epidermal keratinocytes to proliferate and grow downwards, forming hair 
placodes from which hair follicles will arise (Andl et al., 2002; Fuchs et al., 2001; Schmidt-
Ullrich and Paus, 2005).  The importance of Wnt/β-catenin signalling in hair follicle 
induction is further supported by investigations of ectopic Dickkopf 1 (Dkk1) expression in 
mice.  Dkk1, previously shown to be a potent inhibitor of Wnt signalling, was found to 
prevent hair placode formation in embryonic mouse skin.  It was also found to be 
expressed in cells adjacent to developing hair follicles in wild-type embryos, suggesting 
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the involvement of Dkk1 in hair follicle patterning and spacing (Andl et al., 2002).  In 
addition to Wnt/β-catenin signalling, the Eda/Edar/NF-κB signalling pathway has been 
implicated in hair follicle induction and its activation is suggested to be a result of 
ectodermal β-catenin signalling (Zhang et al., 2009).  Eda/Edar/NF-κB signalling was 
originally suggested to play a role in the suppression of inhibitory BMPs and in the 
patterning of hair placode formation (Mou et al., 2006; Zhang et al., 2009).  However, it 
has been shown more recently that fibroblast growth factor (FGF) 20, a growth factor 
downstream of Eda/Edar and Wnt/β-catenin signalling, has a further role in formation of 
the dermal condensate (DC), at least during the primary and secondary waves (Huh et al., 
2013). 
 Between E14 and E15.5 during the primary wave in mice, FGF20 recruited by Wnt/β-
catenin and Eda/Edar signalling in the nascent epidermal hair placode induces a 
condensation of dermal fibroblasts underlying the placode.  This results in formation of the 
DC, and the developing hair follicle is now termed a “hair germ” (Huh et al., 2013; Millar, 
2002).  Platelet-derived growth factor A (PDGF-A) and its receptor PDGFRα have been 
described in the hair placode and underlying dermal cells respectively, and are implicated 
in DC formation by investigations in PDGF-A knockout mice (Karlsson et al., 1999).  
Following formation of the DC, the hair placode produces the protein sonic hedgehog 
(Shh), and its receptor Patched (Ptc), is expressed in the DC (Iseki et al., 1996). 
 Shh has been suggested to be of importance in DC formation and maturation into the 
DP, and in signalling between the epidermis and dermis as indicated by the presence in 
differing layers of the protein and its receptor, respectively (Karlsson et al., 1999; Millar, 
2002).  Studies of Shh knockout mice have found that in the absence of Shh, hair placode 
development still occurs as well as the development of a premature DC, however DP 
formation and further hair follicle development is arrested, supporting the suggested role of 
Shh (Karlsson et al., 1999).  It has also been found that in the absence of Wnt/β-catenin 
signalling, Shh fails to be expressed in the DP, suggesting that Shh occurs downstream of 
this signalling pathway (Huelsken et al., 2001).  More recent evidence using ablation of β-
catenin in the DC has also demonstrated that continued Wnt/β-catenin signalling is 
required within the DC for further progression of hair follicle formation (Tsai et al., 2014).  
Accordingly, in the presence of Shh signalling and continued Wnt signalling, the hair germ 
further develops into the “hair peg” between E16.5 and E17.5.  Keratinocytes of the 
epidermal placode proliferate downwards into the dermis, and the DC matures to form the 
DP (Schmidt-Ullrich and Paus, 2005; St-Jacques et al., 1998).  Shh has been shown to 
mediate its effects through Smoothened (Smo) and glioma-associated oncogene 
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homologs (Gli) 1 and Gli2, with studies using knockout mice for these genes showing 
impaired hair follicle development (St-Jacques et al., 1998; Woo et al., 2012).  Smo has 
been shown to be required for the expression of DP signature genes, in particular those 
associated with hair type fate determination such as sex determining region Y-box (Sox) 2 
and Sox18 (Woo et al., 2012).  Shh signalling has also shown to result in the expression of 
Noggin, an inhibitor of BMP signalling; however, this has been found to be via a different 
pathway to Sox2 and Sox18 expression.  It has been postulated that the function of 
Noggin is to act as part of a Noggin-Shh regulatory feedback loop, maintaining the function 
of the DP and consequent hair follicle development through Shh (Woo et al., 2012).  At this 
stage of development the DP expresses Wnt5a, hepatocyte growth factor, versican, neural 
cell adhesion molecule (NCAM), and increased alkaline phosphatase activity is observed 
(Muller-Rover et al., 1998; Schmidt-Ullrich and Paus, 2005). 
 As epidermal cells continue to proliferate downwards during the peg stage, the DP 
begins to become encapsulated by adjacent keratinocytes, known as the hair matrix cells.  
This proliferation is maintained by signalling from the DP and is proposed to occur through 
a combination of Wnt, Shh, Noggin, follistatin and Lef1 signalling, with the concurrent 
suppression of inhibitory factors such as BMPs (Millar, 2002; Schmidt-Ullrich and Paus, 
2005; Wang et al., 2012; Woo et al., 2012).  At E18.5, the hair follicle bulb is formed and is 
apparent as a widening of the matrix, a hallmark of the bulbous peg stage of development.  
At this point, several gene expression patterns initiate signalling pathways that trigger the 
differentiation of matrix cells into the various layers of the hair follicle (Fuchs, 2007) (see 
Figure 1.1).  Keratinocytes distal to the DP differentiate to form the outer root sheath 
(ORS), a layer continuous with the basal layer of the stratified interfollicular epidermis, 
encapsulating the inner layers of the hair follicle (Fuchs, 2007; Fuchs et al., 2001).  Matrix 
cells proximal to the DP differentiate to form the inner root sheath (IRS), three concentric 
cell layers within which the hair shaft will develop, as well as the companion layer 
separating the IRS and ORS (Fuchs, 2007).  It is suggested that differentiation of matrix 
cells into the IRS and its layers occurs as a result of the transcriptional regulator distal-less 
homeobox 3 (Dlx3), a downstream effector of Wnt signalling and a direct target of BMP 
signalling, as evidenced by phospho-Smad1/5/8 immunostaining in Dlx3 mutant mice 
(Hwang et al., 2008).  Canonical Notch signalling has also been implicated in IRS 
differentiation, with loss-of-function studies showing a failure of IRS development in the 
absence of Notch signalling (Blanpain and Fuchs, 2006). 
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 Within the centre of the IRS, the hair shaft is differentiated and consists of the medulla, 
cortex and cuticle; three concentric layers that are upwards and rapidly proliferating 
(Fuchs, 2007).  Again, the Wnt signalling pathway is implicated, however a prominent role 
in hair shaft differentiation has been attributed to the homeobox (HOX) transcription factor, 
HOXC13, and its upregulation of Forkhead box N1 (Foxn1) (Merrill et al., 2001; Potter et 
al., 2011).  Foxn1 is also described to be an activator of Notch1 expression, and Notch 
signalling in combination with msh HOX 2 (Msx2) is suggested to play an essential role in 
hair cortex and medulla differentiation (Cai et al., 2009).   
 During late embryogenesis and continuing into early postnatal development, the 
sebaceous gland develops at the superior portion of the hair follicle as a bud of the ORS, 
just below where the hair shaft emerges from the epidermis (Fuchs and Horsley, 2008).  
The sebaceous gland has been suggested to arise from a population of Blimp1 expressing 
progenitor cells that differentiate to give rise to the entire gland.  The sebaceous gland 
produces differentiated sebocytes that contain lipid-rich sebum that is expelled into the hair 
canal when these cells degrade (Horsley et al., 2006).  Sebum acts to lubricate the hair 
shaft, and has been shown to have antimicrobial properties (Drake et al., 2008; Fuchs, 
2007). 
 
 
 
 
 
Figure 1.1. Stages of hair follicle induction and morphogenesis.  The stages of hair 
follicle morphogenesis are displayed in the top row, with images in the second row depicting 
the corresponding stage.  Signalling between epidermal keratinocytes (yellow cells) and 
dermal fibroblasts (large blue cells) results in the induction of hair follicle morphogenesis, 
beginning with formation of the dermal papilla (small, dark blue cells).  Signalling 
predominantly by one layer is depicted by red arrows.  The third row depicts signalling 
pathways/mediators that are upregulated (in black) or suppressed (in red) at each stage of 
morphogenesis. [Adapted from (Schmidt-Ullrich and Paus, 2005)]. 
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  The development of the primary hair follicle continues seven to eight days from 
development of the bulbous peg at E18.5, and continuous proliferation of the hair shaft 
allows it to emerge from the surface of the skin and grow postnatally for 14 days, where it 
will then commence hair follicle cycling (Fuchs, 2007). 
 
1.1.2. Sox2 and Sox18 in Dermal Papilla Specification 
 Sox2 is known to be a transcription factor indispensible for the maintenance of 
pluripotency in the mammalian embryo, and for the re-establishment of pluripotency in 
induced pluripotent stem cells (Avilion et al., 2003; Takahashi and Yamanaka, 2006).  
Within the hair follicle, Sox2 has been shown to be a marker of the DP restricted to murine 
guard, awl and auchene hair types after E18.5 (Driskell et al., 2009). Genetic comparison 
of Sox2+ and Sox2- DP cells has revealed the upregulation of two distinct subsets of 
genes, with hair follicle reconstitution assays using Sox2- DP cells only forming zigzag hair 
follicles (Driskell et al., 2009).  Recent studies have shown that conditional ablation of 
Sox2 in the DC still allows these hair follicles to form; however, it was found that Sox2 is 
required for the postnatal maintenance of awl and auchene hair follicles, highlighted by the 
reduced proportion of these hair types in Sox2-ablated animals (Lesko et al., 2013).  An 
earlier study has also demonstrated that Sox2 ablation in the DC does not affect hair 
follicle formation.  The study also suggested that Sox2 negatively regulates BMP signalling 
within the hair follicle, and its absence results in an inability for matrix progenitor cells to 
migrate to the hair shaft as they differentiate (Clavel et al., 2012). 
 The SoxF family of transcription factors is comprised of Sox7, Sox17 and Sox18 (Dunn 
et al., 1995).  Sox18 has been described as an essential regulator of vascular and 
lymphatic development in the embryo, and is implicated during angiogenesis in skin wound 
healing (Darby et al., 2001; Downes and Koopman, 2001; Francois et al., 2008).  In 
contrast to Sox2, Sox18 has been described as a DP marker specific to zigzag hair 
follicles (Driskell et al., 2009; Pennisi et al., 2000a).  A study investigating Sox18-/- mice 
found that although these mice are viable and do not appear to have any cardiovascular 
defects, likely due to redundancy amongst the SoxF transcription factors, they show a 
notable reduction in the proportion of zigzag hair follicles compared to littermate controls. 
Guard, awl and auchene hair follicles did not appear to be affected, supporting further the 
specificity of Sox18 to the DP of zigzag hair follicles.  However, in the same publication it 
was shown that Sox18 starts to be expressed in the DP at E14, suggesting its presence 
within guard hairs as well (Pennisi et al., 2000a).  In addition, hypotrichosis-lymphedema-
telangiectasia, a genetic disorder in humans characterised by hair loss and defects in the 
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cardiovascular and lymphatic systems, is attributed to mutation of Sox18 (Irrthum et al., 
2003).  Interestingly, the phenotype of Sox18-/- mice appears to be largely dependent on 
genetic background.  Initial studies investigating the Sox18-/- mutation were described in 
mice of mixed genetic background; however, a later study that backcrossed these mice for 
11 generations onto a pure B6 background observed a much more severe phenotype.  
This included extensive subcutaneous oedema resulting in only few Sox18-/- embryos 
surviving past E14.5.  The findings of the study suggested that the difference in 
phenotypes observed in Sox18-/- mutants across different genetic backgrounds was a 
result of strain-specific ability for Sox7 and Sox17 to act interchangeably with Sox18 
(Hosking et al., 2009). 
Although the use of Sox2 and Sox18 as DP markers of different hair follicle types is 
well established, much remains to be elucidated regarding their role in hair follicle 
mesenchymal to epidermal signalling. 
 
1.1.3. Hair Follicle Maintenance and Cycling 
 The hair follicle has been described as a “mini-organ” and a model system for 
biological research due to its cycling and self-renewing capabilities (Al-Nuaimi et al., 
2010).  The mature hair follicle begins cycling early in postnatal life and will continue to 
undergo the consecutive phases of anagen, catagen and telogen throughout the entire life 
of a mammal (Fuchs et al., 2001) (see Figure 1.2).  Many signalling pathways present 
during embryonic hair follicle morphogenesis are conserved postnatally, however more is 
being revealed regarding the mechanisms inducing each hair cycle phase.  In order for the 
hair follicle to sustain this lifelong cycling, it is clear that a continual supply of stem cells is 
required for the regeneration of follicle structures.  The reservoir of hair follicle stem cells 
occurs in a region described as the “bulge”, and is located at the bottom of the non-cycling 
upper third of the hair follicle, appearing as an expansion of the ORS (Oshima et al., 
2001).  The multipotent bulge stem cells, also described as epithelial or epidermal stem 
cells, have been shown to be self-renewing and able to differentiate into all cell lineages 
within the hair follicle (Blanpain et al., 2004).  Markers of bulge stem cells include CD34 
and surface α6 integrin, keratin (K) 15, as well as the shared basal keratinocyte markers 
K5 and K14 (Blanpain et al., 2004). 
 After the initial postnatal growth of the hair shaft, matrix cells in the hair bulb cease to 
proliferate and differentiate, and the hair follicle enters into a destructive phase termed 
catagen (Fuchs, 2007).  This phase is characterised by apoptosis in the cycling lower two-
thirds of the hair follicle, which results in regression of the follicle and a drawing up of the 
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DP to the bulge area.  It is suggested that the signals initiating this transition to catagen 
arise predominantly from BMP signalling, and are also modulated by follistatin, TGF-β 
proteins, FGF5, and prolactin (Paus and Foitzik, 2004).  Recently, it has been suggested 
that Dkk1 expression in keratinocytes is involved in the hair follicle transition from anagen 
to catagen.  Injection of recombinant human Dkk1 in mouse skin was found to induce 
catagen in hair follicle keratinocytes, by blocking Wnt signalling and upregulating 
expression of Bcl-2-associated X protein (Bax), a promoter of apoptosis, resulting in 
apoptosis of ORS keratinocytes (Kwack et al., 2012b).   
 Interferon-γ, a cytokine that has been shown to have potent catagen inducing 
properties, has recently been suggested to exert its effects through mechanisms related to 
Dkk1.  Treatment of hair follicles with interferon-γ was shown to inhibit nuclear 
accumulation of β-catenin and increase levels of the catagen inducers glycogen synthase 
kinase (GSK) 3β, Dkk1 and TGF-β2 (Ryu et al., 2014). Earlier studies investigating 
interferon-γ found similar results when treating hair follicles with the cytokine, and found 
strong expression of interferon-γ receptor β in the hair follicle matrix and DP (Ito et al., 
2005b).  Overall control of catagen has been attributed to the hairless gene, with in situ 
hybridisation investigations in the hair follicle suggesting hairless plays a crucial regulatory 
role to ensure the appropriate progression of catagen phase (Panteleyev et al., 2000). 
 Following catagen phase, a “resting” phase known as telogen occurs in the hair 
follicle, where the follicle shows an absence of proliferative cells (Paus and Foitzik, 2004).  
Although the hair follicle appears quiescent during telogen, it has been proposed that 
telogen is in fact a dynamic phase with an important regulatory role in hair follicle cycling, 
highlighted by a 425 gene expression signature (Geyfman et al., 2012).  Furthermore, 
telogen has been described as having two stages, the “refractory” and “competent” phases 
where conditions for anagen induction are less and more conducive, respectively.  These 
stages of telogen have been suggested to occur as a result of differences in BMP 
expression (Plikus et al., 2008).  Induction of telogen from catagen and maintenance of the 
phase has been previously reported to occur as a result of tumor necrosis factor (TNF) α, 
estrogens, neurotrophins and cathepsin-L activity, however more recent evidence 
suggests that BMP signalling, as well as FGF18, are responsible for telogen maintenance 
(Paus and Foitzik, 2004; Schneider et al., 2009).  During refractory telogen, high levels of 
Bmp2 and Bmp4 expression, coupled with elevated levels of the Wnt antagonists Dkk1 
and secreted frizzled-related protein 4 (Sfrp4) produce the less favourable conditions for 
anagen induction that have been reported. In contrast, the reduced BMP and Wnt 
antagonist expression during competent telogen provide an environment that is conducive 
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to anagen induction (Plikus et al., 2011; Plikus et al., 2008).  The expression of BMPs is 
reported to occur in the dermal environment surrounding the hair follicle, including the DP 
and adipocytes of the hypodermis (Blanpain et al., 2004; Plikus et al., 2008).  In addition to 
BMPs, FGF18 has been identified as a key regulator of telogen.  FGF18 has been shown 
to be strongly expressed in the hair follicle bulge cells during telogen and its receptor, 
FGFR3, is also strongly expressed within the bulge, ORS and DP. It was also 
demonstrated that with the knockout of Fgf18, telogen duration was significantly reduced 
compared to control littermates, and pharmacological treatment with FGF18 resulted in 
inhibition of hair matrix cell proliferation (Kimura-Ueki et al., 2012). 
 Anagen is the period of growth in the hair follicle that results in the downward 
proliferation of the follicle, as well as differentiation of matrix cells and proliferation to 
elongate the hair shaft (Fuchs et al., 2001).  The exact pathways causing anagen induction 
remain unclear, however it is largely accepted that many of the aforementioned signalling 
pathways involved in embryonic hair follicle morphogenesis are conserved in the anagen 
hair follicle (Paus and Foitzik, 2004).  Canonical Wnt/β-catenin signalling between the DP 
and epidermal cells of the hair follicle is believed to be involved in the initiation and 
progression of anagen, along with Shh signalling and the suppression of BMP signals as in 
embryogenesis (Paus and Foitzik, 2004; Wang et al., 2012).  Recent evidence has 
demonstrated that both mammalian target of rapamycin (mTOR) and TGF-β2 signalling 
originating in the DP are essential for suppression of BMP signalling, which then facilitates 
anagen initiation (Deng et al., 2015; Oshimori and Fuchs, 2012).   
 In mice, the previous hair shaft, now known as the “club hair”, remains in place as the 
hair follicle proliferates downwards and the DP moves away from the bulge region.  As 
matrix cells terminally differentiate once again and the hair shaft keratinocytes proliferate, 
the club hair is shed to allow the new hair shaft to emerge (Fuchs, 2007).  Anagen is also 
the phase where melanocytes located in the epidermal layers of the hair follicle transfer 
melanin into keratinocytes to give the hair shaft pigmentation (Slominski et al., 2005). 
 As in embryonic hair follicle development, communication between the dermal and 
epidermal components is essential for mature hair follicle cycling.  Without signalling 
between the DP and bulge stem cells, the hair follicle cannot be maintained (Schneider, 
Schmidt-Ullrich and Paus, 2004). 
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1.1.4. The Dermal Papilla and Bulge Stem Cell Modulation 
 The importance of reciprocal dermal and epidermal signalling in hair follicle 
morphogenesis and cycling has long been established.  Studies involving the 
transplantation of dermal and epidermal cells from different origins have highlighted the 
necessity for communication between both layers to induce skin appendage development 
(Dhouailly, 1973).  Another pioneering study demonstrating the hair-inductive properties of 
the DP showed that when cultured DP cells were transplanted to a follicle that had the 
entire lower half removed previously, a new hair bulb and matrix surrounding a DP were 
regenerated, restoring hair follicle function (Jahoda et al., 1984).   
 
 
 
 
 
 
Figure 1.2. Mature hair follicle cycling.  Following morphogenesis, hair follicles enter 
mature hair follicle cycling.  The hair follicle cycles through periods of growth (anagen), 
regression (catagen) and rest (telogen), completely regenerating the cycling portion from 
the onset of each new anagen phase.  Hair follicle cycling occurs under the control of the 
dermal papilla and its reciprocal signalling with epidermal stem cells located in the bulge. 
[Adapted from (Fuchs, 2007)]. 
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 Studies have demonstrated that the DP is a distinct, specialised population of dermal 
fibroblasts with both differences in cell aggregation in culture, and differences in hair 
inductive capabilities compared to non-DP interfollicular fibroblasts.  DP cells have been 
shown to form multi-layered aggregates in vitro, whereas interfollicular fibroblasts do not 
tend to aggregate and form as a monolayer until confluence (Messenger et al., 1986a).   
Furthermore, it has been shown that cultured dermal fibroblasts alone do not have the 
ability to induce hair follicle formation compared to cultured DP cells; however, DP cells 
have been shown to lose their hair inductive properties when remaining in culture for 
multiple passages (Horne et al., 1986).  Studies of the hair follicle in vivo have suggested 
that cells of the DP are slowly renewed by adjacent cells of the dermal sheath surrounding 
the hair follicle (Tobin et al., 2003). 
 As described earlier, it has been shown in mouse studies that the DP is 
heterogeneous, with differential expression of Sox2 and Sox18 leading to the formation of 
different hair follicle types (Driskell et al., 2009; Pennisi et al., 2000a).  This highlights the 
complexity of the DP and leaves much to be revealed concerning the signalling pathways 
involved in hair follicle induction. 
 It has been suggested that as the DP is drawn up during the catagen phase of the hair 
cycle and comes to rest adjacent to the hair follicle bulge during telogen, the proximity of 
the two structures allows induction of bulge stem cell differentiation by signals from the DP 
(Driskell et al., 2011).   
 A study investigating the role of β-catenin activity found that with ablation of the β-
catenin gene specifically in the DP, early catagen was induced in anagen hair follicles and 
hair follicles failed to regenerate (Enshell-Seijffers et al., 2010b).  It has been suggested 
that Wnt/β-catenin signalling begins with the secretion of Wnt by matrix cells, which 
induces β-catenin production in the DP.  Consequently, β-catenin signals follicular 
keratinocytes in the adjacent hair matrix to proliferate, thereby inducing hair follicle 
regeneration (Enshell-Seijffers et al., 2010b).  Increased β-catenin activity in the DP results 
in the upregulation of FGFs, insulin-like growth factors (IGFs), Wnts and BMPs, all of 
which are implicated in the proliferation of hair follicle keratinocytes during anagen.  In 
particular FGF7 and FGF10, as well as IGF-1 are suggested to be the predominant 
regulatory proteins involved in DP to keratinocyte signalling (Greco et al., 2009; Weger 
and Schlake, 2005).  More recent evidence has supported further the key role of β-catenin 
in the DP through deletion experiments, but notes that β-catenin is not required for 
maintenance of bulge stem cells although anagen induction is not possible in its absence 
(Choi et al., 2013). 
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 In addition to the aforementioned proteins, BMPs have been suggested to have a key 
role in hair follicle regeneration. However, ambiguity surrounds their role as there are 
differing reports on their function in the follicular macroenvironment and DP 
microenvironment (Plikus et al., 2008; Rendl et al., 2008).  BMP activity in the dermis has 
been suggested to be inhibitory to anagen induction, with suppression by the BMP 
antagonist, Noggin, showing a shortened refractory telogen phase and therefore earlier 
anagen induction (Plikus et al., 2008).  However, it has been reported that increased β-
catenin activity in the DP results in the upregulation of BMP signalling in the hair follicle 
bulb, which has been shown to be essential to the hair inductive properties of the DP, both 
in vitro and in vivo (Enshell-Seijffers et al., 2010b; Rendl et al., 2008).  In vitro treatment of 
DP cells with BMP6 resulted in maintenance of the DP molecular signature and enhanced 
their ability to induce hair follicle formation in in vivo assays compared to untreated DP 
cells.  Furthermore, ablation of BMP receptor 1a in DP cells rendered them unable to form 
hair follicles in in vivo assays (Rendl et al., 2008). 
 As the DP induces hair follicle regeneration at the end of telogen, a population of 
follicular cells described as the hair germ, immediately in contact with the DP, proliferates 
to begin the initial stages of anagen (Greco et al., 2009).  Following hair germ proliferation, 
bulge stem cells are induced to proliferate and migrate downwards to the hair matrix, 
where they provide the source of cells that will differentiate to form the layers of the 
regenerating hair follicle (Greco et al., 2009).  The CD34 and α6 integrin-expressing bulge 
stem cells have been shown to be able to differentiate into all epidermal lineages of the 
hair follicle, and also to contribute to the interfollicular epidermis during wound healing 
(Levy et al., 2005; Morris et al., 2004).  In addition to the aforementioned markers, bulge 
stem cells have been shown to express Sox9, nuclear factor of activated T cells 
cytoplasmic-1 (Nfatc1), LIM/homeobox protein 2 (Lhx2), Tcf3 and leucine-rich repeat-
containing G-protein coupled receptor 5 (Lgr5) (Greco et al., 2009; Levy et al., 2005). 
 Although several mechanisms describing the induction of anagen have been 
proposed, much remains to be determined regarding the precise mechanisms of 
activation. Nevertheless, it is clear that the DP, epithelial bulge stem cell niche, and their 
tightly coordinated reciprocal signalling are pivotal to hair follicle maintenance and 
regeneration, with much to be elucidated regarding the underlying pathways. 
 
1.1.5. Macroenvironment Signalling 
 As described previously, it is well established that hair follicle development and 
cycling depends on signalling both within and between the epidermal and mesenchymal 
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components of the hair follicle.  However, it is becoming increasingly apparent that the hair 
follicle macroenvironment significantly contributes to the regulation of hair follicle cycling 
also.  This is evidenced most obviously by the cyclic BMP signalling regulating telogen 
phase, where the sources of BMP2 and BMP4 are from cells outside of the hair follicle, 
including non-hair follicle dermal fibroblasts and adipocytes (Plikus et al., 2008). 
A growing body of evidence suggests that adipocytes within the hair follicle 
macroenvironment contribute to the onset of anagen.  A study comparing the telogen to 
anagen transition between wild-type mice and mouse models with affected adipogenesis 
revealed delays in anagen onset when adipocytes were impaired (Festa et al., 2011).  The 
study examined Early B cell factor 1 (Ebf1) null mice, a mouse model lacking adipocyte 
precursor cells, and the A-ZIP/F-1 transgenic mouse model that is characterised by a lack 
of mature white adipocytes.  It was found that only the lack of adipocyte precursors in the 
Ebf1-/- mice, and not mature adipocytes, resulted in defective bulge stem cell activation, 
consequently preventing transition to anagen from telogen.  The study also demonstrated 
that anagen induction was possible in Ebf1-/- mice with the transplantation of wild-type 
adipocyte precursors in their back skin.  Ultimately, it was proposed that adipocyte 
precursors exerted their anagen-inducing effects through PDGF signalling (Festa et al., 
2011). 
Leptin, a well-known hormone responsible for satiety and regulation of energy 
expenditure, is derived from adipocytes and has recently been implicated in the regulation 
of hair follicle cycling.  A recent study found that leptin receptor-deficient mice exhibited an 
extended first telogen phase, and therefore delayed onset of the second anagen phase 
compared to control animals.  The study highlighted that leptin was expressed in the DP 
from catagen to early anagen, and subsequently demonstrated that the administering of 
leptin during telogen resulted in anagen induction around the injection site (Sumikawa et 
al., 2014).  A subsequent study found contradictory results, suggesting that leptin 
produced by dermal white adipocytes inhibits anagen induction and is at peak levels 
during late anagen and telogen (Yang et al., 2015). 
Within the dermis and surrounding the hair follicle are resident populations of immune 
cells that are pivotal to the integumentary system’s role in protection against infection (Di 
Meglio et al., 2011).  Populations of leukocytes that directly surround the hair follicle have 
been identified as Langerhan’s cells, γδ T cells, CD4+ and CD8+ T cells, mast cells and 
macrophages (Castellana et al., 2014; Paus et al., 1998).  These cells are not only 
involved in immune reactions, but some have been demonstrated to directly influence hair 
follicle cycling in steady state conditions. 
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Mast cells have been shown previously to reside in the perifollicular environment, with 
further studies suggesting that the hair follicle provides a microenvironment for the 
development of mast cell precursors (Kumamoto et al., 2003; Paus et al., 1998).  Not only 
does their overall number cycle parallel to hair follicle development and cycle phases, but 
mast cells have been debated to be both anagen- and catagen-inducing as a result of their 
secretory products (Maurer et al., 1997; Paus et al., 1994). 
 Macrophages have been known to be present in the perifollicular environment for 
some time, with earlier studies suggesting that their release of FGF5 is important in the 
transition from anagen to catagen (Suzuki et al., 1998).  A recent study has described a 
novel role for macrophages in anagen induction, where a decrease in skin macrophages 
through apoptosis results in the onset of anagen. Interestingly, the study found that prior to 
anagen induction, expression of the Wnt/β-catenin signalling inducers Wnt7b and Wnt10a 
increased in macrophages. Further in vitro investigations revealed that as macrophages 
undergo apoptosis, a corresponding release of Wnt7b and Wnt10a occurred.  It was 
concluded that as perifollicular macrophages undergo apoptosis, the resulting secretion of 
Wnt7b and Wnt10a contributes to the induction of anagen phase by activating bulge stem 
cells (Castellana et al., 2014). 
In order to meet the nutritional demands of highly proliferative cells during anagen 
phase, an increase in the vascularisation in the hair follicle macroenvironment is indicated.  
This was highlighted in a study that described an increase in vascularisation surrounding 
the hair follicle during anagen phase, followed by regression of the vascular network 
during catagen and telogen.  It was found that this increase in vascularisation during 
anagen was facilitated by an upregulation of vascular endothelial growth factor (VEGF) by 
cells of the ORS, leading to increased angiogenesis (Yano et al., 2001).  Conversely, the 
regression of perifollicular vessels through apoptosis was proposed in a later study to be 
mediated by thrombospondin-1 (TSP-1) (Yano et al., 2003).  Furthermore, it was shown 
that by inhibiting VEGF and TSP-1, a delay and prolongation of anagen was observed, 
respectively (Yano et al., 2001; Yano et al., 2003). 
The increasing knowledge of how the dermal macroenvironment influences hair follicle 
cycling allows new pathways to explore in the understanding of skin and hair pathologies, 
as well as stem cell activation as a whole. 
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1.2. Interventions in Hair Follicle Regeneration 
1.2.1. Hair Follicle Regeneration Assays 
 The remarkable ability of the hair follicle to regenerate itself throughout life has elicited 
substantial interest amongst researchers as a model system to examine cellular 
interactions and biochemical signalling pathways in organ regeneration. Some of the 
earliest investigations of mesenchymal-epidermal interactions involved the recombination 
of dermis and epidermis between species and provided insight into the complexity of 
signalling pathways in tissue regeneration (Dhouailly, 1973). To understand further the 
complex signalling mechanisms involved in the regeneration of hair follicles, and 
potentially stem cell modulation in whole organ regeneration, it is necessary to have 
reliable in vivo investigative models.  There are currently three conventional methods of 
regenerating hair follicles from dissociated cells in mice (Liang et al., 2011). 
 The “chamber assay” of in vivo hair follicle regeneration was initially employed to graft 
entire isolated hair follicles onto the back of athymic Nude mice that do not have hair.  The 
method involves excision of an area of full-thickness skin on the back of Nude mice, and 
implantation of a silicon chamber on the skin graft bed.  Transplanted cells are then placed 
into the chamber and allowed to graft over a period of one week, after which the silicon 
chamber is removed (Rogers et al., 1987).  As with hair follicles, dissociated neonatal 
dermal and epidermal cells have been successfully used in the chamber method to 
regenerate hair follicles (Weinberg et al., 1993).  Recent work has utilised this chamber 
method to show that sorted DP cells can give rise to different types of hair follicles (Driskell 
et al., 2011).  This method results in dense and good quality hair follicles that are normally 
orientated, appearing the most clinically normal of all hair regeneration assays (Liang et 
al., 2011). 
 The “flap assay” involves the creation of a full-thickness skin flap on the back on Nude 
mice by making a three-sided rectangular incision.  A silicon sheet with cultured epidermal 
cells is implanted underneath the flap, with the epidermal cells facing up, after which 
isolated dermal cells are placed on top of the epidermal cells.  The flap is then pulled over 
the implanted sheet with cells and sutured.  After four weeks the flap is re-opened and 
inverted to expose the graft, and the wound sutured.  Following inversion and a further 
growth period, the flap assay results in good quality hair of normal orientation (Qiao et al., 
2008). 
 The “patch assay” has been used successfully as an in vivo hair regeneration model 
using combinations of epidermal cells and various populations of dermal cells.  The model 
involves the subcutaneous or hypodermal injection of a mixture of isolated primary or 
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cultured epidermal cells and primary or cultured dermal cells onto the back skin of athymic 
Nude mice.  After ten days, fully formed hair follicles can be found; however, follicles have 
been shown to be randomly orientated as they grow down into the hypodermis and 
subcutaneous tissue (Zheng et al., 2005) (see Figure 1.3).  Hair follicles generated from 
patch assays have been shown to cycle normally and have been used successfully in 
further follicle transplantation experiments in immunocompromised mice (Biernaskie et al., 
2009). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 Of these three commonly used hair regeneration assays, the chamber and flap assays 
generate the highest densities of hair follicles with a normal orientation (Liang et al., 2011).  
This can be particularly useful in studies investigating hair quality and density, but can be 
unduly labour intensive, time-consuming and demanding in cell number if this is not the 
nature of the study in question.  The patch assay is the least labour intensive method of 
efficiently generating hair follicles, requiring the shortest amount of time and lowest 
number of cells (Liang et al., 2011).  This is particularly useful in studies not primarily 
concerned with hair shaft quality or follicular density. 
 Regardless of the assay used, it is clear that in order to regenerate hair follicles, a 
combination of dermal and epidermal cells is required.  Control assays using solely dermal 
or epidermal cells consistently fail to generate hair follicles, instead generating areas of 
excessive fibrosis or cysts, respectively (Zheng et al., 2005). Furthermore, the use of 
neonatal skin has been suggested to be more effective at generating hair follicles in 
comparison to skin from mice at a later developmental stage (Zheng et al., 2010). 
 
 
 
 
 
 
 
 
Figure 1.3. Hair follicle generation using the patch assay method.  The intradermal 
injection of dermal and epidermal cell combinations onto the Nude mouse back skin results 
in the generation of new hair follicles in the subcutis. Window A depicts a dark, slightly 
elevated patch that is visible where hair follicles are produced beneath the skin. [Image from 
(Zheng et al., 2005)]. 
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 As more is elucidated regarding the hair inductive properties of dermal cell 
populations, the availability of hair regeneration assays provides a useful tool for in vivo 
investigations.  Such investigations can include the use of less well-described dermal cell 
populations, and the manipulation of cell properties to achieve a greater understanding of 
mesenchymal-epidermal interactions.  
 
1.2.2. Skin-Derived Precursors 
 Many groups have attempted to reproduce the hair inductive properties of DP cells by 
using various populations of mesenchymal cells.  Of these populations, skin-derived 
precursors (SKPs) have shown the most promise as a substitute for DP cells (Biernaskie 
et al., 2009).  SKPs were first isolated from juvenile and adult mouse dermis and described 
as multipotent adult stem cells with the capability of differentiating into neural and 
mesodermal lineages.  When cultured in medium containing basic FGF and epidermal 
growth factor (EGF), these dermal cells were shown to proliferate in suspension and form 
floating spheres that maintained their proliferative capacity and ability to differentiate for 
several passages (Toma et al., 2001) (see Figure 1.4).  Undifferentiated SKPs were found 
to express Sox2, CD133, nestin, vimentin and fibronectin, showing similarities to 
embryonic neural crest stem cells that lead to their use in the generation of Schwann cells 
(Fernandes et al., 2006; Fernandes et al., 2004).  SKPs from mice and human sources 
have also been successfully differentiated into mesodermal lineages including adipocytes, 
chondrocytes and osteoblasts, thus demonstrating the multipotency of these cells (Toma 
et al., 2001; Toma et al., 2005). 
 SKPs isolated from various regions of the neonatal mouse such as the face and dorsal 
trunk have been shown to originate from different developmental origins, maintaining 
genetic characteristics of that region yet still showing a high level of resemblance (Jinno et 
al., 2010).  Later research has found that SKPs derive from Sox2+ cells of the DP, 
confirmed by microarray gene expression analyses and immunohistochemistry 
comparisons between cell populations.  The same study found that when transplanted into 
adult mouse skin, SKPs were found throughout the dermis and began to express markers 
corresponding to where they were localised.  These markers included collagen type I and 
fatty-acid binding protein in fibroblasts and adipocytes, respectively (Biernaskie et al., 
2009).  Importantly, it was found that when transplanted into dorsal mouse skin, SKPs 
integrated into the hair follicle DP in adult NOD/SCID mice and induced hair follicle 
morphogenesis in adult Nude mice.  Interestingly, rat SKPs that were injected into mouse 
skin generated larger hair follicles and longer hair shafts relative to the host mouse hairs, 
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highlighting the instructive role of the DP in hair follicle morphogenesis (Biernaskie et al., 
2009). 
 In addition to the hair regenerative capabilities of these cells, when transplanted 
adjacent to excisional wounds in dorsal mouse skin, labelled SKPs were found to be 
present in the wound scar.  These labelled SKPs were found to be expressing fibroblast 
markers, strongly suggesting that these cells can actively contribute to the repair of 
wounded skin (Biernaskie et al., 2009). 
 Together, the findings of these studies suggest that SKPs may be characteristic of a 
previously undefined dermal stem cell population.  Although these cells show several 
characteristics of DP cells, the possibility that SKPs are a separate stem cell population 
that reside within a heterogeneous DP cannot be excluded.  Nevertheless, the significance 
of these cells in the regeneration of cycling hair follicles is undeniable, with much to be 
elucidated regarding their underlying signalling mechanisms. 
 
 
 
 
 
 
 
 
 
1.3. Hair Follicles and Wound Healing 
1.3.1. Wound Healing 
 The skin plays a critical role in the protection of an organism from the hazards of the 
environment, regulation of temperature, sensation and protection from dehydration.  When 
the skin is wounded, the body must act quickly to repair the damaged tissue in order to 
restore its protective function.  Wound healing is a complex process that occurs in three 
phases: inflammation, re-epithelialisation and remodelling (Rodero and Khosrotehrani, 
2010).  During the inflammatory phase, haemostatic processes such as platelet plug 
formation and coagulation occur initially, followed by an infiltration of neutrophils and then 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Neonatal murine skin-derived precursors (SKPs) in culture.  SKPs can be 
isolated from the dermis and proliferate as floating spheres when cultured in medium 
containing basic FGF and EGF.  The figure depicts SKPs derived from neonatal mouse skin 
after one passage in culture. 
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macrophages into the wound site resulting in phagocytosis of necrotic tissue and invading 
pathogens (Rodero and Khosrotehrani, 2010; Ross and Odland, 1968). 
 Re-epithelialisation serves to restore the skin’s barrier function and occurs within hours 
of wounding, commencing with migration of keratinocytes towards the wound.  Secretion 
of collagenases by these keratinocytes results in degradation of the extracellular matrix 
within the wound, and allows proliferation and differentiation of keratinocytes to restore the 
epidermis (Rodero and Khosrotehrani, 2010; Singer and Clark, 1999).  Migration of 
fibroblasts also occurs in order to begin repair of the dermis, and together with 
macrophages the granulation tissue is formed.  Fibroblasts within the granulation tissue 
serve to deposit a collagen matrix, with some differentiating into myofibroblasts that act to 
contract the wound (Gabbiani, 2003; Rodero and Khosrotehrani, 2010).  Macrophages are 
essential within the granulation tissue, as they produce several cytokines and growth 
factors that contribute to re-epithelialisation, fibroblast migration and differentiation to 
myofibroblasts, and angiogenesis (Rodero and Khosrotehrani, 2010). 
 Angiogenesis is essential within the wound in order to sustain the cells within the 
granulation tissue and the proliferating keratinocytes.  Wound keratinocytes, epithelial cells 
and macrophages are suggested to secrete the necessary VEGF for angiogenesis, with 
the collagen matrix also required to support this process (Singer and Clark, 1999). 
 As the wound healing process nears completion, the wound undergoes a process of 
remodelling.  During this phase, cells of the granulation tissue undergo apoptosis, leaving 
behind the collagen matrix formed during the previous phases, chiefly composed of 
collagen type III.  The cells that remain in what is now a scar, as well as the overlying 
keratinocytes, begin to secret matrix metalloproteinases.  These metalloproteinases 
catabolise the collagen type III left behind, which is then replaced by collagen type I 
(Rodero and Khosrotehrani, 2010). 
 Ultimately, the scar that remains following wound healing does not share the same 
properties as unwounded skin.  The strength of the skin is reduced, and appendages such 
as hair follicles and sweat glands may be absent (Singer and Clark, 1999). 
 
1.3.2. Hair Follicle Contributions to Wound Healing 
 In order to repair the skin following wounding, a source of stem or progenitor cells is 
inevitably required.  These sources within the skin include cells of the epidermal basal 
layer that continually self-renew and differentiate to maintain the multiple epidermal layers, 
and follicular stem cells that reside in the bulge and isthmus regions (Fuchs and Horsley, 
2008; Plikus et al., 2012). 
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 The slow-cycling hair follicle bulge stem cells are known to be the primary source of 
stem cells that contribute to the proliferating hair follicle during anagen phase.  However, 
when normal skin physiology is disrupted during wounding, bulge stem cells have been 
shown to mobilise and contribute to wound re-epithelialisation (Ito et al., 2005a).  A study 
investigating this phenomenon through labelling of bulge cells found that following 
wounding, bulge cells migrate from their hair follicle niche to excisional wound areas.  
These cells were found to lose their follicular markers as they differentiated into functional 
keratinocytes. It was also confirmed that these cells do not contribute to normal skin 
homeostasis, and only persist for a limited amount of time in wound conditions.  It was 
concluded that after wounding, bulge stem cells mobilise to the wound site to rapidly 
contribute transit-amplifying cells in order to expedite re-epithelialisation (Ito et al., 2005a).  
Subsequent studies have shown that populations of follicular stem cells suggested to arise 
from the hair follicle isthmus and infundibulum are able to contribute more permanently to 
re-epithelialisation following wound healing. It has been demonstrated through lineage 
tracing of Shh-expressing cells that cells distinct from the bulge population contribute to 
wound repair by converting to epidermal stem cells that persist for months following wound 
repair (Levy et al., 2007; Plikus et al., 2012). 
 The influence of the hair follicle cycle on wound healing has been described recently in 
a study that found improved wound healing during anagen phase.  It was found that when 
excisional wounds were made while hair follicles were in anagen, accelerated wound 
closure was observed compared to when wounds were made during catagen or telogen 
phases.  The study revealed that in the anagen wound condition, increased keratinocyte 
proliferation, a reduced immune response, increased angiogenesis and increased collagen 
production was observed.  Subsequent gene expression analyses comparing conditions of 
accelerated wound healing with anagen hair follicle changes found several conserved 
signalling pathways between the conditions (Ansell et al., 2011).  
 The complex mechanisms that underlie both hair follicle cycling and wound healing 
leave much to be elucidated regarding the hair follicle’s influence on wound healing.  As 
more is uncovered regarding each process, new avenues for investigation into the 
relationship between the hair follicle and its environment during times of both homeostasis 
and its disruption are revealed. 
 Clearly, the reciprocal mesenchymal-epidermal interactions uncovered so far highlight 
the overall complexity of hair follicle development and cycling.  As more is elucidated 
regarding the mechanisms driving DP signalling, additional molecular candidates are 
revealed, offering new pathways that warrant exploration. 
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1.4. STAT5 and the Hair Follicle 
1.4.1. STAT5 Signalling 
 Signal transducer and activator of transcription 5 (STAT5) is a general term used to 
describe two highly genetically related proteins, STAT5A and STAT5B, which are coded 
by two distinct genes.  STAT5 is an important transcription factor in many cytokine and 
growth factor signalling pathways that was initially described as a prolactin-induced 
mammary gland factor (Davey et al., 1999; Wakao et al., 1994).  Since then, further 
studies of the role of STAT5 using genetic knockouts have demonstrated an important role 
for the transcription factor in several physiological processes (Davey et al., 1999). 
 STAT5 is primarily implicated in the Janus kinase (JAK)-STAT signalling pathway, 
which begins with the binding of a cytokine to its associated surface receptor, leading to 
dimerisation of the receptor.  The intracellular domain of the dimerised receptor is then 
phosphorylated by cytoplasmic JAK tyrosine kinases, leading to the binding of STAT 
proteins to the receptor complex.  STAT is then phosphorylated and forms dimers with 
other STAT proteins, after which the phosphorylated STAT dimers rapidly translocate to 
the nucleus and bind to DNA sequences to upregulate target gene expression (Aaronson 
and Horvath, 2002; Davey et al., 1999) (see Figure 1.5). 
 Although the JAK-STAT pathway is the predominant mechanism through which 
STAT5 and other STATs in general have been shown to signal, studies have shown that 
STAT5 signalling can occur independent of this pathway.  STAT5 activation may occur 
through phosphorylation by other receptor tyrosine kinases, such as in EGF receptor 
signalling (David et al., 1996).  
 In addition to JAK-STAT signalling and receptor tyrosine kinase activation of STAT5, 
there is evidence demonstrating that STAT5 can be activated by phosphorylation in the 
cytoplasm by cytosolic signalling proteins.  This has been shown in the T cell receptor 
signalling pathway, where STAT5 phosphorylation occurs due to lymphocyte-specific 
protein tyrosine kinase (Welte et al., 1999). 
 The involvement of STAT5A and STAT5B has been shown in a diversity of receptor-
mediated signalling cascades including those of prolactin, growth hormone, various 
interleukins, epidermal growth factor and erythropoietin amongst others (Grimley et al., 
1999).  Subsequently, investigations involving STAT5 gene inactivation has been shown to 
result in a myriad of biological consequences, one of which includes alterations in hair 
follicle cycling (Udy et al., 1997). 
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1.4.2. Implications of STAT5-Mediated Signalling in the Hair Follicle 
 The pituitary hormone prolactin is known to be involved in several biological processes 
in mammals including reproduction, immunity, angiogenesis and hair growth.  Prolactin 
receptors are found in several tissues throughout the body, including epidermal 
keratinocytes of the hair follicle and in the DP (Choy et al., 1997; Foitzik et al., 2006).  
Furthermore, it has been shown in mice that prolactin is expressed in the hair follicle and 
can regulate hair follicle cycling in an autocrine manner (Foitzik et al., 2003).  Prolactin has 
been shown to induce catagen in human scalp hair follicles and therefore be an inhibitor of 
hair growth (Foitzik et al., 2006).  In mice, prolactin has been debated to prolong telogen or 
induce catagen, however it is accepted that it is an inhibitor of hair growth (Craven et al., 
2006; Foitzik et al., 2006).  Prolactin has been shown to signal through the JAK-STAT 
pathway, with the primary mediator of prolactin signalling suggested to be STAT5A or 
STAT5B, depending on the tissue type (Yip et al., 2012).  This suggests a link between 
STAT5 and the hair follicle that has not previously been investigated. 
 Recent research has demonstrated that secretion of interleukin (IL) 6 protein is 
increased in DP cells in response to dihydrotestosterone (DHT).  Through a suggested 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. The JAK-STAT signalling pathway.  JAK-STAT signalling begins with the 
binding of a ligand to its receptor, in this case a cytokine, leading to receptor dimerisation.  
The cytoplasmic domain of the receptor is then phosphorylated by JAK tyrosine kinase, 
leading to the binding of cytoplasmic STAT proteins to the receptor-JAK complex.  STAT is 
then phosphorylated and forms dimers with other STAT proteins, where they are then 
translocated to the nucleus and bind to DNA sequences, upregulating target gene 
expression. [Adapted from (Yasukawa et al., 2003)]. 
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method of paracrine signalling, it was shown that IL-6 acted on hair follicle keratinocytes to 
inhibit matrix cell proliferation and growth of the hair shaft, and consequently induced 
catagen (Kwack et al., 2012a).  IL-6 has been previously demonstrated in vitro to mediate 
its effects via STAT5A in the JAK-STAT pathway, again implicating STAT5 in a further hair 
follicle signalling pathway in keratinocytes (Fujitani et al., 1997). 
 Interestingly, an investigation of STAT5B in growth hormone signalling in mice found 
that as a side effect of ubiquitous STAT5B knockout, an extended telogen period was 
observed in hair follicles.  However, it was not determined whether the observed hair 
phenotype of STAT5B knockout mice was a result of defective growth hormone signalling, 
or occurred due to disruption of another signalling mechanism involving STAT5 (Udy et al., 
1997). 
 In an investigation of hair follicle type specification in mice, microarray analyses of DP 
cells showed that compared to non-DP dermal cells, STAT5A expression was noticeably 
upregulated (Driskell et al., 2009).  Furthermore, microarray analyses to determine the 
genetic signature of hair follicle components found both STAT5A and STAT5B to be part of 
DP gene expression obtained by comparing DP cells to ORS keratinocytes, bulge stem 
cells, melanocytes or dermal fibroblasts (Rendl et al., 2005).  Finally, microarray gene 
expression profiling also showed that Sox2-positive DP cells and SKPs expressed 
STAT5A, and both at similar levels (Biernaskie et al., 2009).  These findings combined 
suggest that STAT5 is an overlooked signalling protein that may play an important role in 
the mesenchymal-epidermal interactions leading to hair follicle regeneration. 
 
1.5. Summary, Hypothesis and Specific Aims 
1.5.1. Summary and Significance 
 It is well established that the DP plays a key role in the induction of hair follicle 
morphogenesis and in the control of hair follicle cycling (Fuchs, 2007).  It is known that this 
occurs as a result of reciprocal signalling between the primitive DP and the overlying 
epidermal cells during embryonic development, and between the DP and stem cells of the 
epidermal hair follicle bulge during mature hair follicle cycling (Fuchs, 2007; Fuchs and 
Horsley, 2008). 
 Several intrinsic and extrinsic mechanisms have been proposed to be involved in hair 
follicle cycling and regeneration, yet much remains to be elucidated.  STAT5 has appeared 
as part of signalling mechanisms within several investigations related to hair follicle cycling 
and as unpredicted side effects of other investigations; however, these investigations have 
not defined whether STAT5 could play an important role in the DP and the mesenchymal-
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epidermal interactions in these cells (Craven et al., 2006; Kwack et al., 2012a; Udy et al., 
1997).  Nevertheless, STAT5 appears at appreciable levels in microarray analyses in 
various investigations, and genetic knockout studies of STAT5 have shown to elicit a hair 
phenotype although its specific role in the DP compared to other skin components is 
unclear (Biernaskie et al., 2009; Driskell et al., 2009; Rendl et al., 2005; Udy et al., 1997). 
 Sox18 has been described as a regulator of hair follicle type specification, with its 
expression associated with the formation of the zigzag hair follicle type (Driskell et al., 
2009; Pennisi et al., 2000a). However, Sox18 has been shown to be expressed at E14.5, a 
time point synonymous with guard and awl/auchene specification (Pennisi et al., 2000b).  
Consequently, the role of Sox18 in the DP requires further investigation. 
 Finally, cell populations within the dermal component of the hair follicle and its 
macroenvironment are shown increasingly to be involved in regulation of the hair cycle. 
The hair follicle has also been shown to contribute to the wound environment, with 
populations from the epidermal component migrating from follicle niches to facilitate wound 
healing (Ito et al., 2005a; Plikus et al., 2012).  Less is known about contributions to 
wounds from the dermal component of the hair follicle, and therefore warrants further 
investigation. 
 
1.5.2. Hypotheses 
 This thesis will address the following hypotheses: 
  
1. STAT5 plays a key role in the dermal papilla’s hair follicle inductive properties and 
its regulation of cycling. 
 
2. Sox18 plays an essential role in dermal papilla development and function in all 
murine hair follicle types. 
 
3. Dermal cell populations associated with the hair follicle contribute to wound healing 
and can be modulated to improve healing outcome. 
 
1.5.3. Specific Aims 
 To investigate the hypotheses described above, the specific aims of this thesis are: 
 
1. To characterise activation of STAT5 in the dermal papilla during hair follicle 
development and cycling. 
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2. To determine the hair inductive properties of SKPs with constitutively-active or 
defective STAT5. 
 
3. To evaluate the effects of conditional in vivo STAT5 deletion in the dermal papilla 
on hair follicle cycling. 
 
4. To determine the role of Sox18 in dermal papilla specification. 
 
5. To evaluate the contribution of cell populations within the hair follicle’s dermal 
macroenvironment to wound healing. 
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Chapter Two 
Materials and Methods 
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2.1. Animals 
 All animal experimentation was approved by The University of Queensland Animal 
Ethics Committee and was conducted according to institutional ethical requirements and 
the Australian Code for the Care and Use of Animals for Scientific Purposes 8th edition. 
 Animal strains that are contained within this thesis are listed in Table 2.1.  Specific 
animal models and breeding strategies are described within the relevant chapters of this 
thesis. 
 
Table 2.1. List of animal strains used throughout this thesis. 
Mouse Strain Abbreviated Strain Name Source 
C57BL/6 C57BL/6 or WT 
University of Queensland 
Biological Resources, QLD, 
Australia 
Col1α2 (-17kb-+54bp 
proα2(1) gene driving firefly 
luciferase and β- 
galactosidase) 
Col1α2-Luc 
Gift from George Bou-
Gharios, UK 
C57BL/6 Tg(CAG-EGFP) CAG-EGFP 
Animal Resources Centre, 
WA, Australia 
B6.CBA-Tg(Topflash) Topflash, Flash 
Developed within the 
laboratory (Hodgson et al., 
2014)  
Sox18RaOp/+ Sox18
+/Op 
Gift from Peter Koopman, 
Institute for Molecular 
Bioscience, QLD, Australia 
Sox18-GFP-IRES-Cre/ERT2 
Sox18GCre/ER, 
Sox18+/GCre 
Gift from Andrew McMahon, 
Harvard University, MA, USA 
BALB/c-Foxn1nu/Arc Nude 
Animal Resources Centre, 
WA, Australia 
B6.ROSA26-lox-STOP-lox-
EYFP 
YFPlox-stop-lox 
Gift from Christelle Adolphe, 
Institute for Molecular 
Bioscience, QLD, Australia 
STAT5A/Bfl/fl STAT5
lox/lox 
Gift from Andrew Brooks, 
Institute for Molecular 
Bioscience, QLD, Australia 
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Sox7-LacZ Knock-In  Sox7-LacZ 
Gift from Nicolas Fossat, 
Sydney University, NSW, 
Australia 
 
2.2. Histological Techniques 
2.2.1. Skin Sample Collection 
 To collect skin samples for histological purposes, mice were humanely sacrificed first 
according to institutional ethical guidelines.  Dorsal hair was removed using electric hair 
clippers, followed by application of Veet® hair removal cream (Reckitt Benckiser, Slough, 
UK).  The hair removal cream was allowed to stand for one minute and was then removed 
using water, and dried with paper towel.  Back skin was dissected and fixed in 4% 
paraformaldehyde (PFA) (Sigma-Aldrich, MO, USA) for two hours at 4oC.  Skin samples 
were then washed three times in PBS (Gibco, NY, USA) before being placed in the 
appropriate solution for frozen or paraffin sectioning. 
 For collection of subcutaneous hair patches from patch assays (described in section 
2.4.1) the aforementioned methods were followed, however, it was not necessary to 
remove dorsal hair prior to dissection and fixation. 
 
2.2.2. Tissue Processing 
 To prepare fixed skin samples for frozen sectioning, following the methods outlined in 
section 2.2.1, skin samples were infused in a solution of 30% sucrose (Sigma-Aldrich, MO, 
USA) overnight at 4oC.  Skin samples were then mounted in optimal cutting temperature 
(OCT) medium (Sakura Finetek USA, CA, USA) contained within cryomoulds.  Samples 
were then frozen rapidly in a dry ice bath with 100% ethanol.  Frozen embedded samples 
were stored at -80oC.  Sections for immunohistochemistry were cut using a Microm® 
HM550 cryostat (Thermo Fisher Scientific Microm International GmbH, Walldorf, Germany) 
at 7μm thickness and mounted on Superfrost™ Plus microscope slides (Thermo Fisher 
Scientific, MA, USA). 
 For paraffin sectioning, skin samples were placed in a solution of 70% ethanol 
following the methods described in section 2.2.1.  Samples then underwent auto-
processing, paraffin wax embedding and sectioning by histology experts at the 
Queensland Institute for Medical Research Histology Facility. 
 To prepare subcutaneous hair patches for whole-mount imaging, fixed samples were 
infused with a 30% sucrose solution (Sigma-Aldrich, MO, USA) overnight after which the 
epidermis was carefully dissected away from the tissue containing the hair patches.  The 
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hair patch sample was then washed in PBS (Gibco, NY, USA) prior to commencing 
staining methods. 
 
2.2.3. Immunohistochemistry: Frozen Sections 
 For immunohistochemistry, frozen sections were rehydrated in PBS (Gibco, NY, USA) 
with 0.1% Tween-20 (Amresco, OH, USA) (PBST) for five minutes.  Sections were then 
permeabilised in a solution of PBS (Gibco, NY, USA) with 0.5% Triton X-100 (Sigma-
Aldrich, MO, USA) for ten minutes. Sections were then washed three times for five minutes 
each in PBST and then blocked in a solution of PBST with 3% bovine serum albumin 
(BSA) (Sigma-Aldrich, MO, USA) and 20% normal goat serum (Vector Laboratories, CA, 
USA) for 20 minutes.  Sections were then washed once for five minutes in PBST before 
being incubated with primary antibody diluted in PBST with 3% BSA (Sigma-Aldrich, MO, 
USA) at the concentration listed in Table 2.2 for two hours at room temperature.  Sections 
were washed again three times for five minutes each in PBST and then incubated with 
secondary antibody diluted in PBST with 3% BSA (Sigma-Aldrich, MO, USA) at the 
concentration listed in Table 2.3 for 40 minutes at room temperature.  Sections were then 
washed twice for five minutes each in PBST, then counterstained for one minute with 4’,6-
diamidino-2-phenylindole (DAPI) (Invitrogen, CA, USA) in PBST (1:10000 dilution of 
1mg/ml stock).  The sections were then washed for a final time in PBST for five minutes, 
and then mounted in fluorescence mounting medium (Dako, Glostrup, Denmark) and 
coverslipped. 
 
Table 2.2. List of primary antibodies and their dilutions used for immunohistochemistry. 
Antibody Company Dilution 
Rabbit anti-GFP Abcam, Cambridge, UK 1:250 
Chicken anti-GFP Invitrogen, CA, USA 1:200 
Rabbit anti-Sox2 Abcam, Cambridge, UK 1:100 
Rat anti-CD133 eBioscience, CA, USA 1:100 
Rabbit anti-αSMA Abcam, Cambridge, UK 1:200 
Rabbit anti-FSP1 Abcam, Cambridge, UK 1:100 
Chicken anti-vimentin Abcam, Cambridge, UK 1:200 
PE Rat anti-SCA1 BD Biosciences, CA, USA 1:100 
Rabbit anti-LYVE1 Abcam, Cambridge, UK 1:100 
Rabbit anti-STAT5 (phospho Y964) Abcam, Cambridge, UK 1:50 
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Rabbit anti-STAT5 Abcam, Cambridge, UK 1:100 
Rabbit anti-SOCS2 Abcam, Cambridge, UK 1:100 
Rabbit anti-Lef1 Cell Signaling Technology, MA, USA 1:200 
Rabbit anti-phospho-STAT3 (Tyr 705) Cell Signaling Technology, MA, USA 1:50 
Goat anti-CD26 R&D Systems, MN, USA 1:100 
Rabbit anti-Dlk Abcam, Cambridge, UK 1:100 
Rabbit anti-Wnt5a Abcam, Cambridge, UK 1:100 
Rat anti-F4/80 AbD Serotec, Kidlington, UK 1:200 
Rabbit anti-Sox9 Santa Cruz Biotechnology, TX, USA 1:100 
Rabbit anti-CD34 Abcam, Cambridge, UK 1:200 
Rabbit anti-Sox17 Abcam, Cambridge, UK 1:100 
Rabbit anti-Nfatc1 Santa Cruz Biotechnology, TX, USA 1:200 
Rabbit anti-AE13 Abcam, Cambridge, UK 1:100 
Rabbit anti-Ki67 Abcam, Cambridge, UK 1:200 
Rat anti-CD31 BD Biosciences, CA, USA 1:50 
Rabbit anti-K14 Biolegend, CA, USA 1:1000 
 
Table 2.3. List of secondary antibodies and their dilutions used for immunohistochemistry. 
Antibody Company Dilution 
Goat anti-rabbit Alexa® 488 Invitrogen, CA, USA 1:500 
Goat anti-rabbit Alexa® 568 Invitrogen, CA, USA 1:500 
Goat anti-chicken Alexa® 568 Invitrogen, CA, USA 1:500 
Goat anti-chicken Alexa® 488 Invitrogen, CA, USA 1:500 
Goat anti-chicken Alexa® 647 Invitrogen, CA, USA 1:500 
Donkey anti-goat Alexa® 488 Invitrogen, CA, USA 1:500 
 
2.2.4. Immunohistochemistry: Paraffin Sections 
 For immunohistochemistry, paraffin sections were de-waxed by washing in xylene 
three times for five minutes each.  Sections were then rehydrated in decreasing 
concentrations of ethanol, commencing with one wash in 100% ethanol for two minutes, 
then two washes in 100% ethanol for one minute, one wash in 90% ethanol for one 
minute, one wash in 70% ethanol for one minute, and a final wash in distilled water for five 
minutes.  Sections were then placed in an antigen retrieval buffer and underwent heat-
induced antigen retrieval in a decloaking chamber (Biocare Medical, CA, USA).  The 
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antigen retrieval conditions used were 15 minutes at 105oC in a solution of 10mM Tris 
(Sigma-Aldrich, MO, USA), 1mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, 
MO, USA) adjusted to pH 9.0; or four minutes at 125oC in a solution of 10mM sodium 
citrate (Sigma-Aldrich, MO, USA) with 0.05% Tween-20 (Amresco, OH, USA) adjusted to 
pH 6.0.  Following antigen retrieval, sections were washed three times in PBST for five 
minutes each, and then blocked in a solution of PBST with 3% BSA (Sigma-Aldrich, MO, 
USA) and 20% normal goat serum (Vector Laboratories, CA, USA) for 40 minutes.  
Sections were then washed once for five minutes in PBST before being incubated with 
primary antibody diluted in PBST with 3% BSA (Sigma-Aldrich, MO, USA) at the 
concentration listed in Table 2.2 for two hours at room temperature.  Sections were 
washed again three times for five minutes each in PBST and then incubated with 
secondary antibody diluted in diluted in PBST with 3% BSA (Sigma-Aldrich, MO, USA) at 
the concentration listed in Table 2.3 for 40 minutes at room temperature.  Sections were 
then washed twice for five minutes each in PBST, then counterstained for one minute with 
DAPI (Invitrogen, CA, USA) in PBST (1:10000 dilution of 1mg/ml stock).  The sections 
were then washed for a final time in PBST for five minutes, and then mounted in 
fluorescence mounting medium (Dako, Glostrup, Denmark) and coverslipped. 
 
2.2.5. Whole Mount Imaging 
 Subcutaneous hair patches were transferred to a solution containing a 1:1000 dilution 
of 1mg/ml stock DAPI (Invitrogen, CA, USA).  Hair patches were incubated overnight at 
4oC, then washed for five minutes in PBST before transferring to a glass bottom microwell 
dish (MatTek, MA, USA) for imaging. 
 
2.2.6. Histological Imaging 
 All images of frozen, paraffin and whole mount samples were captured using the Axio 
Imager M1 epifluorescence and brightfield microscope with AxioVision 4.8 software (both 
Carl Zeiss, Oberkochen, Germany); or the LSM 710 confocal microscope with Zen 2009 
software (Carl Zeiss, Oberkochen, Germany). 
 
2.3. In vitro and Molecular Techniques 
2.3.1. Skin-Derived Precursor Culture 
 SKPs were cultured from the back skin of neonatal mice at P0-P2.  Mice were 
humanely sacrificed and back skin was dissected under sterile conditions.  Dissected back 
skin was sterilised in one wash of Betadine® povidone-iodine solution (Sanofi, Paris, 
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France), one wash in 70% ethanol and three washes with sterile PBS (Gibco, NY, USA).  
Excess adipose tissue was removed and the back skin was placed in 1mg/ml dispase II 
solution (Life Technologies, CA, USA) for one hour at 37oC.  The epidermis and dermis 
were then separated and the dermis was placed in a solution of 1mg/ml collagenase I (Life 
Technologies, CA, USA) and cut into 1mm3 pieces, then incubated at 37oC for 30 minutes.  
The tissue was then triturated by micropipette and the cell suspension was passed through 
a 100μm cell strainer.  The cell suspension was then diluted 1:20 in DMEM containing 
10% fetal bovine serum (FBS) (Gibco, NY, USA) and centrifuged at 100 x g for five 
minutes.  The cell pellet was then discarded and the supernatant was centrifuged at 330 x 
g for five minutes.  The cell pellet after the second centrifugation was resuspended in SKP 
proliferation medium consisting of 40ng/ml FGF2 (Sigma-Aldrich, MO, USA), 20ng/ml EGF 
(Sigma-Aldrich, MO, USA), 2% B27 (Gibco, NY, USA) and 1x antibiotic-antimycotic 
(Gibco, NY, USA) in DMEM/F12 (3:1) (Gibco, NY, USA).  Cells were counted, and then 
seeded at approximately 2 x 105 cells/ml.  Cells were incubated at 37oC with 5% CO2. 
 SKPs were passaged after 2-3 days by centrifuging culture medium at 380 x g for five 
minutes to pellet the floating spheres.  The supernatant was then discarded, and SKPs 
were resuspended in fresh SKP proliferation medium and mechanically dissociated by 
trituration using a micropipette.  The cell suspension was then reseeded in SKP 
proliferation medium at approximately 2 x 105 cells/ml and incubated at 37oC with 5% CO2. 
 
2.3.2. Neonatal Fibroblast Culture 
 Neonatal fibroblasts were cultured from P0-P2 neonate mice.  Mice were humanely 
sacrificed and sterilised in one wash of Betadine® povidone-iodine solution (Sanofi, Paris, 
France), one wash in 70% ethanol and three washes with sterile PBS (Gibco, NY, USA).  
Under sterile conditions, mouse tails were dissected and placed in fibroblast culture 
medium containing 10% FBS (Gibco, NY, USA) and 1x antibiotic-antimycotic (Gibco, NY, 
USA) in DMEM (Gibco, NY, USA).  One tail was placed in one well of a six-well plate 
containing 3ml of culture medium.  Dissected tails were then cut into 1mm3 pieces and 
incubated at 37oC with 5% CO2.  Fibroblasts from tail explants were allowed to proliferate 
to approximately 80% confluence before passaging.   
 To passage neonatal fibroblasts, culture medium and tail explants were removed and 
cells were washed with PBS (Gibco, NY, USA).   Cells were then dissociated 
enzymatically using TrypLE™ Express (Gibco, NY, USA) and once a single cell 
suspension was achieved, enzymatic activity was inhibited with an equal amount of FBS 
(Gibco, NY, USA). The cell suspension was centrifuged at 380 x g for five minutes after 
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which the supernatant was discarded. The cell pellet was resuspended in fibroblast culture 
medium and cells were seeded at approximately 6 x 104 cells/cm2. 
 
2.3.3. Adenovirus Transduction 
 Adenovirus transduction of SKPs was conducted at the time of first passage as 
described in section 2.3.1.  Once SKPs had been re-seeded, adenovirus containing the 
appropriate constructs was added to cell culture media at 1:40 dilution.  This dilution was 
considered optimal in order to minimise the effects of serum contained within the virus 
medium on SKPs.  Cells were incubated for 48 hours as per previously described culture 
conditions, depending on which construct was used.  SKPs were suitable for further 
experimental procedures after this time (see Figure 2.1). 
 For adenoviral transduction of neonatal fibroblasts, cells were allowed to reach 
approximately 90% confluence.  Culture medium was removed and cells gently washed 
with sterile PBS (Gibco, NY, USA).  Fresh pre-warmed fibroblast culture medium was 
replaced into the culture dish and adenovirus containing the appropriate constructs was 
added at 1:40 dilution into the culture medium.  Cells were then incubated for 72 hours 
before proceeding with further experimental procedures. 
 
 
 
 
 
 
 
 
 
 
 
2.3.4. Quantification of Viral Infection 
 Adenoviral constructs used within this thesis include STAT5A constitutively-active (Ad-
STAT5A-CA), STAT5B constitutively-active (Ad-STAT5B-CA), cre-recombinase (Ad-Cre) 
and GFP control (Ad-GFP) constructs.  The Ad-STAT5A-CA, Ad-STAT5B-CA and Ad-GFP 
constructs were gifts kindly provided by Dr. Andrew Brooks (UQ Diamantina Institute, 
Brisbane, Queensland, Australia).  The Ad-Cre construct was a gift kindly provided by Dr. 
Aaron Schindler (Kids Research Institute, Westmead, New South Wales, Australia). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. SKP culture and transduction overview.  Transduced SKPs were prepared 
for experimental procedures by deriving SKPs from neonates first and culturing for 48 
hours.  SKPs were then passaged and transduced with adenoviral constructs.  SKPs were 
incubated for a further 48 hours before being ready for use in further experimentation. 
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 Ad-STAT5A-CA, Ad-STAT5B-CA and Ad-GFP constructs all contained a GFP label 
and therefore viral infection was quantified simply using flow cytometry.  SKPs cultured 
and transduced according to the methods described in sections 2.3.1 and 2.3.4 were 
analysed using flow cytometry (described in section 2.3.6) to determine percentage of cells 
expressing GFP, indicative of infection percentage. 
 The Ad-Cre construct did not contain a fluorescent label, therefore quantification of 
viral infection was conducted by transducing neonatal fibroblasts derived from YFPlox-stop-lox 
mice. Neonatal fibroblasts were collected 72 hours post-transduction and analysed using 
flow cytometry (described in section 2.3.6) to determine percentage of cells expressing 
YFP, indicative of infection and recombination percentage. 
 
2.3.5. Flow Cytometry 
 Cultured SKPs were prepared for analysis using flow cytometry by first collecting 
culture medium and passing it through a 70μm cell strainer.  To collect SKPs, the cell 
strainer was inverted and placed into a sterile culture dish and the membrane was washed 
with a cold solution of sterile PBS (Gibco, NY, USA) containing 0.5% BSA (Sigma-Aldrich, 
MO, USA) and 2mM EDTA (Sigma-Aldrich, MO, USA) (PBS/BSA/EDTA solution).  The cell 
suspension was then centrifuged at 380 x g for five minutes and the resulting cell pellet 
was resuspended in 1mg/ml collagenase I solution (Life Technologies, CA, USA) after 
discarding the supernatant.  The cell suspension was incubated for five minutes at 37oC 
after which enzyme activity was inhibited with an equal volume of FBS (Gibco, NY, USA).  
Cells were then washed twice by centrifuging at 380 x g for five minutes, discarding the 
supernatant and resuspending the cell pellet in PBS/BSA/EDTA solution.  Where staining 
of cell surface markers was required, SKPs were blocked with anti-CD16/CD32 antibody 
(BD Biosciences, NJ, USA) to prevent non-specific Fc binding before being incubated with 
conjugated antibodies at the appropriate concentrations listed in Table 2.4 at 4oC for forty 
minutes.  Following staining, cells were washed again as described previously before 
being analysed. 
 Cultured neonatal fibroblasts were prepared for analysis using flow cytometry by first 
removing culture medium and washing cells gently with sterile PBS (Gibco, NY, USA).  
Cells were then dissociated enzymatically using TrypLE™ Express (Gibco, NY, USA) and 
once a single cell suspension was achieved, enzymatic activity was inhibited with an equal 
amount of FBS (Gibco, NY, USA).  Cells were then washed twice by centrifuging at 380 x 
g for five minutes, discarding the supernatant and resuspending the cell pellet in 
PBS/BSA/EDTA solution before being analysed. 
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 Cells were analysed by flow cytometry using the Gallios™ flow cytometer (Beckman-
Coulter, CA, USA) with Kaluza 1.1 analysis software (Beckman-Coulter, CA, USA). 
 
Table 2.4. List of conjugated antibodies used for analysis by flow cytometry  
 
Antibody Company Dilution 
PE rat anti-mouse CD31 BD Biosciences, NJ, USA 1:200 
PerCP rat anti-mouse CD45 BD Biosciences, NJ, USA 1:100 
APC rat anti-mouse CD29 BD Biosciences, NJ, USA 1:100 
PE rat anti-mouse CD73 BD Biosciences, NJ, USA 1:100 
PE rat anti-mouse CD105 BD Biosciences, NJ, USA 1:400 
 
2.3.6. Immunohistochemistry: Skin-Derived Precursors 
 Cultured SKPs were prepared for immunohistochemistry purposes by first collecting 
culture medium and centrifuging at 100 x g for five minutes.  SKPs were gently 
resuspended in an appropriate volume of DMEM (Gibco, NY, USA) equating to 100μl per 
slide.  SKPs were centrifuged on to Superfrost™ Plus microscope slides (Thermo Fisher 
Scientific, MA, USA) at 1000 RPM for five minutes using the Cytospin 4 (Thermo Fisher 
Scientific, MA, USA).  Cells were then fixed in -20oC methanol for ten minutes immediately 
after centrifuging.  Microscope slides were stored at -20oC and immunohistochemistry was 
performed according to the frozen section methods described in section 2.2.3. 
 Alkaline phosphatase staining of SKPs was performed using a commercial alkaline 
phosphatase kit (Sigma-Aldrich, MO, USA) and the following methods refer to reagents 
contained within that kit. 
 A diazonium salt solution was prepared by dissolving the contents of one fast violet B 
capsule in 48ml of distilled water.  2ml of Napthol AS-MX Phosphate Alkaline solution was 
then added to the diazonium salt solution to create the final staining solution. Microscope 
slides with centrifuged SKPs were immersed in the staining solution for 30 minutes at 
room temperature and protected from light.  Slides were then washed in distilled water for 
two minutes and counterstained with Mayer’s haematoxylin solution for ten minutes.  
Finally, slides were rinsed in tap water for two minutes and imaged using an Eclipse 80i 
digital brightfield microscope with NIS-Elements software (both Nikon Instruments, Tokyo, 
Japan).  
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2.3.7. RNA Extraction 
 RNA was extracted from cultured SKPs using the commercially-available QIAGEN 
RNA Mini Kit (Qiagen, Limburg, Netherlands).  RNA extraction was performed according to 
the manufacturer’s instructions, and the following methods refer to reagents contained 
within the kit. 
 SKPs were collected by centrifuging culture medium at 380 x g for five minutes.  The 
supernatant was carefully aspirated and the cell pellet was resuspended in 350μl of RLT 
buffer with added β-mercaptoethanol (Sigma-Aldrich, MO, USA).  The cell pellet was then 
homogenised by trituration using a P1000 micropipette.  350μl of 70% ethanol was added 
to the cell suspension in order to precipitate RNA, and the sample was placed in to the 
provided column.  The column was centrifuged at 17000 x g for 15 seconds and the flow 
through solution was discarded.  DNA digestion was then performed by incubating the 
column membrane with 10μl DNase I and 70μl of RDD buffer for 15 minutes at room 
temperature.  On completion of DNA digestion, 350μl of RW1 buffer was added to the 
column and the sample was centrifuged at 17000 x g for 15 seconds, after which the flow 
through solution was discarded.  500μl of RPE buffer was then added to the column 
membrane and the samples were centrifuged at 17000 x g for 15 seconds.  Again, the flow 
through solution was discarded and the samples were centrifuged once more at 17000 x g 
for two minutes after adding 500μl of RPE buffer to the column membrane.  Following this 
step, RNA was eluted by adding 50μl of DNase/RNase free water to the column 
membrane and centrifuging at 17000 x g for one minute.  Quantity of RNA was determined 
using the NanoDrop ND-1000 and its associated software (Thermo Fisher Scientific, MA, 
USA). 
 
2.3.8. cDNA Synthesis 
 cDNA was synthesised from RNA extracted from SKPs.  2μg of RNA was incubated 
with 2μl of oligoDT (Life Technologies, CA, USA) and 2μl of 10mM dNTPs (Life 
Technologies, CA, USA) made up to a final volume of 26μl with DNase/RNase-free 
UltraPure distilled water (Life Technologies, MA, USA). The solution was incubated at 
65oC for five minutes in a Tetrad® 2 thermal cycler (Bio-Rad Laboratories, CA, USA), then 
cooled on ice for five minutes.  The solution was divided into two tubes, with one serving 
as a negative control.  A master mix was made according to Table 2.5 and 7μl was placed 
into each tube, to make a final volume of 20μl per tube.  Reverse transcription was then 
performed by placing tubes in a Tetrad® 2 thermal cycler (Bio-Rad Laboratories, CA, USA) 
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and cycling at 25oC for five minutes, 50oC for one hour and 72oC for 15 minutes, after 
which the solutions were cooled to 4oC. 
 
 Table 2.5. Reverse transcriptase master mix for cDNA synthesis. 
 
Component Company Per Reaction (μl) 
5x First Strand Buffer Life Technologies, MA, USA 4 
0.1M DTT Life Technologies, MA, USA 2 
SuperScript III  
(for reverse transcription reaction) 
Life Technologies, MA, USA 1 
DNase/RNase-Free  
UltraPure distilled water  
(for negative control reaction) 
Life Technologies, MA, USA 1 
 
2.3.9. qPCR 
 Quantitative polymerase chain reaction (qPCR) assays were performed on cDNA that 
had been synthesised from SKP RNA.  Assays were performed using SYBR® Green 
(Applied Biosystems, CA, USA) according to the manufacturer’s instructions. All qPCR 
assays were prepared in 96-well plates with a final volume of 20μl/well, prepared as per 
Table 2.6.  qPCR amplification and detection was performed in a StepOnePlus™ real-time 
PCR system with StepOne 2.1 software (both Applied Biosystems, CA, USA).  Cycling 
conditions were as follows: 95oC for ten minutes; 40 cycles of 95oC for 15 seconds and 
60oC for one minute; and 25oC for two minutes. 
 Analyses of qPCR results were calculated by comparing ΔCT values for the sequence 
of interest against values for the HPRT reference sequence. 
  
Table 2.6. General qPCR assay components per well. 
 
Component Per Reaction (μl) 
10x SYBR® Green 10 
Forward and Reverse Primer Mix 
(at optimised concentrations) 
4 
DNase/RNase-Free  
UltraPure distilled water  
(for negative control reaction) 
2 
cDNA template 4 
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2.3.10. Plasmid Transfection 
For plasmid transfection of SKPs, the electroporation method was utilised.  Firstly, 
SKPs were collected by centrifuging culture medium at 380 x g for five minutes.  SKPs 
were resuspended in DMEM (Gibco, NY, USA) at a density of 1 x 106 cells per 100μl.  For 
electroporation, 2μg of plasmid DNA was added to 100μl of SKP cell suspension and the 
suspension was transferred to sterile electroporation cuvettes (Lonza, Basel, Switzerland). 
The cuvettes were then inserted into the Amaxa™ Nucleofector™ II device (Lonza, Basel, 
Switzerland) and electroporated according to program A-033.  500μl of SKP proliferation 
medium was added to the cuvette immediately following electroporation, and the cell 
suspension was transferred to one well of a six-well plate containing SKP proliferation 
medium to a final volume of 3ml.  Transfected SKPs were incubated for 48 hours at 37oC 
with 5% CO2 before further experimentation. 
 
2.3.11. Luciferase Assay 
Luciferase assays were performed using a commercially-available luciferase assay kit 
(Promega Corporation, WI, USA) according to the manufacturer’s instructions. The 
following methods refer to reagents contained within the kit. 
Luciferase assay reagent was prepared by combining luciferase assay buffer with 
lyophilised luciferase assay substrate.  SKPs transfected with a lactogenic hormone 
responsive element driving luciferase reporter plasmid (LHRE-Luc) were collected by 
centrifuging culture medium at 380 x g for five minutes.  The supernatant was discarded 
and SKPs were washed by resuspending the cell pellet in PBS (Gibco, NY, USA).  Again, 
SKPs were centrifuged at 380 x g for five minutes, after which the supernatant was 
carefully aspirated.  The cell pellet was then resuspended in 200μl of 1x cell culture lysis 
reagent to form a cell lysate.  Immediately prior to analysis, 20μl of cell lysate was 
combined with 100μl of luciferase assay reagent and placed into one well of a 96-well 
plate.  Luminescence of assay samples was quantified using the Paradigm® multi-mode 
microplate reader (Beckman Coulter, CA, USA). 
 
2.3.12. Microarray Analysis 
RNA samples for RNA microarray gene expression analyses were prepared according 
to the methods described in section 2.3.8.  RNA quality was assessed using the Agilent 
2100 Bioanalyzer (Agilent Technologies, CA, USA).  RNA microarray analyses were 
conducted by colleagues at the Translational Research Institute, Woolloongabba, 
Queensland, Australia.   
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Microarray data was interpreted using the Ingenuity Pathway Analysis platform 
(Qiagen, Limburg, Netherlands).  
 
2.4. In vivo Techniques 
2.4.1. Patch Assay Experiments 
 “Patch assay” hair regeneration experiments were performed in female Nude mice 
aged between 8 and 12 weeks. Firstly, a dermal/epidermal cell mixture was obtained by 
humanely sacrificing P0-P2 neonatal C57BL/6 mice and dissecting the back skin.  
Dissected back skin was sterilised in one wash of Betadine® povidone-iodine solution 
(Sanofi, Paris, France), one wash in 70% ethanol and three washes with sterile PBS 
(Gibco, NY, USA).  Excess adipose tissue was removed and the back skin was placed in 
1mg/ml dispase II solution (Life Technologies, CA, USA) for one hour at 37oC.  The 
epidermis and dermis were then separated and the dermis was placed in a solution of 
1mg/ml collagenase I (Life Technologies, CA, USA) and cut into 1mm3 pieces, then 
incubated at 37oC for 30 minutes.  The tissue was then triturated by micropipette and the 
cell suspension was passed through a 100μm cell strainer.  The cell suspension was then 
diluted 1:20 in DMEM containing 10% FBS (Gibco, NY, USA) and centrifuged at 380 x g 
for five minutes.  The resulting cell pellet was resuspended in DMEM/F12 (3:1) (Gibco, NY, 
USA). Using this method, it was found that 33.2%±4% (mean±SD, n=6) of the cells 
obtained were epidermal cells, as evidenced by positive K14 staining (see Figure 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Keratin 14 staining of unsorted dermal cell mixture. Isolation of cells from 
back skin of neonatal mice shows that when the epidermis is removed, K14+ keratinocytes 
(K14 in red, DAPI in blue) can still be found after dissociation of the dermis.  Therefore, cells 
isolated in this way are not pure dermal cells, but an epidermal/dermal cell mix with 
approximately 33% keratinocytes. Scale bar = 100μm.  
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 Next, SKPs were collected by centrifuging culture medium at 380 x g for five minutes.  
The supernatant was discarded and the resulting cell pellet was resuspended in 
DMEM/F12 (3:1) (Gibco, NY, USA).  Cells were counted and divided into mixtures 
containing 1 x 106 dermal/epidermal cells and 1 x 106 SKPs for each patch, centrifuged at 
380 x g for five minutes and resuspended in DMEM/F12 (3:1) (Gibco, NY, USA) to a final 
volume of 100μl. 
 Finally, cell mixtures were injected subcutaneously into the back skin of Nude mice 
using a 25 gauge x 3/4” needle and 1ml syringe.  Four to six mixtures were injected per 
mice at even spacing, depending on the final cell number obtained from culture.  Mice 
were humanely sacrifice following a ten-day period and patches of hair that had formed 
within the hypodermis were collected for analysis as described in sections 2.2.1 and 2.2.2 
(see Figure 2.3).  
 
 
 
 
 
 
 
 
 
 
 
2.4.2. Induction of Recombination 
Specific details of cre-lox conditional knockout models and their associated breeding 
strategies can be found within the appropriate chapters of this thesis.  To induce 
recombination in experimental groups of animals, intraperitoneal injections of tamoxifen 
(Sigma-Aldrich, MO, USA) were administered to mice at birth or at three weeks of age.  
Neonates were administered a single dose of 1mg tamoxifen intraperitoneally at P0, 
whereas mice at three weeks of age were administered 1mg tamoxifen per day for four 
days at P21. 
 
2.4.3. In vivo Pharmacological Experiments 
For experiments examining the effects of pharmacological inhibition of STAT5, six-
week old Topflash mice in the telogen phase of the hair cycle were used.  Under 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Patch assay experiment overview.  Cultured SKPs and a freshly isolated 
epidermal/dermal cell mixture were combined and injected into the subcutaneous tissue of 
Nude mouse back skin.  Following a 10 day period, patches of hair that had formed within 
the hypodermis were collected. 
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isofluorane anaesthesia, dorsal hair was removed using electric hair clippers, followed by 
application of Veet® hair removal cream (Reckitt Benckiser, Slough, UK).  The hair 
removal cream was allowed to stand for one minute and was then removed using water, 
and dried with paper towel. 
Mice were injected with 1mg of ruxolitinib (ChemieTek, IN, USA) intraperitoneally or a 
vehicle control each day for ten days.  Mice were imaged at specific time points using the 
Xenogen IVIS® Spectrum bioluminescence imaging system (PerkinElmer, MA, USA) as 
described in section 2.4.4. 
 
2.4.4. In vivo Bioluminescence Imaging 
In vivo bioluminescence imaging was conducted using the Xenogen IVIS® Spectrum 
bioluminescence imaging system (PerkinElmer, MA, USA) and Living Image® 3.2 software 
(Caliper Life Sciences, MA, USA). 
To prepare animals for imaging, dorsal hair was removed under isofluorane 
anaesthesia using electric hair clippers, followed by application of Veet® hair removal 
cream (Reckitt Benckiser, Slough, UK).  The hair removal cream was allowed to stand for 
one minute and was then removed using water, and dried with paper towel. 
To image, mice were anaesthetised using isofluorane and injected intraperitoneally 
with 150mg/kg of firefly D-luciferin substrate (Regis Technologies, IL, USA). Mice were 
then placed dorsal side up in the Xenogen system and images were acquired.  Image 
acquisition parameters were as described in Table 2.7 and refer to settings available on 
the Living Image software. 
 
Table 2.7. In vivo bioluminescence imaging parameters. 
 Photograph Luminescence Image 
Exposure N/A 15 seconds 
F/Stop 8 4 
Binning Small Small 
Field of View C (for 3 mice or less/image) 
D (for 4 mice/image) 
C (for 3 mice or less/image) 
D (for 4 mice/image) 
  
2.4.5. Dorsal Excisional Wounds 
To prepare animals for wounding, dorsal hair was removed under isofluorane 
anaesthesia using electric hair clippers, followed by application of Veet® hair removal 
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cream (Reckitt Benckiser, Slough, UK).  The hair removal cream was allowed to stand for 
one minute and was then removed using water, and dried with paper towel. 
Under isofluorane anaesthesia, mouse back skin was sterilised with Betadine® 
povidone-iodine solution (Sanofi, Paris, France) and a single 1cm2 or four 6mm diameter 
circular excisional wounds were made. 1cm2 wounds were dissected using forceps and 
scissors, whereas 6mm wounds were made using a sterile punch biopsy tool (Stiefel 
Laboratories, NC, USA).  All wounds were full skin thickness, extending down to the 
panniculus carnosus muscle.  All skin wounds were left open and mice were humanely 
sacrificed at predetermined time points following wounding. 
  
2.4.6. Skin Wound Analyses 
Skin wounds were analysed using the Xenogen IVIS® Spectrum bioluminescence 
imaging system (PerkinElmer, MA, USA) and Living Image® 3.2 software (Caliper Life 
Sciences, MA, USA).  Where a luciferase reporter was present, bioluminescence imaging 
was conducted according to the methods in section 2.4.4.  Otherwise, mice were 
anaesthetised using isofluorane and placed dorsal side up in the Xenogen system, after 
which an image was captured using the photograph-only function of the imaging system.  
Wound images were analysed using ImageJ 1.44p software (Rasband, W.S, National 
Institute of Health, MD, USA). 
 
2.5. Statistical Analyses 
All statistical analyses were performed using GraphPad Prism® v6 (GraphPad 
Software, CA, USA).  Non-parametric data was analysed using Mann-Whitney tests, 
whereas T-tests (paired and unpaired), one-way analysis of variance (ANOVA) and two-
way ANOVA were used for parametric data.  Categorical comparisons were conducted 
using Fisher-Exact tests.  Statistical significance was accepted when a p-value of less than 
0.05 was obtained. 
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Chapter Three 
Maximal STAT5 Activation in the Dermal Papilla Is Associated 
with the Transition from the Resting to the Growth Phase of the 
Hair Follicle 
 
This chapter consists of one first author manuscript prepared for submission 
by the PhD candidate 
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3.1. Rationale 
It is known that hair follicle development and cycling involves complex interactions 
between the mesenchymal dermal papilla and the overlying epidermis. The signalling 
pathways involved are complex and not well understood, and there is evidence to suggest 
that STAT5 plays an important role in hair follicle biology, especially in the dermal papilla. 
In order to elucidate the role of STAT5 activation during hair follicle development and 
cycling, it is necessary to begin by determining when STAT5 is active in the dermal papilla 
in vivo. 
Hair regeneration assays have been performed in previous studies in order to 
investigate signalling pathways involved during hair follicle development and cycling. Skin-
derived precursors (SKPs) have successfully been shown to act as a dermal papilla 
substitute, capable of reintegrating into the dermal papilla of existing hair follicles, and 
inducing new hair follicle growth during hair regeneration assays. To elucidate the role of 
dermal STAT5 activity in hair follicle signalling, hair regeneration assays can be performed 
using SKPs with modulated STAT5 activity. 
 
3.2. Abstract 
The dermal papilla (DP) is central to the regulation of hair follicle development and 
cycling; however, the signalling pathways involved are complex and incompletely 
understood. Expression analyses of the DP and STAT5 knockout studies suggest STAT5 
may play an important role in the regulation of hair follicle cycling by the DP.  We aimed to 
investigate STAT5 activation within the DP during hair follicle development and cycling.  
STAT5 activation in the DP was characterised through immunofluorescence staining of 
mouse back skin at various stages of hair follicle development and cycling.  Back skin was 
obtained from Topflash transgenic Wnt reporter mice to monitor hair cycling through 
bioluminescence. Although absent during embryonic and postnatal hair development, we 
found phospho-STAT5 activation occurring in the DP during telogen in the first hair cycle, 
while beginning in late catagen and persisting until anagen in adult skin.  STAT5 activity 
was found to increase throughout telogen and be maximal at early anagen before 
disappearing for the rest of the cycle. Hair regeneration assays using SKPs transduced 
with constitutively-active STAT5 adenovirus constructs were significantly better at forming 
DP than control SKPs transduced with GFP alone.  Wnt, FGF and Notch signalling genes 
were found to be downregulated in STAT5-/- SKPs compared to control, suggesting STAT5 
activation plays a role in mediating well-known anagen signalling pathways.  We conclude 
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that STAT5 activation may act as a mesenchymal switch to improve hair inductive 
potential and induce natural anagen entry following the first hair follicle cycle. 
 
3.3. Introduction 
The hair follicle is an important skin appendage that arises from complex interactions 
between the epidermis and mesenchyme during embryonic development.  Postnatally, the 
hair follicle has the remarkable ability to regenerate itself throughout adult life, cycling 
through phases of growth, regression and rest known as anagen, catagen and telogen, 
respectively (Fuchs, 2007).  This continual process of hair follicle cycling is enabled by a 
population of multipotent stem cells residing in the hair follicle bulge, and is regulated 
primarily through signalling by the dermal papilla (DP), the mesenchymal component of 
hair follicles (Fuchs et al., 2001).  
Several signalling pathways have been implicated within each stage of both the 
developing and adult cycling hair follicle, with the importance of Wnt/β-catenin, BMP and 
hedgehog signalling being well-described in the epidermal layers of the hair follicle (Fuchs 
et al., 2001; Millar, 2002).  Furthermore, studies have demonstrated the importance of 
Sox2 and Sox18 in DP specification (Driskell et al., 2009; Pennisi et al., 2000a). However, 
much remains to be elucidated regarding the molecular mechanisms at play in the DP 
driving transitions between hair cycle phases.  RNA expression analyses of DP cells have 
identified subsets of genes that are differentially expressed and upregulated in the DP 
(Biernaskie et al., 2009; Driskell et al., 2009; Rendl et al., 2005). Amongst these genes, 
signal transducer and activator of transcription (STAT5) A and STAT5B have been shown 
to be specifically upregulated within the DP. 
An important transcription factor in many cytokine and growth factor signalling 
pathways, STAT5 is primarily implicated in the JAK-STAT signalling pathway (Aaronson 
and Horvath, 2002). The role of STAT5A or STAT5B have not been investigated in detail 
within the context of the hair follicle, however an earlier study investigating STAT5B in 
growth hormone signalling demonstrated a hair cycle phenotype in  
STAT5B-/-  mice (Udy et al., 1997).  The study found a significant delay in anagen entry 
following the initial period of postnatal hair follicle development; however, this finding was 
not investigated further.  This implicates further the role of STAT5 in hair follicle cycling 
and therefore warrants additional investigation. 
Our study sought to elucidate the role of STAT5 in hair follicle development and 
cycling.  We achieved this by characterising the activation of STAT5 in the DP during hair 
follicle development and cycling.  We also performed hair follicle regeneration assays 
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using DP-derived cells with STAT5 activity modified through adenovirus constructs.  Our 
findings suggest a previously undescribed role of STAT5 in the control of hair follicle 
cycling by the DP. 
 
3.4. Materials and Methods 
3.4.1. Skin Sample Collection 
All murine work within this study was performed according to institutional ethical 
requirements.  Samples of embryonic mouse back skin at E14.5, E16.5 and E18.5 were 
collected from time-mated C57BL/6J mice.  Postnatal skin was collected from Topflash 
reporter mice developed in our laboratory as previously described (Hodgson et al., 2014).  
Skin samples for postnatal hair follicle developmental time points were collected at P1, P4, 
P19, P24 and hair follicle stage was confirmed histologically using criteria described in a 
previous study (Paus et al., 1999).  For adult skin samples, hair follicle phase was 
determined using luminescence as previously described (Hodgson et al., 2014).  Briefly, 
mice were injected intraperitoneally with 150mg/kg firefly D-luciferin (Regis Technologies, 
IL, USA) and imaged using the Xenogen IVIS Spectrum live animal imaging system 
(Perkin Elmer, MA, USA).  Image analysis was performed using Living Image® 3.2 
software (Perkin Elmer, MA, USA).  Using this method, sections of back skin were 
obtained containing hair follicles in refractory and competent telogen, early and late 
catagen and early and late anagen. Again, hair follicle phase was confirmed histologically 
using previously described criteria (Muller-Rover et al., 2001).  Early catagen was defined 
as catagen I-IV; late catagen was defined as catagen V-VIII; early anagen was defined as 
anagen I-III; and late anagen was defined as anagen IV-VI. 
 
3.4.2. Immunofluorescence 
All immunofluorescence staining was performed on 4% paraformaldehyde fixed 
paraffin-embedded skin sections of 5-7μm thickness.  Staining for phospho-STAT5, 
STAT5 and SOCS2 was performed following standard dewaxing, rehydration and heat-
induced epitope retrieval methods.  Sections were incubated in blocking solution 
composed of 20% normal goat serum, 3% bovine serum albumin (BSA), 0.1% Tween-20 
in PBS for 40 minutes.  Sections were washed with 0.1% Tween-20 in PBS then incubated 
with primary antibody for two hours at room temperature.  Antibodies were used at 1:50 
(rabbit anti-STAT5 (phospho Y694), Abcam), 1:100 (rabbit anti-STAT5, Abcam) and 1:100 
(rabbit anti-SOCS2, Abcam) diluted in PBS containing 3% BSA and 0.1% Tween-20.  
Sections were washed again and then incubated with secondary antibody for 40 minutes 
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at room temperature.  Secondary antibodies were used at 1:500 dilution (goat anti-rabbit 
Alexa 488 or goat anti-rabbit Alexa 568, Invitrogen) in PBS containing 3% BSA and 0.1% 
Tween-20.  Sections were then washed again, counterstained with DAPI (1:10000 dilution 
of 14.3μM stock solution in PBS, Invitrogen) and mounted.  All images were acquired 
using either the Zeiss LSM 710 confocal microscope and Zen 2009 software (Carl Zeiss, 
Oberkochen, Germany), or Axio Imager M1 fluorescence microscope and AxioVision 4.8 
software (Carl Zeiss, Oberkochen, Germany). 
 
3.4.3. Cell Culture and Viral Transduction 
SKPs were cultured from neonatal C57BL/6 or STAT5lox/lox mice as described 
previously (Biernaskie et al., 2006) and plated in six-well plates.  STAT5A-CA, STAT5B-
CA and GFP adenoviral constructs kindly developed and provided by Dr. Andrew Brooks 
(UQ Diamantina Institute, Woolloongabba, Queensland, Australia) were added at 1:40 
dilution in each well containing C57BL/6 SKPs in 3ml culture medium.  The cre-
recombinase adenoviral construct (Marks et al., 2003; Zha et al., 2008) was kindly 
provided by Dr. Aaron Schindler (Kids Research Institute, Westmead, New South Wales, 
Australia) and was added along with the aforementioned GFP construct at 1:40 dilution in 
each well containing STAT5lox/lox SKPs in 3ml culture medium.  Viral constructs were 
allowed to incubate for 48 hours at 37oC and 5% CO2 before proceeding with further 
experiments. 
 
3.4.4. Quantification of Viral Infection 
Quantification of viral infection for STAT5A-CA, STAT5B-CA and GFP constructs was 
determined firstly by dissociating transduced SKPs in 1mg/ml collagenase I (Gibco, NY, 
USA).  Dissociated SKPs were then analysed with a Gallios™ flow cytometer and Kaluza 
1.1 software (Beckman-Coulter, CA, USA) to determine the percentage of cells expressing 
GFP.  Quantification of viral infection for the cre-recombinase construct was determined by 
infecting dermal fibroblasts cultured from neonatal B6.ROSA26-lox-STOP-lox-EYFP 
mouse back skin explants.  Fibroblasts were cultured in DMEM with 10% fetal bovine 
serum (Gibco, NY, USA) at 37oC and 5% CO2. Cre-recombinase adenoviral construct was 
added to culture medium at 1:40 dilution and cells were harvested with TrypLE Express 
(Gibco, NY, USA) after 48 hours.  B6.ROSA26-lox-STOP-lox-EYFP fibroblasts were again 
analysed with a Gallios™ flow cytometer and Kaluza 1.1 software (Beckman-Coulter, CA, 
USA) to determine the percentage of cells expressing YFP. 
 
49 
 
3.4.5. In vitro Luciferase Assay 
SKPs transduced with STAT5A-CA, STAT5B-CA and GFP constructs were 
transfected with an LHRE driving luciferase plasmid construct using the Amaxa 
Nucleofector™ II system (Lonza, Basel, Switzerland).  1x106 SKPs were transfected using 
2μg of plasmid and allowed to incubate for 48 hours post-transfection.  Quantification of 
luciferase activity was then determined using a commercial luciferase assay kit (Promega 
Corporation, WI, USA) and Paradigm plate reader (Beckman Coulter, CA, USA). 
 
3.4.6. Hair Regeneration Assays 
Patch assay experiments were performed in female Nude mice between 8 and 12 
weeks of age.  Using a 25 gauge x 3/4” needle, a combination of 1x106 transduced SKPs 
and 1x106 freshly isolated epidermal and dermal cell mixture suspended in 100μL 
DMEM:F12 (3:1) (Gibco, NY, USA) was injected subcutaneously into the back skin.  The 
epidermal and dermal cell mixture was isolated from the back skin of either C57BL/6 or 
STAT5lox/lox neonates by digesting the skin for one hour in 1mg/ml dispase II (Sigma-
Aldrich, MO, USA) at 37oC and then 30 minutes in 1mg/ml collagenase I (Gibco, NY, USA) 
at 37oC.  The epidermal and dermal cell mixture used in the patch assay was matched to 
the mouse strain that SKPs were derived from.  Mice were sacrificed following a ten-day 
period and patches of hair that had formed within the hypodermis were collected for 
analysis. 
 
3.4.7. Whole Mount Imaging 
Patches of hair collected from patch assay experiments were fixed in 4% 
paraformaldehyde for two hours at room temperature and then incubated overnight at 4oC 
in a solution of DAPI (14.3μM stock solution) (Invitrogen, CA, USA) diluted in PBS at 
1:1000.  Excess adipose tissue was removed from the fixed samples, after which the 
samples were placed on microscope slides.  Whole mount images of hair patches were 
taken using the Zeiss LSM 710 confocal microscope and Zen 2009 software (Carl Zeiss, 
Oberkochen, USA).  The number of GFP-positive DP present within each patch was 
quantified. 
 
3.4.8. Microarray 
Microarray experiments were performed on n=6 control and n=6 STAT5-/- SKP 
samples. Biotin labeled cRNA was produced using Illumina® TotalPrep™ RNA 
Amplification (Life Technologies, CA, USA) as per the manufacturer’s instructions. 50ng of 
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starting total RNA was used and a 14 hour IVT reaction. cRNA samples were hybridised to 
Sentrix Illumina_MouseWG-6 v2.0 Expression BeadChip overnight for 18 hours at 58oC 
then scanned on a BeadStation 500 System using Beadscan software v3.5.31 (Illumina, 
CA, USA). Raw data was then imported into GenomeStudio v2010.2 (Illumina, CA, USA) 
for bead summarization and quality control assessment. For data analysis, raw probe 
intensity data were imported into GeneSpring GX 11 (Agilent Technologies, CA, USA) and 
subsequent normalisation and significance analysis to identify differentially expressed 
probes were performed.  Microarray data was interpreted further using the Ingenuity 
Pathway Analysis platform (Qiagen, Limburg, Netherlands).  
 
3.4.9. Data Analysis 
Phospho-STAT5 staining intensity was quantified using ImageJ 1.44p software 
(Rasband, W.S, National Institute of Health, MD, USA).  All images of simultaneously 
stained samples were captured at the same exposure using the Axio Imager M1 
fluorescence microscope and AxioVision 4.8 software (Carl Zeiss, Oberkochen, Germany). 
For each captured image, the threshold value of colour intensity (between 0-255) at which 
stained DP cells could be clearly distinguished from the background was determined.  This 
value was then calculated as a percentage of the maximum threshold value of 255.  All 
statistical analyses were performed using GraphPad Prism v6 software (GraphPad 
Software, CA, USA).  Non-parametric data was analysed using Mann-Whitney tests and 
statistical significance was accepted at a p-value less than 0.05. 
 
3.5. Results 
3.5.1. Dermal Papilla STAT5 Presence and Activation Begins during the Final Stages of 
Hair Follicle Development 
Given the description of STAT5 gene expression specifically in the DP, we first sought 
to show its activation using antibodies against the phosphorylated active form of STAT5 at 
this position. Through immunostaining of skin sections, we found phospho-STAT5 (P-
STAT5) restricted to the nuclei of DP cells and not elsewhere in the hair follicle (see Figure 
3.1 A).  We therefore undertook a more systematic approach to identify the timing of 
expression and activation of STAT5 genes. We collected samples of skin at various stages 
of hair follicle development between E14.5 and P24.  Postnatal hair follicle phase was 
determined in vivo using Topflash β-catenin reporter mice developed in our laboratory, and 
confirmed histologically using criteria described in a previous study (Hodgson et al., 2014; 
Paus et al., 1999).  The presence of P-STAT5 in the DP could only be detected from the 
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first catagen phase at P19 and was most prominent during the first telogen phase at P24. 
No P-STAT5 could be detected within the DP or other regions of the hair follicle at the 
earlier time point samples of E14.5, E16.5, E18.5, P1 and P4 (see Figure 3.1 C).   
We next sought to determine whether total STAT5 (both phosphorylated and non-
phosphorylated forms) was present within the DP of developing hair follicles, but only 
became active through phosphorylation from P19.  Immunostaining revealed that STAT5 
was only present at P19 and P24 and was restricted to the DP (see Figure 3.1 A and B).  
Staining was observed to be less intense at P19 compared to P24, however in contrast to 
P-STAT5, staining appeared to be cytoplasmic as opposed to nuclear (see Figure 3.1 A).  
No cytoplasmic or nuclear STAT5 staining could be detected at earlier time points, 
suggesting that STAT5 was only being expressed at the protein level and activated at the 
late stages of hair follicle development immediately before the first hair follicle cycle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.2. Cyclic Activation of STAT5 in the Hair Follicle Dermal Papilla 
Following completion of hair follicle development and the first catagen and telogen 
phases, the mature hair follicle begins a new anagen phase from approximately P25 
(Hodgson et al., 2014).  Following characterisation of STAT5 activation during 
development, we sought to investigate STAT5 activation in the DP of adult cycling hair 
follicles.  We used Topflash mice to track molecularly defined phases of the hair follicle 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Expression and activation of STAT5 during the first hair follicle cycle.  A) 
Immunofluorescence detection of total STAT5 (red, top panels) and phospho-STAT5 (P-
STAT5) (green, bottom panels) in the dermal papilla during hair follicle embryonic and 
postnatal development. Both P-STAT5 and total STAT5 are only detected from P19 and 
immunofluorescence becomes most prominent at P24. Dotted lines demarcate the dermal 
papilla. Scale bar = 20μm. B) P-STAT5 immunofluorescence showing detection only in the 
DP and not elsewhere in the hair follicle. Is: Isthmus; Bu: Bulge; SG: Sebaceous gland; HG: 
Hair germ.  Dotted lines demarcate the dermal papilla. Scale bar = 20μm. C) Quantification 
of P-STAT5-positive dermal papilla at selected time points during hair follicle development.  
The time points are representative of embryonic hair follicle development (E14.5, E16.5, 
E18.5), the initial postnatal growth phase (P1, P4), and the early (P19) and late (P24) 
stages of the first telogen phase. Mean+SD, n=3. 
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cycle and confirmed this histologically using a study describing adult hair follicle 
morphology (Muller-Rover et al., 2001).  Analogous to the observations in hair follicle 
development, we found P-STAT5 restricted to the DP of adult cycling hair follicles within 
specific phases.  P-STAT5-positive nuclei were observed in the DP of hair follicles 
beginning in late catagen through to early anagen phase (see Figure 3.2 A-B).  No P-
STAT5 was detectable in the DP of mid-late anagen and early catagen hair follicles (see 
Figure 3.2 A).  Quantification of staining intensity revealed that P-STAT5 staining was 
most intense during competent telogen and early anagen (see Figure 3.3 A). 
As conducted in the first hair follicle cycle, the presence of total STAT5 was examined 
in adult hair follicle DP.  Similar to the aforementioned results, total STAT5 was only found 
within the DP at phases corresponding to the presence of P-STAT5, and was again found 
to be cytoplasmic (see Figure 3.2 A). 
Suppressor of cytokine signaling 2 (SOCS2) is a negative regulator of the JAK-STAT 
signalling pathway and is known to be a downstream transcriptional target of activated 
STAT5A and STAT5B (Davey et al., 1999; Sen et al., 2012).  To determine if the STAT5 
activation we observed in the DP was eliciting downstream effects typical of the JAK-STAT 
signalling pathway, we looked for the presence of SOCS2 in the DP of hair follicles.  We 
examined adult cycling hair follicles and although SOCS2 was present in other areas of 
the skin, we found SOCS2-positive nuclei within the DP only during competent telogen and 
early anagen (see Figure 3.3 B).  This finding reflected the phases of the hair follicle cycle 
that showed the most intense P-STAT5 staining (see Figure 3.3 C).  SOCS2-positive 
nuclei were not detectable in the DP at any other time point examined. 
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Figure 3.2. Expression and activation of STAT5 during the adult hair follicle cycle. A) 
Immunofluorescence of total STAT5 (red, top rows) and phospho-STAT5 (P-STAT5) (green, 
bottom rows) in the dermal papilla during adult hair follicle cycling.  Both total and P-STAT5 
is detected from late catagen through to early anagen. Dotted lines demarcate the dermal 
papilla. Scale bar = 20μm. B) Quantification of P-STAT5-positive dermal papilla during each 
phase of the adult hair follicle cycle. Mean+SD, n=3. 
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Figure 3.3. Intensity of phospho-STAT5 during the adult hair follicle cycle and 
activation of downstream targets.  A) Quantification of phospho-STAT5 (P-STAT5) 
staining intensity within the dermal papilla during each phase of the adult hair follicle cycle. 
Mean±SD, n=4. B) Immunofluorescence of SOCS2 (green) in the dermal papilla during 
competent telogen and early anagen.  SOCS2 was not detected in the dermal papilla at any 
other phase of the hair cycle. Dotted lines demarcate the dermal papilla. Scale bar = 20μm.  
C) Schematic representation of STAT5 activation and SOCS2 presence within the dermal 
papilla during the hair follicle cycle. 
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3.5.3. Skin-Derived Precursors Transduced with Constitutively-Active STAT5 Constructs 
Are More Effective at Forming Hair Follicle Dermal Papillae 
Skin-derived precursors (SKPs) are multipotent stem cells derived from the DP that 
have the ability to form new dermal papillae and induce de novo hair follicle formation in in 
vivo hair regeneration assays (Biernaskie et al., 2009; Driskell et al., 2012; Toma et al., 
2001).  Characterisation of SKP cultures before first passage confirmed their 
mesenchymal origin as stained by vimentin and CD29 in the absence of hematopoietic 
contamination. SKPs harboured characteristics of DP cells as they had alkaline 
phosphatase activity as well as CD133 and Sox2 (see Supplemental Figure 3.1). Of note, 
SKPs in their culture condition harboured inconsistent STAT5 activity as revealed by 
nuclear P-STAT5 staining. We cultured SKPs derived from neonatal C57BL/6 mice and 
transduced these cells with adenovirus containing GFP, constitutively-active STAT5A 
(STAT5A-CA) or constitutively-active STAT5B (STAT5B-CA) constructs.  Both the 
STAT5A-CA and STAT5B-CA constructs contained a GFP fluorescent label to enable 
quantification of infection and facilitate tracing of cell fate.  SKPs were allowed to incubate 
for 48-hours with adenovirus constructs, after which quantification of infection by flow 
cytometry was performed.  We found an infection percentage of 98%, 95% and 99% for 
the GFP, STAT5A-CA and STAT5B-CA constructs, respectively (see Figure 3.4 A). 
Next, we determined if the constitutively-active STAT5 constructs introduced into 
SKPs were indeed causing increased STAT5 activity as expected.  Transduced SKPs 
were further transfected with a lactogenic hormone responsive element driving luciferase 
reporter plasmid (LHRE-Luc) and allowed to incubate in culture for 48-hours.  Luciferase 
assays showed significantly elevated levels of luminescence in the STAT5A-CA (P<0.05) 
and STAT5B-CA (P<0.01) transduced SKPs compared to control SKPs transduced with 
the GFP alone (see Figure 3.4 B). Of note, the baseline STAT5 activity in these cells was 
not different from background levels in the absence of LHRE transfection (not shown).   
These data provide confirmation of the expected changes in STAT5 activity within the 
transduced SKPs, and together with the high levels of infection found earlier, we 
concluded that these transduced SKPs were appropriate for use in our subsequent patch 
assay experiments. 
We performed patch assay experiments by transplanting transduced SKPs in 
combination with a mix of freshly isolated unlabelled neonatal C57BL/6 epidermal and 
dermal cells into the hypodermis of Nude mice back skin.  We chose to transplant SKPs 
with a combination of freshly isolated “helper” dermal cells as previous studies have shown 
that this method maximises SKP engraftment (Driskell et al., 2012).  Following a ten-day 
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growth period, the hair patches were collected and DP formation by transduced SKPs was 
quantified by whole mount imaging through the presence of GFP.  In patch assays using 
SKPs transduced with GFP-alone, we found that 34.2%±6.5% (mean±SD, n=6) of hair 
follicles contained a GFP-positive DP (see Figure 3.4 C-D).  Patch assays using SKPs 
transduced with STAT5A-CA and STAT5B-CA constructs showed significantly higher 
proportions of hair follicles with a GFP-positive DP at 52.9%±10.1% (mean±SD, n=6, 
P<0.01) and 61.8%±7.3% (mean±SD, n=6, P<0.01), respectively (see Figure 3.4 C-D).  
These data suggest that SKPs transduced with constitutively-active STAT5 constructs are 
more effective at forming hair follicle DP than control SKPs transduced with GFP alone. 
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Supplemental Figure 3.1. Characterisation of skin-derived precursors. Characterisation 
of skin-derived precursors (SKPs) by (A) immunofluorescence and (B) flow cytometry. Scale 
bars = 20μm.  C) GFP SKPs used in patch assay experiments show successful formation of 
hair follicle dermal papillae (green). Scale bar = 100μm. 
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Figure 3.4. Hair follicle regeneration using skin-derived precursors with 
constitutively-active STAT5. A) Neonatal C57BL/6J skin-derived precursors (SKPs) were 
transduced with adenoviral GFP (Ad-GFP) as a control, constitutively-active STAT5A (Ad-
STAT5A-CA) and constitutively-active STAT5B (Ad-STAT5B-CA) constructs, all containing 
a GFP label.  Flow cytometry analysis was performed 48 hours post-infection to determine 
the percentage of SKPs infected.  B) SKPs transduced with adenoviral constructs were 
transfected with a STAT5 luciferase reporter plasmid.  In vitro luciferase analysis was 
performed to confirm STAT5 overexpression due to adenoviral constructs. Mean+SD, n=9, 
Mann-Whitney test.  C) Patch assays were performed in Nude mice using transduced SKPs 
and an epidermal/dermal cell mixture.  Whole mount imaging of collected hair patches was 
performed after 10-days to observe dermal papilla (DP) formation by SKPs (green). Scale 
bar = 100μm. D) Quantification of DP formation by transduced SKPs as a percentage of 
total hair follicles. Mean+SD, n=6, Mann-Whitney test. 
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3.5.4. STAT5-/- Skin-Derived Precursors Are Less Effective at Forming Hair Follicle 
Dermal Papillae 
We next sought to perform patch assay experiments using SKPs with genetic deletion 
of both STAT5 genes.  For these experiments, we aimed to culture SKPs derived from 
genetically modified mice containing floxed STAT5A and STAT5B genes (STAT5A/B lox/lox 
mice) (Cui et al., 2004) and transduce these cells with an adenoviral cre-recombinase (Ad-
Cre) construct.  Prior to these experiments, we tested the efficiency of the Ad-Cre by 
transducing fibroblasts derived from B6.ROSA26-lox-STOP-lox-EYFP neonates (Srinivas 
et al., 2001).  Through quantification of EYFP by flow cytometry 48-hours post-infection, 
we found the percentage of recombination enabled by the Ad-Cre to be 97% (see Figure 
3.5 A). 
We used SKPs derived from neonatal STAT5A/Blox/lox mice and transduced these cells 
with Ad-Cre to delete both the STAT5A and STAT5B alleles.  These SKPs were also co-
infected with an adenoviral GFP construct to trace cell fate. PCR assays confirmed the 
proper deletion of both STAT5 alleles in culture upon Ad-Cre infection (see Figure 3.5 B). 
Patch assay experiments were performed by transplanting transduced SKPs in 
combination with a freshly isolated unlabelled epidermal and dermal cell mix from 
STAT5A/Blox/lox neonates into the hypodermis of Nude mice back skin.  DP formation was 
quantified after a ten-day growth period in the same manner described earlier.  We found 
that a significantly lower proportion of hair follicles contained a GFP-positive DP within 
patch assays using STAT5 deleted SKPs compared to those using control SKPs 
transduced with GFP alone (P<0.01).  The mean proportion of GFP-positive DP in the 
STAT5 deleted condition was found to be 43.1%±5.6% (mean±SD, n=3), as opposed to 
the GFP control condition where the mean proportion was 66.8%±4.6% (mean±SD, n=3) 
(see Figure 3.5 C-D).  Additionally, we found that the overall number of hair follicles 
formed in patch assays using STAT5 deleted SKPs was significantly less compared to the 
control condition (P<0.05) (see Figure 3.5 E).  These data suggest that within SKPs, the 
absence of STAT5 results in an impaired ability to form hair follicle DP. 
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Figure 3.5. Hair follicle regeneration with STAT5-deleted skin-derived precursors.  A) 
Neonatal ROSA26-lox-STOP-lox fibroblasts were transduced with an adenoviral cre 
construct (Ad-Cre).  Flow cytometry analysis was performed 72-hours post-infection to 
quantify YFP expression and Ad-Cre efficiency.  B) PCR confirmation of floxed STAT5 allele 
(top) and cre-mediated STAT5 deletion (bottom) in transduced STAT5lox/lox SKPs. I: 
SKPs+Ad-GFP; II: SKPs+Ad-Cre; III: SKPs+Ad-Cre and Ad-GFP; IV: Negative control; V: 
Positive control; VI: No template control. C) Patch assays were performed in Nude mice 
using STAT5A/Blox/lox SKPs transduced with Ad-Cre to delete STAT5 and an adenoviral 
GFP construct for labelling.  SKPs were transplanted with an epidermal/dermal cell mix.  
Whole mount imaging of collected hair patches was performed after 10-days to observe 
dermal papilla (DP) formation by SKPs (green). Scale bar = 100μm. D) Quantification of DP 
formation by transduced SKPs as a percentage of total hair follicles. Mean+SD, n=3, Mann-
Whitney test. E) Quantification of total hair follicle number within hair patches. Mean+SD, 
n=3, Mann-Whitney test. 
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3.5.5. STAT5-/- Gene Expression Alterations 
In order to gain further insight into how STAT5 affects gene expression within the DP, 
we performed gene expression microarray on SKPs isolated from STAT5lox/lox neonates 
transduced with an Ad-Cre or Ad-GFP construct to produce STAT5-/- or control SKPs, 
respectively. 10,281 genes were differentially expressed with a p-value less than 0.05 after 
correction for multiple testing. Among these, 1209 showed over 1.5-fold difference 
between STAT5-/- and control SKPs.  We compared our results to the previously published 
gene expression signature of the DP (Rendl et al., 2005) (see Table 3.1), as well as 
previously published gene expression data for early anagen hair follicles (Lin et al., 2004) 
(see Table 3.2 and 3.3).  We also identified genes known to be implicated in hair follicle 
development and cycling that did not overlap with the two aforementioned data sets. 
Among the dysregulated genes with over 1.5-fold difference, known regulators of 
anagen induction/progression, FGF7 (1.55 fold, p = 6.69x10-4), follistatin (1.59 fold, p = 
3.42x10-4), Wnt6 (5.62 fold, p = 1.25x10-13) and IGF1 (2.26 fold, p = 1.08x10-8), were all 
significantly downregulated in the STAT5-/- condition compared to control.  Expectedly, 
known downstream transcriptional targets of STAT5 were found to be significantly 
downregulated within the STAT5-/- condition compared to the control condition, including 
SOCS3 (1.54 fold, p = 2.27x10-4) and CSN3 (1.63 fold, p = 1.76x10-4).  Dkk3 (2.69 fold, p 
= 5.75x10-9) and Dlk1 (2.84 fold, p = 6.86x10-12), known inhibitors of Wnt and Notch 
signalling, respectively, were found to be significantly upregulated in the STAT5-/- condition 
compared to control.  Genes described as being involved in hair morphogenesis including 
tenascin C (2.07 fold, p = 4.73x10-9), MMP9 (11.57 fold, p = 1.88x10-13) and TNF (5.95 
fold, p = 5.01x10-17) were also found to be significantly downregulated in the STAT5-/- 
condition. Although not reaching the 1.5-fold threshold, Wnt5a (1.22 fold, p = 6.49x10-3) 
and FGF10 (1.34 fold, p = 1.75x10-10) were also found to be significantly downregulated in 
the STAT5-/- condition. 
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Table 3.1. Dermal papilla signature genes up- and downregulated.  List of genes 
described as part of the dermal papilla signature (Rendl et al., 2005) found in this study to 
be ≥1.5x up- or downregulated in STAT5-/- SKPs compared to control. 
Downregulated 
Gene Symbol Gene Name Fold Change p-value 
ASIP Agouti signalling protein 1.64 4.68x10
-3 
CD1d1 CD1d molecule 2.19 4.35x10
-9
 
ENPP2 Ectonucleotide pyrophosphate/phosphodiesterase 2 2.05 8.18x10
-9
 
FGF7 Fibroblast growth factor 7 1.55 6.69x10
-4
 
FST Follistatin 1.59 3.42x10
-4
 
IGFBP3 Insulin-like growth factor binding protein 3 3.59 5.32x10
-10
 
INHBA Inhibin, beta A 2.11 1.25x10
-8
 
NOTUM Notum pectinacetylesterase homolog (Drosophila) 1.56 1.56x10
-5
 
PLOD2 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 1.57 3.40x10
-6
 
SOCS3 Suppressor of cytokine signalling 3 1.54 2.65x10
-4
 
SSBP2 Single-stranded DNA binding protein 2 1.96 1.63x10
-9
 
TMEM2 Transmembrane protein 2 1.82 1.48x10
-7
 
TMEM47 Transmembrane protein 47 1.59 1.96x10
-6
 
VCAM1 Vascular cell adhesion molecule 1 2.35 3.40x10
-9
 
ZCCHC18 Zinc finger, CCHC domain containing 18 2.25 1.45x10
-10
 
Upregulated 
Gene Symbol Gene Name Fold Change p-value 
 AARD Alanine and arginine-rich domain containing protein 1.77 2.01x10
-5
 
CAPN6 Calpain 6 1.90 2.56x10
-8
 
CPXM1 Carboxypeptidase X (M14 family), member 1 1.57 7.77x10
-5
 
CYR61 Cysteine-rich, angiogenic inducer, 61 1.67 2.77x10
-3
 
DRAM1 DNA-damage regulated autophagy modulator 1 1.79 2.73x10
-6
 
GPRASP1 G protein-coupled receptor associated sorting protein 1 1.61 2.81x10
-7
 
GPX3 Glutathione peroxidase 3 (plasma) 2.11 7.62x10
-8
 
IGDCC4 Immunoglobulin superfamily, DCC subclass, member 4 1.92 1.32x10
-8
 
Masp1 Mannan-binding lectin serine peptidase 1 1.66 5.44x10
-6
 
MDK Midkine (neurite growth-promoting factor 2) 1.54 1.16x10
-4
 
MYH3 Myosin, heavy chain 3, skeletal muscle, embryonic 1.94 5.59x10
-6
 
NCAM1 Neural cell adhesion molecule 1 1.50 2.72x10
-5
 
PAPPA Pregnancy-associated plasma protein A, pappalysin 1 2.33 3.82x10
-8
 
PRSS12 Protease, serine, 12 (neurotrypsin, motopsin) 2.94 9.06x10
-9
 
SHOX2 Short stature homeobox 2 1.52 2.91x10
-5
 
ST8SIA2 ST8 α -N-acetyl-neuraminide α-2,8-sialyltransferase 2 1.60 2.07x10
-5
 
TGFBR1 Transforming growth factor, beta receptor 1 1.64 4.92x10
-8
 
ZBTB20 Zinc finger and BTB domain containing 20 1.54 7.84x10
-4
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Table 3.2. Downregulated early anagen genes. List of genes described as having peak 
expression during early anagen (Lin et al., 2004) found in this study to be ≥1.5x 
downregulated in STAT5-/- SKPs compared to control. 
Downregulated 
Gene Symbol Gene Name Fold Change p-value 
2610524H06RIK RIKEN cDNA 2610524H06 gene 1.76 4.97x10
-7
 
2810417H13RIK RIKEN cDNA 2810417H13RIK gene 2.16 3.03x10
-10
 
ACOT7 Acyl-CoA thioesterase 7 1.55 3.30x10
-5
 
ATP13A3 ATPase type 13A3 1.55 1.26x10
-6
 
AURKA Aurora kinase a 1.62 1.34x10
-5
 
BIRC5 Baculoviral IAP repeat containing 4 1.99 3.55x10
-9
 
CD44 CD44 molecular (Indian blood group) 1.50 9.96x10
-6
 
CDC20 Cell division cycle 20 1.88 6.35x10
-7
 
CDCA8 Cell division cycle associated 8 1.77 6.37x10
-8
 
CDK1 Cyclin-dependent kinase 1 1.99 1.96x10
-8
 
CSNK1D Casein kinase 1, delta 1.95 4.08x10
-9
 
ETV4 Ets variant 4 2.11 4.67x10
-8
 
FAM162A Family with sequence similarity 162, member A 2.15 1.55x10
-7
 
FEN1 Flap structure-specific endonuclease 1 1.50 3.15x10
-5
 
HNRNPA2B1 Heterogenous nuclear ribonucleoprotein A2/B1 1.67 1.95x10
-6
 
Hnrnpa1 Heterogenous nuclear ribonucleoprotein A1 1.59 5.85x10
-6
 
IPO5 Importin 5 1.55 5.84x10
-6
 
IVL Involucrin 6.16 1.30x10
-12 
KIF2C Kinesin family member 2C 1.76 1.22x10
-7
 
MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) 1.68 2.04x10
-7
 
MCM3 Minichromosome maintenance complex component 3 1.63 1.24x10
-6
 
MKI67 Marker of proliferation Ki-67 1.55 1.22x10
-5
 
MYCL 
 
v-myc avian myelocytomatosis viral oncogene lung 
carcinoma derived homolog 
1.62 
 
9.84x10
-6
 
PDLIM7 PDZ and LIM domain 7 (enigma) 1.76 2.33x10
-8
 
PLK1 Polo-like kinase 1 1.72 3.01x10
-7
 
PVRL2 Poliovirus receptor-related 2 (herpesvirus entry mediator B) 1.51 5.62x10
-6
 
SOX4 SRY (sex determining region Y)-box 4 1.73 1.05x10
-6
 
TAGLN2 Transgelin 2 2.40 5.42x10
-11
 
TK1 Thymidine kinase 1, soluble 1.95 7.17x10
-8
 
TOP2A Topoisomerase (DMA) II alpha 170 kDa 1.61 1.10x10
-4
 
TRAF4 TNF receptor-associated factor 4 1.63 8.52x10
-6
 
UBA1 Ubiquitin-like modifier activating enzyme 1 1.66 3.25x10
-6
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Table 3.3. Upregulated early anagen genes. List of genes described as having peak 
expression during early anagen (Lin et al., 2004) found in this study to be ≥1.5x 
upregulated in STAT5-/- SKPs compared to control. 
Upregulated 
Gene Symbol Gene Name Fold Change p-value 
AHCY Adenosylhomocysteinase 1.55 1.55x10
-6
 
GIPC1 GIPC PDZ domain containing family, member 1 1.74 9.69x10
-8
 
KIT 
 
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene 
homolog 
1.73 
 
7.63x10
-5
 
NID2 Nidogen 2 (osteonidogen) 1.99 1.17x10
-4
 
NME4 NME/NM23 nucleoside diphosphate kinase 4 2.02 1.05x10
-8
 
NREP Neuronal regeneration related protein 2.22 2.14x10
-7
 
PDAP1 PDGFA associated protein 1 1.59 1.00x10
-3
 
PLXNA2 Plexin A2 1.57 2.79x10
-4
 
RPS4l Ribosomal protein S4-like 2.54 1.90x10
-11
 
SET SET nuclear proto-oncogene 2.58 7.54x10
-10
 
SIVA1 SIVA1, apoptosis inducing factor 1.74 2.61x10
-7
 
 
Table 3.4. Further genes of interest implicated in hair follicle cycling. List of genes 
linked to hair follicle cycling found in this study to be ≥1.5x up- (red) or downregulated 
(black) in STAT5-/- SKPs compared to control. 
Gene Symbol Gene Name Fold Change p-value 
Dkk3 Dickkopf WNT signaling pathway inhibitor 3 2.69 5.75x10
-9
 
Dlk1 Delta-like homolog (Drosophila) 2.84 6.86x10
-12
 
IGF1 Insulin-like growth factor 1 (somatomedin C) 2.26 1.08x10
-8
 
MMP9 Matrix metalloproteinase 9 11.57 1.88x10
-13
 
Sox7 SRY (sex determining region Y)-box 7 2.75 1.45x10
-11
 
TNC Tenascin C 2.07 4.73x10
-9
 
TNF Tumor necrosis factor 5.95 5.01x10
-17
 
VEGFA Vascular endothelial growth factor A 1.88 6.54x10
-9
 
VEGFC Vascular endothelial growth factor C 2.02 5.91x10
-10
 
Wnt6 Wingless-type MMTV integration site family, member 6 5.62 1.25x10
-13
 
 
3.6. Discussion 
The hair follicle arises during development from complex interactions between the 
epidermis and mesenchyme, then continues to undergo periods of growth, regression and 
rest throughout adulthood (Fuchs et al., 2001; Millar, 2002).  The indispensability of the DP 
for the control of hair follicle cycling is well-described, with its key instructive role 
highlighted in multiple studies (Biernaskie et al., 2009; Jahoda et al., 1984; Yamaguchi et 
al., 2005).  Although some pathways involved in the DP’s control of hair cycling have been 
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described, other mediators of DP signalling throughout various phases of the hair follicle 
cycle continue to be uncovered (Enshell-Seijffers et al., 2010a; Rendl et al., 2008).   
In this study, our results indicate that STAT5 is expressed and activated following the 
initial postnatal anagen phase, immediately prior to and during the first telogen phase.  
STAT5 was not shown to be activated or expressed during embryonic hair follicle 
development, or at any time during the initial postnatal anagen phase.  This finding 
suggests that STAT5 expression and activation in the DP does not play a role in its 
specification or in the development of the hair follicle.  However, our results demonstrate 
that during hair follicle cycling, STAT5 expression and activation occurs during late 
catagen and persists and increases through to anagen, indicating a role for STAT5 in the 
adult DP. Furthermore, the pattern of STAT5 activation as evidenced by quantification of 
staining intensity and expression of its downstream target, SOCS2, suggests that STAT5 
activity in the DP is most pronounced during competent telogen and early anagen.  Given 
the increased levels of active STAT5 from late catagen through to early anagen, these 
data suggest that STAT5 may be playing a role in the hair follicle’s transition from 
regression to growth.  Whether STAT5 activation in the DP is functioning to suppress 
growth-inhibiting signals (i.e. during catagen or refractory telogen) or promote anagen 
induction was initially unclear, however our subsequent patch assay experiment results 
were able to shed light on this question. 
Patch assay experiments performed in our study using SKPs transduced with 
STAT5A-CA and STAT5B-CA constructs found that activation of STAT5 improved the 
ability for these cells to form hair follicle DP compared to control SKPs transduced with a 
GFP construct only.  Furthermore, we found that the deletion of STAT5 in SKPs reduced 
the ability for these cells to form DP, as well as reducing the overall number of hair follicles 
formed in the assay compared to control SKPs.  This mostly reflects on the role of STAT5 
in hair follicle regeneration, as previous studies have demonstrated that these assays 
replicate the dermal-epidermal interactions that are required for hair follicle development. 
These newly formed hair follicles have been shown to undergo an initial period of anagen 
phase and then undergo cycling through the appropriate phases (Zheng et al., 2005; 
Zheng et al., 2010).  These data combined with our findings characterising STAT5 
activation in the DP suggest that STAT5 activation also is important for induction of a new 
anagen phase. 
To date, a role for STAT5 in the DP has not been described.  Transcriptional profiling 
of the hair follicle has shown that both STAT5A and STAT5B form part of the genetic 
signature of the DP (Rendl et al., 2005).  In addition, studies of murine SKPs derived from 
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the back skin of both neonatal and adult animals demonstrate specific upregulation and 
expression of STAT5A. These studies suggest that SKPs are derived from the DP, and in 
particular, those cells that are Sox2-positive (Biernaskie et al., 2009; Driskell et al., 2009).  
Nevertheless, these studies implicate a role for STAT5 in DP signalling.  Interestingly, the 
cells used for microarray analyses in these studies were obtained from neonates at P2-P4.  
Our results fail to show STAT5 staining in the DP prior to P19, suggesting that STAT5 only 
becomes translated at detectable levels and activated at this later time point.   
An earlier study using STAT5B-/- knockout mice to investigate the effects of disrupted 
growth hormone signalling briefly noted a hair phenotype. The authors described a 
minimum two-week delay in commencement of the second anagen phase in STAT5B-/- 
mice compared to their control animals (Udy et al., 1997).  These results support further 
our notion that STAT5 activation plays a role in the induction of anagen, as we also 
describe impaired hair follicle growth with the absence of STAT5. Of note, a similar 
phenotype in STAT5A-/- mice has not been noted (Liu et al., 1997). The described study 
found that STAT5A-/- mice did not appear to be phenotypically different to their wild-type 
littermates and no hair follicle phenotype was reported at any stage.  It is possible that a 
compensatory mechanism involving STAT5B may have overcome any defects in hair 
follicle cycling attributed to loss of STAT5A within these mice.  Furthermore, these findings 
may suggest that STAT5A does not play a significant role compared to STAT5B within the 
DP; however, our study demonstrates that the overexpression and activation of both 
STAT5A and STAT5B individually results in increased DP formation, thereby contradicting 
this suggestion. 
Our microarray results found alterations in several genes known to be involved in 
anagen induction or progression.  Notably, Wnt6 and Wnt5a were shown to be significantly 
downregulated in STAT5-/- SKPs compared to control.  Wnt6 and Wnt5a are implicated in 
Eda/Edar and Wnt signalling during hair follicle morphogenesis, respectively (Laurikkala et 
al., 2002; Reddy et al., 2001).  It is known that Wnt/β-catenin signalling is absolutely 
necessary for hair follicle development and postnatal anagen; however, less is known 
about the specific function of each Wnt protein (Schmidt-Ullrich and Paus, 2005).  Wnt6 
has been suggested to be an upstream regulator of Eda/Edar signalling, whereas the role 
of Wnt5a is disputed (Laurikkala et al., 2002; Reddy et al., 2001; Xing et al., 2013). 
Furthermore, our results show a significant upregulation of Dkk3 and Dlk1.  Dkks are 
known Wnt/β-catenin pathway inhibitors, and Dkk3 has been described specifically as a 
negative regulator of β-catenin (Lee et al., 2009).  On the other hand, Dlk1 is known to be 
an inhibitor of Notch1, an important regulator of postnatal hair follicle development 
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(Baladron et al., 2005; Falix et al., 2012; Vauclair et al., 2005).  Taken together, 
downregulation of Wnt combined with upregulation of Wnt and Notch signalling inhibitors 
may be responsible for the observed reduction in hair follicle number in patch assay 
experiments using STAT5-/- SKPs. We also found FGF7 and FGF10 to be significantly 
downregulated in STAT5-/- SKPs.  Both FGF7 and FGF10 are expressed within the DP 
and have been shown to promote cell proliferation within the hair germ (Greco et al., 
2009). 
Follistatin has been described as a mediator of anagen propagation, with high levels of 
extra-follicular follistatin expression found during competent telogen and early anagen 
(Chen et al., 2014).  Furthermore, follistatin is suggested to be important in hair follicle 
development, with its expression described in hair matrix and outer root sheath cells 
(Nakamura et al., 2003).  Interestingly, although part of the DP’s genetic signature 
described in a previous study, a role for follistatin in the DP control of hair follicle cycling 
has not been described (Rendl et al., 2005).  We found follistatin significantly 
downregulated in STAT5-/- SKPs, suggesting that follistatin expression within the DP may 
play a role in anagen induction. 
Although we identify STAT5 as having an important role during hair follicle cycling, as 
well as identifying possible downstream transcriptional targets, the upstream signals 
resulting in translation and activation of this transcription factor remain unclear.  Many type 
I cytokine receptors are known to signal through the JAK-STAT pathway, some of which 
are known to be expressed within the DP.  Furthermore, tyrosine kinase receptors such as 
EGFR, FGFR3, and PDGFR have the potential to activate STAT5 directly, bypassing 
classical signalling pathways (David et al., 1996; Kong et al., 2002).  Amongst the group of 
receptors that are known to signal via the JAK-STAT5 pathway and have been implicated 
in the DP are erythropoietin receptor (EPOR) and prolactin receptor (PRLR).  The DP has 
not only been shown to express EPOR, but there is evidence demonstrating that 
erythropoietin (EPO) promotes the induction of anagen from telogen, possibly by 
stimulating DP cells (Kang et al., 2010).  These findings correspond with our data that 
suggests STAT5 activation is an anagen-inducing signal.   Furthermore, prior studies 
investigating tissue responses to EPO identified the presence of active STAT5 in the DP 
(LeBaron et al., 2007).  The hair follicle has also been described as an extrarenal source 
of EPO, hinting at the possibility of autocrine/paracrine modulation of hair follicle growth by 
EPO and its receptor (Bodo et al., 2007). 
Limited evidence has highlighted the presence of PRLR within the DP (Choy et al., 
1997). However, several studies have demonstrated the presence of PRLR within the 
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epidermal compartment of the hair follicle, and described modulation of the hair follicle 
cycle by prolactin (Craven et al., 2006; Foitzik et al., 2006; Foitzik et al., 2003).  In addition, 
a recent study has shown that PRLR activation and downstream signalling by STAT5 
results in quiescence of hair follicle stem cells during pregnancy and lactation.  This study 
also remarked that STAT5 activation was present in the DP of non-pregnant, pregnant and 
lactating mice (Goldstein et al., 2014).  These studies conclude that PRLR activation 
results in either quiescence or catagen induction within the hair follicle, which is 
contradictory to our proposed role of STAT5. However, it is important to note that these 
studies only focused on the epidermal component of the hair follicle and do not describe a 
role for STAT5 within the DP. 
At present, there is conflicting literature regarding the role of FGF18 in hair cycling. 
Studies have suggested that FGF18 is an inducer of anagen phase, whereas others have 
suggested that FGF18 is important for the maintenance of telogen (Kawano et al., 2005; 
Kimura-Ueki et al., 2012).  FGF18 is known to interact with FGFR3, which has been shown 
to be expressed within several regions of the hair follicle including the DP (Kimura-Ueki et 
al., 2012; Zhang et al., 2006).  FGFR3 activation has been shown to result in 
phosphorylation and nuclear translocation of STAT5, which is suggested to be mediated 
through SH2 adaptor protein B (SH2-B) (Kong et al., 2002).  This suggests that signalling 
by FGFR3 is a potential upstream activator of STAT5-mediated anagen induction by the 
DP. 
Recently, it has been found that inhibition of JAK2, a receptor tyrosine kinase that 
recruits STAT5, results in reversal of the hair follicle autoimmune condition, alopecia 
areata (Xing et al., 2014).  The authors found that with JAK inhibition, the immune 
response causing alopecia areata was inhibited and complete hair regrowth was achieved 
in both mice and humans.  These results appear contradictory to our findings at first, 
however previous studies have shown that alopecia areata primarily affects hair follicles 
that are in anagen phase only (Gilhar et al., 2012; Paus et al., 1993).  Therefore, in line 
with our findings, JAK inhibition may result in the arrest of hair follicles in telogen phase, 
resulting in protection from the pathological immune response associated with alopecia 
areata. 
 
3.7. Conclusion 
In conclusion, we describe a novel role for STAT5 within the DP, where its activation 
occurs following hair follicle development and acts as an anagen-inducing signal.  These 
effects may be due to STAT5-induced upregulation of Wnt, Notch or FGF signalling 
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pathways, or through upregulation of less conventional anagen-inducing factors, such as 
follistatin. Identification of STAT5 as a mediator of DP signalling may provide a new target 
for the clinical treatment of hair follicle conditions.  However, additional studies must be 
done to elucidate the downstream targets of STAT5 within the DP to enable further 
understanding of its role in both adult hair cycling and pathological conditions of the hair 
follicle. 
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Chapter Four 
Mesenchymal Sox18 Activity Is Essential for Dermal Papilla 
Development and Function in All Murine Hair Types 
 
This chapter consists of one manuscript prepared for submission by the PhD 
candidate 
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4.1. Rationale 
Sox18 is known to be a regulator of hair follicle type specification, with its expression 
associated with the formation of the zigzag hair follicle type (Driskell et al., 2009; Pennisi et 
al., 2000a). Loss of Sox18 in mice has been shown to reduce the proportion of zigzag hair 
follicles compared to the Sox2 expressing types, guard and awl/auchene. Although zigzag 
hair follicles begin their development during the third hair development wave at E18.5, 
Sox18 has been shown to be expressed at E14.5, a time point synonymous with guard 
and awl/auchene specification (Millar, 2002; Pennisi et al., 2000b).  This suggests that 
Sox18 may have a role earlier in hair follicle development and consequently, the role of 
Sox18 in the dermal papilla requires further investigation. 
 
4.2. Abstract 
Molecular cues in the morphogenesis of the dermal condensate (DC) and dermal 
papilla (DP) driving hair follicle development remain unclear. Here we established a 
restricted spatio-temporal expression of Sox18 to DCs of all hair types. In guard (primary) 
hair DCs, we identified Sox18 expression from E14.5 until E16.5 that correlated with Sox2 
expression. Similarly, expression of Sox18 was detected in the DC of each hair type at 
E16.5 and E18.5. Loss of Sox18 function did not prevent dermal Wnt signalling or DC 
formation in any hair type. However, it affected the second dermal signal restricting 
epidermal invagination and hair formation especially in secondary and tertiary hairs. Sox18 
loss of function also prevented neonatal dermal cells or DP spheres from forming hair in 
regeneration assays. It also affected the quiescence of epidermal stem cells in primary 
hairs resulting in permanent anagen, increased hair length and finally stem cell 
exhaustion. Gene expression arrays of normal control or Sox18 mutant dermal spheres 
pointed to Wnt5a and FGF7 as potential downstream effectors of Sox18 in driving 
epidermal hair development. In conclusion, Sox18 acts as a mesenchymal molecular 
switch necessary to the formation and function of the DP in all hair types. 
 
4.3. Introduction 
Hair follicle development is a classical situation of epithelial-mesenchymal interaction 
in embryonic life. This process starts at E14.5 in three consecutive waves in mice, each 
characterised by the formation of a dermal condensate (DC) in response to epidermal 
signals (Millar, 2002). The condensate then induces further invagination of epidermal cells 
in hair placodes that then further develop to form hair follicles. Of significant interest, each 
of these waves gives rise to a different type of hair follicle in dorsal epidermis: the first 
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wave, or primary phase, starting at E14.5 gives rise to guard hairs, the second wave, or 
secondary phase, at E16.5 gives rise to awl and auchene hairs and the final wave, or 
tertiary phase, at E18.5 gives rise to zigzag hairs, the most abundant hair type in dorsal 
murine skin. 
Although many of the molecular cues, such as Wnt, Eda/Edar or hedgehog signalling 
that drive epidermal specification towards a hair follicle fate have been identified, few have 
addressed this same question in their mesenchymal counterparts. Identification of Sox2 as 
a specific DP marker and its restricted expression in guard, awl and auchene hairs 
prompted studies characterizing its role at E14.5 in the DC of the first hair wave (Driskell et 
al., 2009). Unexpectedly, conditional ablation of Sox2 in the DC at E14.5 has allowed DP 
and hair follicles to form. The resulting phenotype was modest and restricted to these 
three hair types (Clavel et al., 2012; Lesko et al., 2013). This suggests that expression of 
Sox2 is dispensable for DP specification even if it could be important for some aspects of 
its function. In particular, the ablation of Sox2 had no effect on zigzag hairs, suggesting 
that other Sox-dependent mechanisms might act redundantly to rescue Sox2 loss of 
function as previously described (Graham et al., 2003). 
DP cells that do not express Sox2 have been shown to be enriched for Sox18 (Driskell 
et al., 2009). Sox18 is a member of the SoxF family of transcription factors that also 
includes Sox17 and Sox7 (Dunn et al., 1995). SoxF transcription factors have shown to 
modulate arteriovenous identity and lymphatic endothelial cell specification (Cermenati et 
al., 2008; Corada et al., 2013; Francois et al., 2008; Herpers et al., 2008; Pendeville et al., 
2008). Previous studies have shown that adult Sox18-/- mice have a defect restricted to 
zigzag hairs supporting the view that Sox2 and Sox18 have complementing and non-
overlapping functions, driving the formation of different hair types (Pennisi et al., 2000a). 
However, Sox18 is expressed as early as E14.5 in the DCs suggesting that it may also 
influence the development of other hair types (Pennisi et al., 2000b). 
In the present study we sought to determine the role of Sox18 and SoxF family 
members in DP specification. Mutation in Sox18 has been reported to cause the human 
syndrome hypotrichosis-lymphedema-telangiectasia (HLT), a condition which manifests 
with hair loss, lymphatic and cardiovascular defects (Irrthum et al., 2003). As Sox18-/- has 
only a mild hair defect, we chose to study a dominant negative version of Sox18 
(Sox18+/Op) which suppresses the endogenous function of all Sox proteins interacting with 
Sox18, which much closer resembles the HLT hair defect than Sox18-/- alone. 
Homozygous Sox18Op/Op mice are embryonic lethal while heterozygous Sox18+/Op mice 
have been reported to have a hair phenotype similar to HLT allowing detailed exploration 
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of the role of Sox18 function. Here, our findings suggest an essential role of Sox18 in the 
specification of the DP in most hair types. 
 
4.4. Materials and Methods 
4.4.1. Mouse Models 
Sox18GCre/ER mice were generated and kindly provided by Dr. Andrew McMahon 
(Kartopawiro et al., 2014; McMahon et al., 2008), Sox18+/Op mice were obtained from Prof. 
Peter Koopman (Institute for Molecular Bioscience, Brisbane, Queensland, Australia) and 
Topflash indicator mice were created in house (Hodgson et al., 2014). Sox7-LacZ knock in 
mice were generated using Velocigene® targeting of Sox7 gene using a BAC clone with a 
LacZ insert (Regeneron, NY, USA). These mice were kindly provided by Dr. Nicolas 
Fossat. All murine work was performed to institutional ethical requirements. Mice were 
genotyped by phenotypic presentation (absence of whiskers and presence of blisters) for 
Sox18+/Op and using PCR for Sox18+/GCre (CreF 5’-caccctgttacgtatagccg-3’ and CreR 5’-
ctaatcgcccatcttccag-3’) and +/Topflash (LucF 5’-taaggctatgaagagatacgc-3’ and LucR 5’-
ccatactgttgaccaattca-3’).  
 
4.4.2. Immunofluorescence 
Antibodies used were Sox2 (Abcam, Cambridge, UK), GFP (Life Technologies, CA, 
USA), Lef1 (Cell Signaling Technology, MA, USA), CD26 (R&D Systems, MN, USA), Dlk 
(Abcam, Cambridge, UK), αSMA (Abcam, Cambridge, UK), CD133 (eBioscience, CA, 
USA), Sox9 (Santa Cruz Biotechnology, TX, USA), Nfatc1 (Santa Cruz Biotechnology, TX, 
USA), CD34 (Abcam, Cambridge, UK). Secondaries used were anti-rabbit A568, anti-
rabbit A488, anti-goat A488, anti-chicken A647 (Invitrogen, CA, USA). 
Immunofluorescence was performed on both 4% paraformaldehyde (PFA)-fixed paraffin-
embedded skin or 1% PFA-fixed cryoembedded skin and all sections were counterstained 
with DAPI. Images were acquired on the Zeiss LSM 710 confocal microscope with Zen 
2009 software (Carl Zeiss, Oberkochen, Germany).  
 
4.4.3. Luciferase Analysis 
Luciferase analyses were performed as previously described (Hodgson et al., 2014). 
Briefly, post-hair removal, mice were injected with 150mg/kg firefly D-luciferin substrate 
(Regis Technologies, IL, USA) and imaged after 10 minutes using a Xenogen IVIS® 
Spectrum live animal imaging system. Analysis was performed using Living Image 3.2 
software (Caliper Life Sciences, MA, USA). 
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4.4.4. Microarray 
Microarray experiments were performed on n=3 control and n=3 Sox18+/Op sex-
matched littermate SKP samples. Biotin labeled cRNA was produced using the Illumina® 
TotalPrep™ RNA Amplification (Life Technologies, CA, USA) as per the manufacturer’s 
instructions. 50ng of starting total RNA was used and a 14 hour IVT reaction. cRNA 
samples were hybridized to Sentrix Illumina_MouseWG-6 v2.0 Expression BeadChip 
overnight for 18 hours at 58oC then scanned on a BeadStation 500 System using 
Beadscan software v3.5.31 (Illumina, CA, USA). Raw data was then imported into 
GenomeStudio v2010.2 (Illumina, CA, USA) for bead summarisation and quality control 
assessment. Raw data files were submitted to Gene Express (accession number E-MEXP-
3189). For data analysis, raw probe intensity data were imported into GeneSpring GX 11 
Agilent Technologies, CA, USA) and subsequent normalisation and significance analysis 
to identify differentially expressed probes were performed according to the default 
parameters used in the “Guided Workflow” adapted from GeneSpring GX 11 manual. 
Analysis was performed using previously established parameters (Rodero et al., 2013a). 
 
4.4.5. RT-PCR 
SKPs were cultured from neonatal C57BL/6 or STAT5lox/lox mice as described 
(Biernaskie et al., 2006) and plated in 6-well plates.  RNA was isolated from approximately 
1x106 SKP cells using the commercially-available QIAGEN Mini Kit (Qiagen, Limburg, 
Netherlands) and according to the manufacturer’s instructions. 1µg of RNA was used for 
cDNA preparation using SuperScript III (Life Technologies, CA, USA), as per 
manufacturer’s instructions. RT-PCR was performed using SYBR® Green (Applied 
Biosystems, CA, USA) on a StepOnePlus™ real-time PCR system (Applied Biosystems, 
CA, USA). CT values were exported and data analysed using GraphPad Prism v6 
(GraphPad Software, CA, USA). 
 
4.4.6. Patch Assay 
Dermal and epidermal cells were prepared after skin was removed from neonatal 
mice, washed in antibacterial/antimycotic solutions and the dermis and epidermis 
separated overnight in 1mg/ml dispase II (Sigma Aldrich, MO, USA) at 4°C. Epidermal 
sheets were then incubated on TrypLE Express (Gibco, NY, USA) for 20 mins at room 
temperature and epidermal cells centrifuged at 380 x g for five minutes. SKPs were 
cultured as described previously (Biernaskie et al., 2006). For each patch assay between 
1-2 x 106 dermal cells and 1 x 106 epidermal cells were injected subcutaneously in 8 to 12 
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week old Nude mice using a 25 gauge x 3/4” needle. Mice were sacrificed following a ten-
day period and patches of hair that had formed within the hypodermis were collected for 
analysis. 
 
4.5. Results 
4.5.1. Sox18 Is Expressed in the Dermal Papilla of All Hair Follicles during Early 
Development 
The expression of Sox18 has been reported in a single study via in situ hybridization at 
14.5d.p.c and has not been systematically addressed. Using Sox18GCre/ER reporter mice 
we performed a comprehensive analysis of Sox18 expression pattern as determined by 
the activity of its endogenous promoter during skin embryonic development (from E14.5 to 
E18.5) (Kartopawiro et al., 2014; McMahon et al., 2008). Expression of Sox18 at all time-
points was restricted to the DC with expectedly some remnant expression in vascular 
structures. At E14.5, Sox18 was expressed in the early DCs, as revealed by GFP 
detection (see Figure 4.1 A). Sox18 expression co-localised with Sox2 although its 
detection was not uniform within the DC. To ensure that all DC formed at E14.5 expressed 
Sox18, we performed whole mount staining of embryonic Sox18GCre/ER back skin with 
Sox2 to identify DCs and with GFP to reveal Sox18 expression. It appeared that all 
primary hair follicle mesenchymal regions identified by Sox2 staining were expressing 
Sox18 (see Figure 4.1 B). The expression of Sox18 in the primary hair follicles was short-
lived, as at E16.5 and E18.5 the DC from primary hair follicles, identified by robust Sox2 
expression, was devoid of any GFP signal. The expression of Sox18 was much more 
obvious at E16.5 and E18.5 on all DC cells of secondary and tertiary hair follicles. As 
expected, tertiary hairs did not express Sox2 (see Figure 4.1 A).  To confirm further the 
early expression of Sox18 at E14.5, we used lineage tracing by combining the 
Sox18GCre/ER line with an EYFP conditional reporter allele (+/ROSA-EYFP). By induction 
of cre-recombinase with tamoxifen at E14.5, we labelled cells derived from Sox18 
expressing lineages post-E14.5 in primary hair follicles (see Supplemental Figure 4.1 A). 
This confirmed that the DP of primary hair follicles were YFP+ indicating that Sox18 was 
expressed at E14.5 in this hair type. Overall, Sox18 was expressed in the DC of all hair 
waves.  We finally explored the expression of Sox7 using a Sox7-LacZ reporter mouse 
and Sox17 using immunofluorescence. At E14.5 and E16.5, neither Sox7 identified by 
beta-galactosidase immunostaining nor Sox17 could be identified in Sox2 expressing DCs 
although their presence was clearly visible in surrounding vascular structures (see 
Supplemental Figure 4.1B). Similarly at E18.5, skin sections did not reveal any Sox7 or 
77 
 
Sox17 staining in primary, secondary or tertiary hair follicles (see Supplemental Figure 4.1 
C). Overall these data point to the unique profile of expression of Sox18 among SoxF 
family members in the mesenchymal component of developing hair follicles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Restricted temporal expression of Sox18 in the mesenchymal component 
of all hair types. A) Immunofluorescence detection of GFP (green) for Sox18 and Sox2 
(red) in the dermal papilla at E14.5, E16.5 and E18.5 in Sox18GCre/ER embryonic skin. At 
each time point, primary, secondary and tertiary hair follicles are figured. B) Whole mount 
immunofluorescence confirms primary hair follicle staining, showing overlap of Sox2 and 
Sox18 in the hair follicles at E15.5.  
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Supplemental Figure 4.1: Sox18 expression in the dermal condensate is not 
associated with the expression of Sox7 and Sox17. A) Sox18GCre/ER;+/EYFP embryos 
were induced at E14.5 with tamoxifen and collected at E18.5. Skin sections were co-stained 
for GFP/EYFP using anti-GFP antibodies as well as Keratin14 (K14) for epidermal cells. 
Knowing that primary hair follicles do not express Sox18 from E16.5 onwards, presence of 
anti-GFP staining in the DP of primary hair follicles reflected the presence of EYFP. B and 
C) Sox7-LacZ reporter mice were sacrificed at E14.5, E16.5 and E18.5. B) Whole mount 
immunofluorescence of beta-galactosidase revealing Sox7 expression (green-cytoplasmic) 
combined with Sox17 (blue, nuclear) did not co-localize with dermal clusters as revealed by 
Sox2 (red) staining at E14.5 and E16.5. Sox7 and Sox17 could be visualized in vascular 
structures expectedly. C) At E18.5, sections were stained for Sox17 using 
immunofluorescence or histochemically stained with X-gal to reveal Sox7 related beta-
galactosidase activity (blue) and counterstained with fast red. 
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4.5.2. Dominant Negative Sox18 Affects Hair Follicle Development 
Having established the mesenchymal expression pattern of Sox18 using endogenous 
reporters during hair follicle organogenesis we next investigated its function. The human 
syndrome HLT and phenotypic analysis on mice carrying the dominant negative Sox18+/Op 
mutation has indicated a major hair follicle defect, however the molecular mechanism has 
yet to be elucidated (Pennisi et al., 2000b; Slee, 1962). Histological analysis of a 
developmental time series showed that at E14.5 primary hair follicle induction was 
occurring comparably in Sox18+/Op as to control littermates (see Figure 4.2 A). At E16.5 
however, although placodes of secondary hair follicles formed normally, a delay in the 
further growth of primary follicles was evident. By the tertiary wave at E18.5, the delay in 
hair development was significant and affected all hair types despite clear formation of 
placodes (see Figure 4.2 A). Similarly at birth (P0), there was a marked difference 
between mutant and wild-type mice regarding outgrowth of secondary and tertiary hair 
follicles whereas primary hairs could still be observed. The early induction of proliferation, 
revealed by Ki67, occurred in both Sox18+/Op and wild-type controls in the epithelial and 
mesenchymal compartments of the developing hair follicles at all stages (see Figure 4.2 
B). Importantly, hair development did not proceed normally in postnatal Sox18+/Op skin. 
Evaluation of hair follicle types in mutant mice and wild-type littermates clearly revealed a 
complete lack of zigzag and auchene hair in the Sox18+/Op mice (see Figure 4.2 C). In a 
large proportion of secondary and tertiary follicles, development was totally disrupted 
resulting in thin epithelial strands into the upper dermis (see Figure 4.2 D). These hair 
remnants seemed to derive from the secondary and tertiary hairs. The remaining primary 
hair follicles, a much smaller proportion, also exhibited altered morphology and polarity 
despite apparently preserved proliferation (see Figure 4.2 E). Overall these results indicate 
that dominant negative Sox18+/Op mutation affects hair follicle development of all hairs 
especially in zigzag and auchene hair types immediately post placode development.  
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4.5.3. Sox18 Loss of Function Inhibits Dermal Papilla Formation but Not Its Specification 
In accordance with our initial findings of Sox18 expression in the DC, we sought to 
determine whether Sox18 mutation was affecting DC specification. Although some Sox2 
positive DCs could be identified in primary hair follicles at E18.5 and P0 (see Figure 4.3 A), 
secondary and tertiary hair remnants completely lacked DC differentiation as no alkaline 
phosphatase, αSMA or CD133 staining could be identified at the extremity of invaginating 
epithelial structures (see Figure 4.3 B-D). Sox18+/Op mutant mice had similar levels and 
 
 
 
Figure 4.2. Hair follicle development is delayed and hair type ratios are altered in 
Sox18+/Op skin compared to littermate controls. A) Haematoxylin and Eosin staining of 
control littermate and Sox18+/Op skin at E14.5, E16.5, E18.5 and P0. Black arrows indicate 
primary follicles, * indicate secondary follicles and ^ indicates tertiary follicles. B) 
Immunodetection of Ki67, co-stained with Keratin14, K14 (green), in control and Sox18+/Op 
skin during hair follicle development at E16.5 and E18.5. C) Quantification of hair types in 
Sox18+/Op compared to control/WT skin and Sox18-/- null mice (as reported in (Pennisi et al., 
2000a)). D) Haematoxylin and Eosin staining at P22 postnatal mice, black arrow indicates 
guard hair and white arrow indicates hair remnant. E) Immunodetection of Ki67 (red), co-
stained with K14 (green) in control and Sox18+/Op skin displaying guard hair follicle 
development at P22. Inset displays Ki67 expression in hair remnants in Sox18+/Op mice. 
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distribution of CD26+ and Dlk1+ mesenchymal progenitors suggesting that the early 
events preceding DC formation were not altered in these mutants during hair follicle 
formation (see Figure 4.3 E-F). Furthermore, we showed that the Wnt signalling 
responsible for DC specification was occurring normally as Lef1 staining could be detected 
in the condensate of developing hair follicles at all stages (see Figure 4.3 G-I). These 
findings indicate that Sox18’s dominant negative effects lead to a defect that initially allows 
formation of a mesenchymal condensate with Lef1 expression. However, this DC does not 
seem to specify further into a DP and to generate the second dermal signal for hair follicle 
development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5.4. Dominant Negative Sox18 Function Disturbs Guard Hair Follicles Development and 
Cycling 
Although we showed that Sox18 is expressed in E14.5 DCs, the Sox18+/Op mutation 
did not seem to prevent the formation of DP in guard hairs, allowing their development. To 
determine whether these guard hair follicles were normal, we explored their morphology 
and cycling. Firstly, analysis of the hair showed morphological differences in the hair shaft 
of Sox18+/Op mice compared to littermates. Sox18+/Op hairs appeared to resemble guard 
hairs however were in general longer and often showed a bent shape, though never to the 
same level as control awl hair types (see Figure 4.4 A) and the hair density on the back 
skin was certainly decreased in Sox18+/Op skin (see Figure 4.4 B). Consistent with their 
 
 
 
Figure 4.3. Dermal papilla differentiation is inhibited in Sox18+/OP skin. 
Immunofluorescence staining of skin sections from Sox18+/OP (RaOP) and WT littermate 
controls. A) Sox2 (green) immunofluorescence at E18.5. B-D) Dermal papilla markers at P0: 
B) Alkaline Phosphatase staining (blue colour). C) alpha-smooth muscle actin (red) stains 
the DP and the dermal sheath in addition to pericytes and D) CD133 (red) stains the DP in 
control P0 skin. E) CD26 (green) and F) Dlk (red) reveal the normal separation of papillary 
fibroblasts and pre-adipocytes. G-I: Lef1 (green) expression in developing hairs at D) E14.5, 
E) E16.5 and F) E18.5 in control and Sox18+/OP skin.  
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increased length, Ki67 staining also identified that Sox18+/Op hair follicles did not stop 
proliferating and did not enter telogen which occurred normally at P22 in control littermates 
(see Figure 4.4 C). To better characterise the remaining guard hair cycling, we crossed 
Sox18+/Op mice with a Flash reporter line expressing luciferase in cells with active 
canonical Wnt signalling (Hodgson et al., 2014). Luminescence in Sox18+/Op:Flash+/- mice 
indicated that Wnt signalling, and therefore hair growth, was much reduced in Sox18+/Op 
mice compared to controls, at all phases of the hair cycle (see Figure 4.4 D). Lef1 
immunofluorescence performed on adult skin further confirmed that the remaining Wnt 
signal activation in Sox18+/Op skin was originating from the epidermal compartment of the 
skin and seemed reduced in intensity in Sox18+/Op mice (see Figure 4.4 E). Quantification 
of luminescence over time also indicated that the peak growth phase of anagen was 
delayed in Sox18+/Op mice during both development and the first anagen. However, there 
seemed to be some variations in Wnt signalling reminding a normal cycling (see Figure 4.4 
F). 
To understand this alteration in cycling we next evaluated the effect of loss of Sox18 
function in the DP on the epidermal compartment. We first investigated hair differentiation 
using an AE13 antibody which showed that the differentiated inner root sheath was 
completely absent from follicle remnants, but also severely reduced in the remaining guard 
hairs in the Sox18+/Op mouse (see Supplemental Figure 4.2). We then analysed epidermal 
progenitor cell markers, with Sox9 staining indicating that mutant mice maintained a 
proliferative progenitor compartment comparable to controls (Vidal et al., 2005). However, 
markers of dormant epidermal bulge stem cells, Nfatc1 and CD34, appeared significantly 
reduced in Sox18+/Op compared to control follicles (see Supplemental Figure 4.2 B-D). The 
loss of this population combined with the observed hyperproliferation, lack of telogen 
stage, increased hair length suggested an excessive activation of hair follicle stem cells 
maintaining an anagen phase permanently that would result in their exhaustion at later 
stages. In accordance with this hypothesis, in 12 month old Sox18+/Op mice, all hair shafts 
were lost and only few hair remnants were still observed that no longer showed positive 
staining for Sox9 (see Supplemental Figure 4.2 E-F). 
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Figure 4.4. Sox18+/Op guard hairs exhibit constant proliferation and altered hair cycle. 
A) Control and Sox18+/Op hair types, viewed at same magnification. B) Whole mount 
visualisation of Control and Sox18+/Op skin identifying differences in hair shaft density in the 
skin. C) Ki67 (brown) immunostaining in P1, P14 and P22 skin indicates continual 
proliferation in the remaining guard hairs, back arrows, despite telogen entry, indicated by 
decreased Ki67 positive hair follicles in P22 control skin. D) Sox18+/Op:Flash+/-  and Flash+/-  
control mice were injected with luciferin at P1, P5, P7, P9, P16 and P22 of age and imaged 
for bioluminescence. E) Lef1 immunostaining showed Lef1 staining in the hair matrix and 
dermal papilla during early anagen at p24 in Flash+/- control mice however in 
Sox18+/Op:Flash+/-   mice Lef1 is only detectable in guard hairs, only in the epidermal matrix 
compartment. F) Quantification of bioluminescence over time post birth, n=22 Control and 
n=23 Sox18+/Op, data shows mean +/-SEM. 
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Supplemental Figure 4.2. Decreased hair differentiation and lack of stem cell 
quiescence in guard hairs in Sox18+/OP mice. A) AE13 (green) in P24 skin control, 
Sox18+/OP (RaOP) guard and non-guard hair remnants. B) Sox9 (red) in P24 skin control, 
Sox18+/OP guard and non-guard hair remnants. C) Nfatc1 (green) in P22 skin control, 
Sox18+/OP guard and non-guard hair remnants. D) CD34 (red) and K14 (green) in P24 skin 
control, Sox18+/OP guard and non-guard hair remnants, white arrows indicate regions of 
CD34/Keratin14 co-staining. E-F) WT and RaOP skin at 1 year of age. E) Haematoxylin and 
eosin stain, F) Sox9 staining (green) counterstained with DAPI. 
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4.5.5. Sox18 Function Is Cell Autonomous in Dermal Mesenchymal Cells during Hair 
Regeneration 
Given the multistep interactions between epithelium and the underlying mesenchyme, 
it could be argued that the defect observed in Sox18+/Op mice is due to a failure of the 
mesenchyme to specify epidermal hair follicle fate. In order to ensure that the Sox18+/Op 
mutation was responsible for a mesenchymal and not an epithelial defect in hair follicle 
formation we made use of hair regeneration assays. Wild-type (WT) or Sox18+/Op mutant 
neonatal dermis and keratinocytes were mixed in multiple combinations and 
subcutaneously injected into Nude mice to assess hair follicle regeneration (see Figure 
4.5). WT keratinocytes combined with WT dermis resulted in significant hair regeneration 
two weeks post injection (see Figure 4.5 A) while combination of Sox18+/Op keratinocytes 
and Sox18+/Op dermis recapitulated the Sox18+/Op phenotype of greatly decreased hair 
formation (see Figure 4.5 B). Interestingly, WT keratinocytes combined with Sox18+/Op 
dermis could not induce hair regeneration (see Figure 4.5 C) while Sox18+/Op keratinocytes 
and WT dermis produced hair follicles normally (see Figure 4.5 D), suggesting that the 
defect was of dermal origin.  
We next developed neonatal dermal-derived spheres, adopting the skin-derived 
precursor (SKP) culture method from both WT and Sox18+/Op mutant mice (Biernaskie et 
al., 2007; Biernaskie et al., 2006). SKPs were easily produced from neonatal dermis and 
expressed mesenchymal markers without any sign of hematopoietic or endothelial 
contamination. Of interest, they also unanimously expressed Sox2 (see Supplemental 
Figure 4.3). As we obtained SKPs from Sox18GCre/ER mice, GFP expression in the SKPs 
clearly revealed the expression of Sox18 in these cells derived from the DP (see 
Supplemental Figure 4.3). SKPs from Sox18+/Op mice did not change the phenotype 
observed in hair regeneration assays when added to Sox18+/Op dermis and keratinocytes 
(see Figure 4.5 E). However, WT dermal-derived SKPs partially restored hair regeneration 
in the same assay mixing mutant dermis and keratinocytes (n=3) (see Figure 4.5 F). This 
confirms that the Sox18 function is cell autonomous and indicates that WT dermal SKPs 
have intrinsic Sox18-dependent properties that can rescue the defect resulting from 
dominant negative Sox18 mutation in the dermal component. 
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Figure 4.5. Wild-type dermal derived spheroids (SKPs) rescue hair regeneration 
assays using Sox18+/OP cells. Photomicrograph of whole mount subcutaneous view of 
patches obtained in hair regeneration assays by subcutaneous injection of different cell 
populations. A) Patch assay performed by combining neonatal WT keratinocytes and WT 
dermis. B) Patch assay performed with neonatal Sox18+/Op keratinocytes and Sox18+/Op 
dermis. C) Patch assay performed with WT keratinocytes and Sox18+/Op dermis. D) Patch 
assay performed with Sox18+/Op keratinocytes and WT dermis. E) Patch assay performed 
with Sox18+/Op dermis and keratinocytes with the addition of Sox18+/Op dermal-derived 
SKPs. F) Patch assay performed with Sox18+/Op dermis and keratinocytes with addition of 
WT derived SKPs. Images are representative of three independent experiments. 
 
 
 
 
 
 
 
Supplemental Figure 4.3. Skin-derived precursors (SKPs) isolated from neonatal 
dermis express Sox2 and Sox18. Left panel) Neonatal SKPs generated from wild-type 
mice were stained for Sox2 (green) and counterstained with DAPI (blue). Other panels) Live 
imaging of neonatal SKPs generated from Sox18GCre/ER mice showing GFP expression in 
forming spheres over time after culture (as indicated on each panel). 
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4.5.6. Sox18 Dominant Negative Gene Expression Alterations   
In order to better understand how dominant negative Sox18 mutation is affecting the 
DP we performed gene expression microarray on SKPs isolated from Sox18+/Op and WT 
littermate neonates that demonstrated differential hair inductive capacity. Comparisons 
were made within the same litter and animals were matched for sex. Unsupervised 
clustering analysis classified samples according to their genotype (see Supplemental 
Figure 4.4). 2570 genes were differentially expressed with a p-value less than 0.05 after 
correction for multiple testing. Among these, 576 showed over two-fold difference between 
control and Sox18+/Op SKPs. This gene set was enriched for response to interferon-γ, 
immune response and muscle contraction. Among the dysregulated genes, Wnt5a (2.40 
fold, p<0.05), FGF7 (2.20 fold, p=0.014), Wnt7b (2.20 fold, p<0.05), MMP9 (18.11 fold, 
p<0.05) and Tnc (1.8 fold, p<0.01), all known as important contributors to the regulation of 
hair cycling or hair development by the DP, were significantly downregulated in Sox18+/Op 
mutants. Other genes such as Epha7, a known target of Sox18, were also downregulated 
(2.4 fold, p<0.05) (Hoeth et al., 2012). Wnt5a, MMP9 and Tnc downregulation was 
confirmed by RT-PCR in Sox18+/Op compared to control SKPs (see Figure 4.6 A-C). 
Furthermore, Wnt5a and Tnc immunofluorescence showed a significant reduction of 
expression in the Sox18+/Op skin, in part explaining the observed phenotype (see Figure 
4.6 D-E) (Kaplan and Holbrook, 1994; Youssef et al., 2012). 
To enrich further for genes important for hair development regulation and specifically 
expressed in the DP, we next compared our results to previously published gene 
expression signatures of dermal papillae (Driskell et al., 2009; Rendl et al., 2005) and 
identified eight high priority candidate genes that could be found in all three datasets (see 
Figure 4.6 F). These genes were affected by Sox18 mutation and were previously 
identified as DP signature genes (Driskell et al., 2009; Rendl et al., 2005). This list 
included Wnt5a and FGF7, previously mentioned as important initiators of hair growth 
(Reddy et al., 2001; Rosenquist and Martin, 1996) but also identified Frzb, Enpp2, Gpx3, 
Plod2 and Cd1d1 that were confirmed to be differentially expressed by RT-PCR (see 
respectively Figure 4.6 G-K). 
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Figure 4.6. Expression array identifies genes affected by Sox18 loss of function. A) 
Realtime PCR on cDNA from dermal SKPs for Wnt5a (control n=5, Sox18+/OP n=5), B) 
MMP9 (control n=6, Sox18+/OP n=6) and C) Tnc (control n=5, Sox18+/Op n=3) as genes 
regulated by Sox18 activity. D) Wnt5a (red) immunostaining in E18.5 control and Sox18+/OP 
skin, and E) Tenascin-C (Tnc-C, red) immunostaining in E18.5 control and Sox18+/OP skin. 
F) The Venn diagram represents comparison of our list of 583 significantly different, over 2 
fold Sox18 regulated genes in SKPs compared to the combined guard/awl/auchene and 
zigzag dermal papilla gene list of Driskell et al. (2009) and the dermal papilla signature gene 
list of Rendl et al. (2005) (For complete list see Supplemental Table 4.2) (Driskell et al., 
2009; Rendl et al., 2005). 8 genes were identified as shared by all three datasets. RT-PCR 
validation of expression of these genes in Sox18+/Op SKPs compared to controls, G) Frzb 
(control n=5, Sox18+/Op n=3), H) Ennp2 (control n=5, Sox18+/Op n=3), I) Gpx3(control n=5, 
Sox18+/Op n=3), J) Plod2 (control n=5, Sox18+/Op n=3), K) Ennp2 (control n=5, Sox18+/Op 
n=3). Error bars: SD. 
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4.6. Discussion 
Hair follicle development is a tightly regulated process requiring an intimate interaction 
between the epidermis and the underlying dermis. Although many of the molecular cues 
driving hair follicle epidermal specification are established, the factors important for the 
development and function of their mesenchymal counterparts in the dermal clusters and 
 
 
 
 
 
Supplemental Figure 4.4. Unsupervised hierarchical clustering of WT and Sox18+/Op 
SKPs. Gene expression analysis of Sox18+/Op and WT SKP spheres derived from 
littermates matched for sex allowed clear clustering of mutant and control mice. 
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DP remain to be clarified. We here examined Sox18 in hair development and identified its 
essential role for DP function, especially in secondary and tertiary hairs. Indeed, Sox18 
was expressed in a highly temporally restricted manner in the developing DP of all hair 
follicle types. Sox18 was co-expressed with Sox2 during primary or guard hair 
development and secondary or awl and auchene hair development, whereas it was 
expressed alone in tertiary or zigzag hairs. Dominant negative mutation of Sox18 in the 
Sox18+/Op mouse model inhibited DP formation without affecting early stages of dermal 
condensation, indicating that Sox18/SoxF are necessary for progression of the DC into a 
fully functioning DP that is supportive of hair growth. The absence of other SoxF family 
members in the DC of dorsal skin further supported the important role of Sox18 in this 
process. SKPs from WT mice restored the  Sox18+/Op phenotype in hair regeneration 
assays further demonstrating that the defect in Sox18+/Op mice is dermal and that Sox18 
function is cell autonomous. Finally, gene expression arrays using SKPs identified Wnt5a 
among other genes as a potential downstream effector of Sox18 driving hair follicle 
development. 
A first contradiction that motivated this study was the proposed role of Sox18 in only 
zigzag hairs opposed to its observed expression in the DC at E14.5 (Pennisi et al., 2000a). 
Our data undoubtedly indicate that Sox18 is expressed at the RNA level in the 
mesenchymal component of all hair follicles for a limited time. Indeed, using the 
Sox18GCre/ER model, we identified that Sox18 expression was limited to a small number 
of cells in the DC, and was only present at stage 1-2 of hair follicle development (Paus et 
al., 1999). When the follicle developed beyond stage 3, when the DP is engulfed by the 
epidermal matrix, Sox18 expression could no longer be detected in primary or secondary 
follicles. Lineage tracing studies further confirmed a broader expression of Sox18 in most 
DC cells in primary follicles. To date there is no reliable anti-Sox18 antibody allowing a 
robust confirmation of protein expression. The tight temporal expression pattern of Sox18 
explains its absence in previous studies that examined primary hairs (guard hairs) at E16.5 
(Driskell et al., 2009). 
The inhibition of hair development in Sox18+/Op skin supports that Sox18/SoxF are 
required for the normal formation of the DP. The neonatal epidermis was not affected by 
dominant negative Sox18 mutation as it could be induced to form hair follicles. This clearly 
indicated that the dermal component of the skin was modified in Sox18+/Op. The papillary 
and non-papillary dermis in the Sox18+/Op displayed normally the CD26 and Dlk1 
populations suggesting that progenitor populations giving rise to DC were not affected. 
Initial condensation of the mesenchyme also occurred in Sox18+/Op skin. Moreover, Sox2 
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expression was normally detected in primary and secondary DCs and Lef1 expression 
could be detected in the developing DCs in all three hair types suggesting that the first Wnt 
signal from the epidermis was not the reason for the hair defect.  The formation of the hair 
placode was not affected, suggesting that the first ‘inductive’ dermal signal was 
independent of Sox18 activity. Rapidly, after DC formation in Sox18+/Op mice at all stages, 
there was a defect in epidermal invagination and proliferation suggesting that the second 
dermal signal inducing hair follicle growth was absent. In addition, after Lef1 expression, 
Sox18+/Op skin did not display normal DP formation as witnessed by the loss of CD133, 
αSMA and alkaline phosphatase activity, commonly used markers of differentiated DP. 
Combined these data suggest that Sox18 is necessary post-DC induction for the 
differentiation of functional DP cells and their hair inductive properties. Our gene 
expression array and further validation clearly identified Wnt5a among potential candidates 
affected by Sox18 mutation that might be necessary for hair development. 
The role of Sox18 in the DP of primary hair follicles was not limited to a single point of 
functionality during development. Indeed the absence of functional Sox18 at that critical 
time point at E14.5 in primary DCs had long term consequences despite the expression of 
Sox2. Our observations suggest that the mesenchymal component of guard hairs could 
not regulate the epidermal component of the hair follicles resulting in a loss of the 
quiescent epidermal stem cell population, extended anagen periods, poor differentiation 
possibly due to reduced Wnt signalling and finally long term exhaustion of epidermal stem 
cells. These indirect effects on the epidermis in guard hairs further highlight the importance 
of Sox18 activity in the long-term regulatory function of the DP. 
While we identify that Sox18 is expressed in all flank follicles, the difference in 
phenotype in guard versus awl/auchene/zigzag hairs observed in the Sox18+/Op model 
suggests that Sox18 function is different in different hair types. We propose that 
interactions between Sox18 and other Sox factors, such as Sox2, may be behind the 
observed hair type differences.  The Sox18+/Op mutation, a single point cytosine mutation 
at residue 1048, creates a missense transcript and a truncated version of the protein that 
prevent this transcription factor to recruit normal Sox18 or its interacting partners Sox7 or 
Sox17 (James et al., 2003). The absence of Sox7 and Sox17 in the DC of all hair types in 
dorsal skin strongly suggests that Sox18 is the only SoxF family member involved in hair 
development in conjunction with Sox2.  
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4.7. Conclusion 
In summary, Sox18 expression is spatio-temporally regulated and detected in the 
mesenchymal component of all developing hair types. Its function is required to mediate 
DP differentiation and promotion of epidermal changes that will form the hair possibly 
through Wnt5a activity. Sox18 function at E14.5 is further needed for proper regulation of 
quiescence and cycling of guard hair epidermal stem cells. These findings elucidate the 
development of the DP as well as the mechanism of the human HLT syndrome. This will 
open new avenues in the identification of the molecular cues in the dermal component 
leading the development of hair follicles. 
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Chapter Five 
Consequences of In vivo Conditional STAT5 Inhibition in the 
Dermal Papilla on Hair Follicle Cycling 
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5.1. Rationale 
To investigate the importance of STAT5 activity in regulating mature cycling hair 
follicles, in vivo inhibition of STAT5 can be performed through pharmacological inhibitors, 
and through a conditional knockout model using the cre-lox system. In vivo inhibition 
experiments have the potential to provide further insight regarding the role of STAT5 
during normal mature hair follicle cycling, as opposed to assays using in vitro techniques. 
Previous studies have shown that STAT5B knockout mice exhibit a hair phenotype; 
however this has not been investigated further (Udy et al., 1997). Furthermore, recent 
studies have shown that pharmacological inhibition of JAK/STAT signalling has the ability 
to reverse alopecia areata, but its effect on normal hair cycling has not been examined in 
detail (Xing et al., 2014).   
Finally, Sox18 has been shown to be expressed in the DP of the majority of murine 
back skin hair types and important for hair follicle type determination, with results 
described in Chapter 4 of this thesis suggesting that Sox18 expression is functionally 
important in driving DC formation and hair follicle development.  As a result, 
Sox18GCre/ER mice present as a useful model for conditionally targeting the DP.  
 
5.2. Abstract 
Previous studies have shown that STAT5B knockout mice exhibit a prolonged telogen 
phase during hair cycling; however, it is unclear whether STAT5B has a role in the DP or 
in the epidermis (Udy et al., 1997).  Subsequently, a breeding strategy was adopted to 
generate Sox18GCre/ER STAT5lox/lox mice in order to conditionally delete STAT5 within 
the DP and observe the consequences on hair follicle cycling.  Incorporation of the Flash 
Wnt-reporter transgene allowed quantification of hair follicle cycling through 
bioluminescence.  Upon conditional ablation of STAT5A and STAT5B in the DP by P19, 
the onset of the second postnatal anagen phase was delayed compared to the control 
group, and this was confirmed through bioluminescence and histology.  Finally, 
pharmacological STAT5 inhibition experiments were conducted using systemic treatment 
of Flash mice with ruxolitinib, a JAK1/2 inhibitor. No difference in the onset or progression 
of anagen was observed in the ruxolitinib-treated group compared to the control group.  
Overall, the findings suggest that conditional deletion of STAT5 in the DP affects the hair 
follicle’s ability to enter anagen during adult hair follicle cycling and that this process is 
independent of JAK2. 
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5.3. Introduction 
The mesenchymal-epidermal interactions that occur during hair follicle cycling are 
complex and incompletely understood.  It is known that the DP is central to hair follicle 
regulation; however, signals involved in the initiation and maintenance of the various 
phases of the hair cycle continue to be uncovered (Fuchs, 2007; Fuchs et al., 2001).  One 
potential candidate that has arisen in recent times is the transcription factor, STAT5, with 
multiple gene expression array analyses and knockout studies supporting a role for STAT5 
in hair follicle cycling (Driskell et al., 2009; Rendl et al., 2005; Udy et al., 1997). 
A study using multicolour labelling to sort various populations of cells within the hair 
follicle followed by microarray gene expression analysis was able to define a specific 
“molecular signature” for each of the populations obtained.  These populations included 
the DP, dermal fibroblast, matrix, ORS, and follicular melanocyte cells.  The study 
attributed a specific genetic signature to each population according to which genes were 
specifically upregulated by over two-fold compared to each of the four other populations.  It 
was found that STAT5A and STAT5B formed part of the genetic signature that was 
determined for the DP (Rendl et al., 2005).  Two later studies involving microarray gene 
expression analysis of DP cells also found that STAT5A was differentially expressed 
(Biernaskie et al., 2009; Driskell et al., 2009).  These findings further implicate STAT5 in a 
previously undescribed role in DP signalling. 
In an unrelated study examining the role of STAT5B in growth hormone signalling, it 
was noted that a hair phenotype was present in STAT5B-/- mice.  The study found that the 
hair follicles of these mice appeared normal; however, the onset of the first postnatal 
anagen phase was observed to be delayed by at least two weeks compared to control 
animals.  The study did not conclude whether the phenotype was a result of insensitivity to 
growth hormone signalling, or a disruption of other signalling pathways related to hair 
follicle cycling (Udy et al., 1997). 
Recently, it has been shown that alopecia areata, an autoimmune disease 
characterised phenotypically by hair loss, is caused by an infiltration of cytotoxic CD8+ T 
lymphocytes around the hair follicle.  It was suggested that interferon-γ produced by these 
T cells and the subsequent IL-15-mediated inflammatory response was responsible for the 
pathogenesis of alopecia areata.  Interestingly, it was found that ruxolitinib, a JAK1/2 
inhibitor, was able to not only prevent the onset of alopecia areata but reverse the 
condition, resulting in significant hair regrowth (Xing et al., 2014). 
A recent investigation of hair follicle stem cell quiescence has found that 
calcineurin/Nfatc1 signalling regulates the expression of PRLR in bulge stem cells.  It was 
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found that downstream activation of STAT5 by PRLR results in the quiescence of bulge 
stem cells observed during pregnancy and lactation.  Although this implicates STAT5 in 
the regulation of hair cycling, these mechanisms were observed in the epidermal 
component and not the DP. Furthermore, these effects are described in hair follicle cycling 
during pregnancy and not during native hair cycling.  Notably, the study showed 
localisation of activated STAT5 within the DP; however, this did not appear to be related to 
prolactin signalling (Goldstein et al., 2014). 
Taken together, these studies suggest STAT5 plays an undescribed role in the 
regulation of hair follicle cycling by the DP that warrants further investigation.  Results from 
previous chapters of this thesis demonstrate that STAT5 is expressed in the DP at time 
points that suggest a role in telogen to anagen transition, and in vitro manipulation of 
STAT5 has shown that those cells with constitutively-active STAT5 are more effective at 
forming hair follicle dermal papillae.  Therefore, investigation of the effects of STAT5 
manipulation in vivo is a logical progression in determining its role in hair follicle cycling.  
To do so, a STAT5 conditional knockout model was developed using Sox18GCre/ER mice 
to target the DP, which was first validated through immunofluorescence and by crossing 
with a cre reporter strain.  In addition, the effects of pharmacological inhibition of STAT5 
would be examining using agents known to inhibit the JAK2/STAT5 pathway. 
It was hypothesised that when STAT5 is inhibited in vivo through both conditional 
deletion and pharmacological agents, transition from telogen to anagen would be delayed 
compared to control animals.  This hypothesis would be investigated by developing a cre-
lox conditional knockout model targeting STAT5 in the DP, and by using ruxolitinib, an 
inhibitor of JAK1/2.  The effects of in vivo STAT5 inhibition would be examined in the 
natural hair follicle cycle, as opposed to pathological conditions. 
 
5.4. Materials and Methods 
5.4.1. Mice 
All mouse work was approved by the University of Queensland Animal Ethics 
Committee and performed in accordance with institutional ethical guidelines.  Mouse 
strains used for these studies included the Topflash, Sox18GCre/ER, YFPlox-stop-lox and 
STAT5lox/lox strains described in Table 2.1. 
 
5.4.2. Mouse Models 
Firstly, Sox18GCre/ER and YFPlox-stop-lox mice were crossed appropriately to generate 
experimental groups of Sox18GCre/ER+ and Sox18GCre/ER- mice, both homozygous for 
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the YFPlox-stop-lox reporter allele (see Figure 5.1). These mice were induced with a single 
dose of 1mg tamoxifen at birth or four consecutive doses of 1mg tamoxifen from P21, and 
were sacrificed at eight weeks of age. Non-induced control animals were also sacrificed at 
P3 and P21. 
To generate conditional knockout models, STAT5lox/lox mice were first crossed with 
Topflash reporter mice to generate mice homozygous for the STAT5 floxed allele 
containing the previously described Flash Wnt-reporter transgene (Hodgson et al., 2014).  
These mice were then crossed with Sox18GCre/ER mice to generate Sox18GCre/ER+ 
mice homozygous for the STAT5 floxed allele, while also containing the Flash reporter 
transgene (see Figure 5.2). These experimental mice were described as Topflash 
Sox18GCre/ER+ STAT5lox/lox.  Recombination in these mice and their appropriate control 
groups was induced at birth using a single dose of 1mg tamoxifen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Cre-lox breeding strategy to examine Sox18 expression using 
Sox18GCre/ER and EYFP reporter mice. Sox18GCre/ER (Sox18Cre) mice were mated 
with YFPlox-stop-lox for one generation and their progeny backcrossed to YFPlox-stop-lox mice to 
generate Sox18GCre/ER mice homozygous for the YFPlox-stop-lox reporter allele.  The 
experimental and control groups shown were induced at birth with tamoxifen. 
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5.4.3. Pharmacological Inhibition 
For pharmacological inhibition experiments, six-week old Topflash mice were used 
that were determined to be in telogen phase through bioluminescence imaging.  Mice were 
injected with either 1mg of ruxolitinib (ChemieTek, IN, USA) intraperitoneally or a vehicle 
control each day for seven days.  Mice were imaged daily to examine bioluminescence. 
 
5.4.4. Bioluminescence Imaging 
Mice were imaged according to the methods described in section 2.4.4 of this thesis.  
Briefly, mice were anaesthetised and prepared for imaging by removing dorsal hair using 
electric clippers and commercially-available hair removal cream.  Mice were injected 
intraperitoneally with 150mg/kg firefly D-luciferin substrate (Regis Technologies, IL, USA) 
and imaged using the Xenogen IVIS® Spectrum bioluminescence imaging system 
(PerkinElmer, MA, USA) and Living Image® 3.2 software (Caliper Life Sciences, MA, 
USA).  
 
 
 
 
 
 
 
Figure 5.2. Breeding strategy for the generation of Topflash Sox18GCre/ER+ 
STAT5lox/lox experimental animals.  Sox18GCre/ER (Sox18Cre) mice were mated with 
STAT5lox/lox mice for two generations to generate Sox18GCre/ER mice homozygous for the 
STAT5lox/lox allele. These animals were then crossed with STAT5lox/lox mice that had been 
previously crossed with Topflash mice to incorporate the Topflash reporter allele into their 
genome. The desired experimental and control groups shown were induced at birth with 
tamoxifen. 
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5.4.5. Immunofluorescence 
Sox18GCre/ER+ YFPlox-stop-lox animals were humanely sacrificed at P3, P21 and P56.  
Back skin was collected and prepared for frozen section immunohistochemistry as 
described in section 2.2.3.  Immunofluorescence staining for CD31 (BD Biosciences, CA, 
USA; 1:50; Rat IgG), LYVE1 (Abcam, Cambridge, UK; 1:100 dilution; rabbit IgG) and GFP 
(Invitrogen, CA, USA; 1:200; Chicken IgY) was performed as described in section 2.2.3. 
Goat anti-rabbit Alexa® 488, Goat anti-rabbit Alexa® 568 and Goat anti-chicken Alexa® 488 
antibodies (all Invitrogen, CA, USA; all 1:500 dilution) were used as secondary antibodies. 
All sections were counterstained with DAPI (1:10000 dilution of 1mg/ml stock). 
Topflash Sox18GCre/ER+ STAT5lox/lox mice were humanely sacrificed at P55 and mice 
part of pharmacological inhibitor experiments sacrificed at D13.  Back skin was collected 
and prepared for paraffin immunohistochemistry as described in section 2.2.4.  
Immunofluorescence staining for phospho-STAT5 (Abcam, Cambridge, UK; 1:50 dilution; 
rabbit IgG), STAT5 (Abcam, Cambridge, UK; 1:50 dilution; rabbit IgG) and phospho-
STAT3 (Cell Signaling Technology, MA, USA; 1:50 dilution; rabbit IgG) was performed 
after heat-induced antigen retrieval using Tris-EDTA pH 9.0 at 105oC for 15 minutes in a 
decloaking chamber.  Goat anti-rabbit Alexa® 488 and Alexa® 568 antibodies (Invitrogen, 
CA, USA; 1:500 dilution) were used as secondary antibodies.  All sections were 
counterstained with DAPI (1:10000 dilution of 1mg/ml stock). 
 All images were captured using the Axio Imager M1 epifluorescence and brightfield 
microscope with AxioVision 4.8 software (both Carl Zeiss, Oberkochen, Germany), or the 
LSM 710 confocal microscope with Zen 2009 software (Carl Zeiss, Oberkochen, 
Germany).  Importantly, the Sox18GCre/ER mice used in this study express GFP under 
the control of the Sox18 promoter.  Therefore, it was necessary to carefully separate GFP 
and YFP channels to ensure no overlap in the detection ranges of their respective 
emission spectra. 
 
5.4.6. PCR 
Tissue samples were collected from mice after sacrifice in order to extract genomic 
DNA.  Using the commercially-available QIAamp DNA Mini Kit (Qiagen, Limburg, 
Netherlands), genomic DNA was extracted according to the manufacturer’s instructions 
and the following methods refer to reagents contained within the kit.  Briefly, tissue 
samples were digested in a combination of 20μl Proteinase K and 180μl of ATL buffer at 
55oC for four hours. 200μl of AL buffer was then added, and the samples were mixed with 
a vortex mixer prior to being incubated for a further 10 minutes at 70oC. 100% ethanol was 
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then added to the samples, which were then transferred into the provided columns and 
centrifuged at 17000 x g for one minute.  The flow through solution was discarded and 
500μl of AW1 buffer was added to the column membrane before being centrifuged again 
at 17000 x g for one minute.  The flow through solution was discarded again before adding 
500μl of AW2 buffer and centrifuging at 17000 x g for a further three minutes. Finally, 
genomic DNA was eluted with DNase/RNase-free UltraPure distilled water (Life 
Technologies, MA, USA). 
Primers to detect the presence of the floxed STAT5 allele and whether a conditional 
deletion had occurred were designed using Primer Express v3 (Applied Biosystems, CA, 
USA) and tested using the Basic Local Alignment Search Tool (National Centre for 
Biotechnology Information, MD, USA) to ensure there was no overlap against other 
genomic regions.  Primer sequences used to detect the floxed STAT5 allele and to detect 
the presence of a deleted allele are described in Table 5.1. 
 
Table 5.1. Primers used for STAT5 floxed allele and deleted STAT5 allele PCR 
STAT5 floxed allele  
Forward 5’-AAGTTATCTCGAGTTAGTCAGG-3’ 
Reverse 5’-AGCAGCAACCAGAGGACTAC-3’ 
Deleted STAT5 allele 
Forward 5’-CCCATTATCACCTTCTTTACAG-3’ 
Reverse 5’-AGCAGCAACCAGAGGACTAC-3’ 
 
Each PCR tube contained a mixture of 12.6μl DNase/RNase-free UltraPure distilled 
water (Life Technologies, MA, USA), 4μl Phire reaction buffer (Thermo Fisher Scientific, 
MA, USA), 1μl of forward primer, 1μl of reverse primer, 0.4μl 10mM dNTP mix, 0.4μl Phire 
Hot Start II DNA polymerase (Thermo Fisher Scientific, MA, USA) and 0.6μl of genomic 
DNA template.  PCR was then performed in the Tetrad® 2 thermal cycler (Bio-Rad 
Laboratories, CA, USA) under the following cycling conditions: hold at 98oC for three 
minutes; 35 cycles of 98oC for five seconds, 59oC for five seconds and 72oC for ten 
seconds; hold at 72oC for one minute; and a final hold at 4oC indefinitely. 
PCR products were then analysed by gel electrophoresis with expected bands at 
approximately 200 base pairs and 500 base pairs for the STAT5 floxed allele and deleted 
STAT5 allele conditions, respectively. 
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5.4.7. Statistical Analyses 
All statistical analyses were performed using GraphPad Prism v6 software (GraphPad 
Software, CA, USA).  Non-parametric data was analysed using Mann-Whitney tests and 
statistical significance was accepted at a p-value less than 0.05. 
 
5.5. Results 
5.5.1. Sox18GCre/ER Mouse Line Can Be Used to Target the Dermal Papilla in Inducible 
Conditional Knockout Models 
Sox18 has been shown to be a marker of zigzag hair follicle dermal papillae within 
mouse pelage, with expression occurring as early as E14.5 (Pennisi et al., 2000b).  Sox18 
has not been used previously to target the DP as part of a cre-lox recombination strategy, 
despite being a known DP marker. GFP immunofluorescence staining of non-induced 
Sox18GCre/ER+ YFPlox-stop-lox mice revealed positive staining within the DP of P3 neonates 
and P21 juveniles (see Figure 5.3 A).  This suggests that Sox18 continues to be 
expressed in the DP at least during postnatal hair follicle development and into the first 
telogen phase.   GFP-positive staining surrounding the hair follicle within the dermis was 
also noted, particularly at P3.  Co-localisation of GFP with the endothelial cell marker, 
CD31 (see Figure 5.3 B), and lymphatic endothelial cell marker, LYVE1 (see Figure 5.3 C), 
was observed through immunofluorescence.  However, co-localisation with GFP appeared 
more pronounced in CD31-positive cells compared to LYVE1-positive cells. YFP 
expression within the DP was investigated in skin samples that had cre-lox recombination 
induced at birth and P21, and collected at three or eight weeks of age.  It was found that 
YFP expression could be detected in the DP of mice induced at birth (see Figure 5.3 D), 
with no endogenous GFP detected at eight weeks.  Some YFP expression was also 
observed within cells of the surrounding dermis.  Little to no YFP expression could be 
detected in samples collected from mice induced at P21.  No YFP or GFP expression was 
detected in Sox18GCre/ER- YFPlox-stop-lox control mice.  This suggests that with the 
induction of recombination at birth, the DP can be effectively targeted using the 
Sox18GCre/ER mouse line.  Given the results of experiments in Chapter 4 of this thesis, it 
is expected that targeting will be restricted to zigzag hairs. 
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Figure 5.3. Immunofluorescence of Sox18GCre/ER+ YFPlox-stop-lox mice with or without 
induction of recombination.  A) Non-induced P3 neonatal (left) or P21 juvenile (right) skin 
sections showing GFP-positive staining of the dermal papilla (dotted line), indicative of 
Sox18 expression. B) GFP-positive cells can be seen in the dermis surrounding the hair 
follicle (left) and appear to co-localise with CD31-positive cells (right).  C) GFP-positive cells 
surrounding the hair follicle (left) co-localise to a lesser extent with LYVE1-positive cells 
(right). D) Induction of cre-lox recombination with tamoxifen at birth results in detection of 
YFP within the dermal papilla (dotted line) at eight weeks in Sox18GCre/ER+ YFPlox-stop-lox 
experimental animals (right), whereas no YFP is detected in Sox18GCre/ER- YFPlox-stop-lox 
controls (left) also treated with tamoxifen at birth. Scale bar = 50μm. 
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5.5.2. In vivo STAT5 Conditional Knockout in the Dermal Papilla Results in Delayed 
Anagen Entry in the Second Postnatal Hair Cycle 
After confirming that the Sox18GCre/ER mouse line is suitable for targeting the DP in 
an inducible conditional knockout model, Topflash Sox18GCre/ER+ STAT5lox/lox mice were 
produced to specifically delete STAT5 within the DP and follow the hair phenotype through 
a luciferase reporter.  Hence, hair cycling was quantified through bioluminescence of back 
skin.  Conditional deletion through cre-lox recombination was induced at birth in an attempt 
to observe potential hair cycling defects beginning with the first postnatal cycle.   
Firstly, to confirm successful recombination following induction by tamoxifen, genomic 
DNA was analysed by PCR.  It was confirmed that recombination and subsequent deletion 
of STAT5 had occurred in Topflash Sox18GCre/ER+ STAT5lox/lox mice (STAT5 cKO group) 
through the presence of a band indicating deletion of the STAT5 allele, whereas this was 
not present in Topflash Sox18GCre/ER- STAT5lox/lox mice (control group) (see Figure 5.4 
A). 
Next, successful deletion of STAT5 in the DP was investigated further through 
immunofluorescence staining for phospho-STAT5.  As telogen hair follicles are expected 
to display phospho-STAT5 staining in the DP (as described in Chapter 3), this hair cycle 
phase was chosen for histological analysis.  It was found that telogen hair follicles in 
samples from the STAT5 cKO group were devoid of phospho-STAT5 expression in the 
DP. This is in contrast to the expected phospho-STAT5 staining found in telogen hair 
follicles of control group samples (see Figure 5.4 B).  Furthermore, phospho-STAT5 
expression could still be seen in the DP of Sox2-positive hair follicles within the STAT5 
cKO group (see Figure 5.4 C).  These findings suggest that cre-lox recombination has 
occurred as expected in Sox2-negative DPs where STAT5 has been inhibited.  
Regarding the effects on hair cycling, analysis of bioluminescence found that the 
STAT5 cKO group appeared to exhibit a slight delay in anagen entry as indicated by 
luminescence values in the first postnatal hair cycle compared to the control group as they 
began to enter anagen at P28; however, this was not statistically significant (p=0.33).  
However, upon completion of the first postnatal hair cycle, luminescence remained 
significantly lower in the STAT5 cKO group compared to the control group at P49 (p<0.05), 
P52 (p<0.001) and P54 (p<0.01) (see Figure 5.4 D) showing a delayed entry into the 
subsequent anagen phase.  Analysis of back skin percentage in anagen found that a 
significantly higher percentage of back skin had entered anagen phase by P52 in the 
control group (24.07±27.15%) compared to the STAT5 cKO group (0% for all mice) 
(p<0.05, n=9 control vs. n=6 STAT5 cKO) (see Figure 5.4 E and G).  Together, these 
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findings suggest that anagen entry is delayed in the STAT5 cKO group compared to the 
control group. 
Analysis of hair follicle types found no significant difference in the proportion of guard, 
awl/auchene and zigzag hair types between the control and STAT5 cKO groups. As 
expected, the most abundant hair type in both conditions was zigzag (78.89±8.87% 
control, 76.74±10.71% STAT5 cKO, p=0.83), followed by awl/auchene (17.51±7.45% 
control, 19.93±10.44% STAT5 cKO, p=0.66) and then guard (3.70±1.43% control, 
3.33±0.98% STAT5 cKO, p=0.97) (see Figure 5.4 F). 
Finally, histological analysis of skin samples taken from each group following sacrifice 
at P54 confirmed that hair follicles in control group animals were more advanced in the 
hair follicle cycle compared to hair follicles of STAT5 cKO group animals (see Figure 5.4 
H).  This was reflective of the findings for hair cycle quantification through bioluminescence 
and overall, provides strong evidence to suggest that the second postnatal anagen phase 
is delayed in the STAT5 cKO group. 
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Figure 5.4. In vivo STAT5 inhibition in the dermal papilla delays onset of the second 
postnatal anagen phase.  A) PCR showing presence of a floxed STAT5 allele (top) and/or 
deleted STAT5 allele (bottom). i: STAT5lox/wt ii: STAT5lox/lox iii: negative control iv: STAT5 
cKO positive control v: no template vi: STAT5 cKO group animal vii: ladder. B) Phospho-
STAT5 staining of control group (top) or STAT5 cKO group (bottom) skin samples. Dotted 
lines denote dermal papilla. C) Phospho-STAT5 staining (right) still present in Sox2+ dermal 
papillae (left) of STAT5 cKO skin samples.  Serial skin sections. Dotted lines denote dermal 
papilla.  D) Bioluminescence of control group (n=9) vs. STAT5 cKO group (n=6). Mean+/-
SD; *: p<0.05; **: p<0.01; ***: p<0.001.  E) Percentage of back skin in anagen for control 
(n=9) vs. STAT5 cKO (n=6) groups. Mean+/-SD; *: p<0.05. F) Proportions of hair follicle 
type in control (n=4) vs. STAT5 cKO (n=4) groups. Mean+/-SD. G) Bioluminescence at P52 
for control (left) vs. STAT5 cKO (right) mice. H) Histology of skin samples taken from control 
(top) and STAT5 cKO mice at P54. All scale bars = 50μm. 
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5.5.3. In vivo STAT5 Inhibition with Ruxolitinib Does Not Affect Natural Hair Follicle Cycling 
Ruxolitinib has been shown in a recent study to prevent onset of alopecia areata, as 
well as effectively reversing the condition once established (Xing et al., 2014).  Ruxolitinib 
is an inhibitor of JAK1/2 and has been shown to prevent phosphorylation of STAT5 as a 
downstream effect (Maude et al., 2015).  Given that the administering of ruxolitinib 
systemically has shown effects on hair cycling under pathological conditions, its effects 
during natural hair cycling was examined.  Indeed, in addition to the proposed mechanism 
of action around inhibition of CD8+ T cells, it may be argued that induction of prolonged 
telogen in hair follicles by inhibition of STAT5 could protect them from the pathological 
immune response. 
Systemic treatment with ruxolitinib was commenced in six-week old Flash mice in 
telogen phase in an attempt to observe any effects on hair follicle entry into the second 
postnatal anagen phase.  It was found that ongoing daily treatment with ruxolitinib did not 
show differences in luminescence compared to vehicle-treated controls at any time point, 
suggesting no difference in anagen entry or progression of the hair cycle (see Figure 5.5 A 
and B). 
The presence of phospho-STAT5 within the DP was examined through 
immunofluorescence and phospho-STAT5-positive dermal papillae were observed in both 
control and ruxolitinib-treated samples (see Figure 5.5 C).  Ruxolitinib is also known to 
inhibit phosphorylation of STAT3, which has been described in previous studies to be 
present in hair follicle keratinocytes and important for anagen progression (Maude et al., 
2015; Sano et al., 2000). Therefore, the presence of phospho-STAT3 was also examined 
in control and ruxolitinib treated skin samples.  Hair follicles at this time point were 
observed to be in telogen phase, and no phospho-STAT3 staining was found to be present 
in follicular keratinocytes in both the control and ruxolitinib-treated conditions.  However, 
phospho-STAT3-positive cells were observed in basal keratinocytes in both the control 
and ruxolitinib-treated conditions (see Figure 5.5 D).  Quantification of the number of 
phospho-STAT3-positive nuclei in the interfollicular epidermis revealed a significantly 
lower proportion of positive nuclei in the ruxolitinib-treated condition (25.61±8.62%, 
mean±SD, n=4) compared to the control condition (67.98±16.68%, mean±SD, n=4) 
(p<0.05) (see Figure 5.5 E).  
Together, these results suggest that ruxolitinib treatment is inhibiting JAK-dependent 
phosphorylation of STAT proteins, but does not affect STAT5 phosphorylation within the 
DP and has no effect on hair cycling in normal physiological conditions. 
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Figure 5.5. Systemic pharmacological inhibition of STAT5 with ruxolitinib does not 
affect hair follicle cycling.  A) Comparison of bioluminescence between Topflash Wnt-
reporter mice treated systemically with 1mg ruxolitinib daily or a vehicle control.  No 
significant difference was seen between the two conditions (n=4 ruxolitinib vs. n=4 control).  
B) Percentage of back skin in anagen for control (n=4) vs. ruxolitinib-treated (n=4) groups. 
C) Phospho-STAT5 immunofluorescence after five days of treatment showing positive 
staining in the dermal papilla (dotted lines) in both control (left) and ruxolitinib-treated (right) 
samples. Scale bar = 50μm. D) Phospho-STAT3 immunofluorescence after five days of 
treatment showing positive staining in the nuclei of interfollicular epidermal cells in the 
control condition (left), with less positive nuclei in ruxolitinib-treated (right) samples. Scale 
bar = 50μm. E) Quantification of phospho-STAT3 (pSTAT3)-positive cells within the 
interfollicular epidermis between control (n=4) and ruxolitinib-treated (n=4) groups. *: 
p<0.05.  F) Bioluminescence images of control (left) or ruxolitinib-treated (right) mice at 
D13. 
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5.6. Discussion 
Hair follicle cycling is a complex process that involves multiple signalling pathways 
both within and between the epidermal and mesenchymal components, as well as 
receiving cues from the macroenvironment.  The DP is known to be indispensable to hair 
cycling and although many of its signalling mechanisms are described, much remains to 
be uncovered. 
Described in previous studies as a marker of zigzag hair follicle dermal papillae, this 
study found that Sox18 is suitable for use to target the DP in conditional knockout studies 
(Pennisi et al., 2000a; Pennisi et al., 2000b).  By using inducible Sox18GCre/ER mice 
expressing GFP under control of the Sox18 promoter, this study found that Sox18 
continues to be expressed within the DP at neonatal (P3) and juvenile (P21) time points.  
This suggested that by inducing cre-lox recombination at these time points, the DP could 
be effectively targeted.  Indeed, it was found that by generating Sox18GCre/ER+ YFPlox-
stop-lox mice and inducing recombination at birth, cre-mediated deletion of the STOP codon 
resulted in YFP labelling of the DP that could be detected at eight weeks.  Curiously, 
induction of recombination in these mice at P21 resulted in only minimal detection of YFP 
in the DP at eight weeks, and this finding requires further investigation.  These findings 
suggest that the optimal time point for inducible targeted deletion within the DP using the 
Sox18GCre/ER line is at birth. However, Sox18 is known to be involved in the 
development of blood and lymphatic vessels, and therefore genetic deletion using the 
Sox18GCre/ER line may impair other developmental and physiological processes 
(Downes and Koopman, 2001; Francois et al., 2008).  This study confirmed through 
immunofluorescence that in neonates and at P21, Sox18 (visualised through GFP) co-
localised with CD31- and LYVE1-positive cells within the skin, markers of blood and 
lymphatic vessels, respectively.  This suggests that targeted deletion within the DP using 
the Sox18GCre/ER line must consider potential effects on vasculature and lymphatics.   
In this study, Sox18GCre/ER mice were crossed with STAT5lox/lox mice to create a 
STAT5 conditional knockout model targeting the DP. Previous studies that have developed 
STAT5A-/- and STAT5B-/- mice report that these mice are viable and display no 
abnormalities in vascular or lymphatic development (Liu et al., 1997; Udy et al., 1997). 
Therefore, it was anticipated that induction of recombination at birth would not have 
significant impacts on Sox18-expressing endothelial and lymphatic endothelial cells.  
Through visualisation of hair cycle dynamics using the incorporated Topflash Wnt-
reporter transgene, this study found that STAT5 deletion in the DP resulted in delayed 
entry into the second postnatal anagen phase.  This finding concurs with a previous study 
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that described a delay in anagen entry in STAT5B-/- mice (Udy et al., 1997).  However, the 
aforementioned study found that the first postnatal anagen phase was delayed by at least 
two weeks in STAT5B-/- mice, whereas our study found only a slight delay at the onset of 
the second postnatal anagen phase.  We found significantly lower luminescence levels, 
indicative of reduced Wnt/β-catenin signalling, in the STAT5 cKO group for at least six 
days and a consequent delay in anagen entry of at least three days compared to the 
control group.  This difference in severity of the phenotypes between studies is most likely 
attributed to the different experimental models investigated in each study.  The previous 
study utilised a ubiquitous STAT5B-/- model, while our study sought only to delete STAT5 
within the DP.  Therefore, it is likely that the effect seen on hair cycling in the earlier study 
is not a result of impaired DP signalling, but occurs due to alterations in another anagen-
inducing mechanism.  The effect on hair cycling observed in the STAT5B-/- mice may be 
due to impairments in adipocytes that were described (Udy et al., 1997).  Adipocytes within 
the hair follicle macroenvironment have been shown to contribute to bulge stem cell 
activation and the subsequent telogen to anagen transition, possibly exerting their effects 
through PDGF signalling (Festa et al., 2011).  Nevertheless, it is important to note the 
differences in quantification of hair cycle dynamics between studies, as our study used 
bioluminescence imaging to monitor Wnt/β-catenin signalling, while the earlier study used 
rudimentary methods of determining anagen entry.  Consequently, the difference in 
anagen delay between studies may not be as pronounced as it appears. 
Given that the use of Sox18GCre/ER was expected to target only zigzag hair follicles, 
effects on the proportion of this hair follicle type was investigated between experimental 
groups. Analysis of hair follicle type proportions between the control and STAT5 cKO 
groups found no significant difference in the proportion of guard, awl/auchene or zigzag 
hair follicles.  This finding was not surprising, as previous results described in Chapter 3 of 
this thesis do not indicate a role for STAT5 activation in the DP during hair follicle 
development, and therefore hair follicle proportions are not expected to be altered. 
Signalling pathways that have been implicated in the DP’s control of anagen induction 
in adult hair cycling include those of EPOR, PDGFRα and FGF receptor (Kang et al., 2010; 
Kawano et al., 2005).  Investigations into EPOR signalling specifically noted strong 
activation of STAT5 within the DP, and STAT5 is known to be implicated in PDGFRα and 
FGF receptor signal transduction (Kong et al., 2002; LeBaron et al., 2007; Piccaluga et al., 
2014). Activation of these receptors with their appropriate ligands has been shown to 
induce anagen in the adult mouse, and thus, these present as possible upstream signals 
that lead to activation of STAT5 in the DP (Kang et al., 2010; Kawano et al., 2005; Tomita 
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et al., 2006).  Therefore, deletion of STAT5 within the DP may be delaying anagen entry 
by inhibiting the aforementioned signalling pathways; however, this cannot be concluded in 
this study and requires further investigation.  Furthermore, only a modest delay in anagen 
entry is observed in this study, suggesting the predominant mechanisms involved in 
anagen progression (i.e. Wnt signalling) are able to overcome this impairment. 
Systemic pharmacological inhibition of STAT5 using the JAK1/2 inhibitor, ruxolitinib, 
did not appear to affect anagen induction in this study.  This compound was selected to 
inhibit the effects of STAT5, as it is well known that JAK1 and JAK2 interact with STAT5 
during JAK/STAT signalling, resulting in its phosphorylation (Fujitani et al., 1997).  
Previous studies have shown that in alopecia areata, treatment with ruxolitinib was able to 
prevent and reverse the condition in both mice and humans (Xing et al., 2014).  Although 
inhibition of JAK1/2 leading to anagen induction appears to be contradictory to the findings 
of this study, the effects described in the previous study are related to suppression of the 
pathological immune response responsible for alopecia areata.  The study found that 
ruxolitinib inhibited interferon-γ receptor signalling, preventing the expansion of the 
CD8+NKG2D+ T cells responsible for disease pathogenesis (Xing et al., 2014).   
Moreover, this study found that with daily administration of ruxolitinib, phosphorylation 
of STAT5 was not inhibited in the DP.  Phospho-STAT3 was not detected within hair 
follicles of either condition; however, it was detected in the nuclei of interfollicular 
epidermal cells, with a significantly reduced proportion of positive nuclei in the ruxolitinib-
treated condition, suggesting that JAK-dependent phosphorylation of STAT3 is 
successfully inhibited by ruxolitinib treatment.   
 In light of these findings, it is suggested that under normal physiological conditions, 
inhibition of JAK1/2 by ruxolitinib is not an effective inhibitor of DP STAT5 activation, and 
has no effect on hair follicle cycling. These findings also suggest that STAT5 is activated 
within the DP in a manner that is not dependent on JAK receptor tyrosine kinase activity. 
 
5.7. Conclusion 
In summary, the Sox18GCre/ER line can be used to target the DP for conditional 
genetic knockout studies, with optimal effects seen when inducing recombination at birth.  
Using this strain, a STAT5 conditional knockout model was developed and when inducing 
STAT5 deletion in the DP at birth, it was found that the second postnatal anagen phase 
was delayed.  Further experiments using ruxolitinib, a pharmacological inhibitor of JAK1/2, 
found no effect on anagen induction, clearly suggesting that activation of STAT5 occurs in 
a JAK1/2-independent manner.  This study uncovers a previously undescribed role for 
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STAT5 in hair cycling, where its deletion in the DP delays transition from telogen to 
anagen in the adult cycling follicle.  Further investigation is required to determine the 
downstream targets of STAT5 that modulate anagen entry. 
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Chapter Six 
Contributions of Dermal Populations to Skin Wound Healing 
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6.1. Rationale 
Skin wound healing is a complex process that must occur rapidly in order to restore 
the skin’s essential barrier function.  Adult would healing results in formation of a fibrotic 
scar largely composed of collagen and devoid of skin appendages.  Re-epithelialisation of 
wounds has been shown to be promoted when hair follicles within the skin are in anagen 
phase, and the hair follicle is known to provide stem cells that contribute to the wound 
healing process (Ansell et al., 2011; Ito et al., 2005a; Levy et al., 2007; Plikus et al., 2012).  
The findings of this thesis have so far described that STAT5 activation in the DP is 
associated with anagen entry and when deleted, the transition to anagen from telogen is 
delayed.  Furthermore, transplantation of DP-derived SKPs overexpressing STAT5 was 
shown to improve DP formation in hair regeneration assays.  Given that the DP is known 
to be at the centre of hair follicle development and cycling, transplantation of DP-derived 
cells in an effort to improve wound healing warrants investigation. 
Within the wound, macrophages are believed to provide important cytokines and 
growth factors necessary for the wound healing process (Rodero and Khosrotehrani, 
2010).  However, depletion of macrophages at the early stage of wound healing has been 
shown to minimise scar tissue formation (Lucas et al., 2010).  This suggests that 
macrophages may play a role in collagen deposition early on in the wound healing process 
and therefore requires further investigation. 
 
6.2. Introduction 
Skin wound healing is a complex process that has been proposed to occur in three 
distinct phases: the inflammatory phase; re-epithelialisation; and the remodelling phase 
(Rodero and Khosrotehrani, 2010).  The inflammatory phase consists of the initial immune 
response upon wounding where an infiltration of neutrophils and macrophages into the 
wound area serves to remove necrotic tissue and fight infection (Rodero and 
Khosrotehrani, 2010; Ross and Odland, 1968).  The wound healing process then 
progresses to the re-epithelialisation phase where proliferation of keratinocytes and 
fibroblasts serves to restore the skin’s essential barrier function.  Fibroblasts deposit 
collagen in an effort to restore the dermis, while some differentiate into myofibroblasts that 
will act to contract the wound (Gabbiani, 2003; Rodero and Khosrotehrani, 2010; Singer 
and Clark, 1999).  Macrophages are also an important component of the newly formed 
granulation tissue, providing cytokines and growth factors necessary for re-
epithelialisation, fibroblast recruitment and angiogenesis within the wound (Rodero and 
Khosrotehrani, 2010).  Wound healing concludes with the remodelling phase, where the 
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granulation tissue is degraded and replaced by collagen I (Rodero and Khosrotehrani, 
2010). 
After wound healing, adult skin is left with a scar that is composed of fibrotic tissue 
with poorly arranged collagen that is generally devoid of skin appendages.  As a result, the 
skin also has a marked reduction in tensile strength (Hu et al., 2014; Singer and Clark, 
1999).  This is in contrast to skin wound healing in the early to mid-gestational fetus, which 
has been shown to leave no scarring and result in normally arranged skin and appendages 
(Hu et al., 2014; Lorenz et al., 1992).  This difference in wound healing between the fetal 
and adult organism has been suggested to be a result of a myriad of differences in 
inflammatory processes, cytokine and growth factor signalling, and extracellular matrix 
organisation following wounding (Hu et al., 2014).  In addition to scarring in the adult, 
wound healing can be delayed or impaired resulting in chronic wounds as seen in diabetic 
foot ulcers, or wounds may heal excessively through overproduction of extracellular matrix 
as seen in hypertrophic and keloid scars (Baltzis et al., 2014; Gurtner et al., 2008). 
Several therapies exist for the management of chronic wounds including surgical 
revascularisation, bioengineered skin substitutes, growth factor therapy and hyperbaric 
oxygen therapy (Baltzis et al., 2014).  Therapeutic options for hypertrophic and keloid 
scars include corticosteroid injections, cryotherapy and surgical excision (Rabello et al., 
2014; Shockman et al., 2010).  Although these therapeutic options to improve wound 
repair exist, it is largely accepted that seeking methods of skin regeneration rather than 
repair is more ideal.  As a result, therapeutic options involving stem or progenitor cells 
being introduced into the wound environment are required.  In addition, an understanding 
of the macroenvironmental cues driving stem cell proliferation and differentiation within the 
skin is essential. 
The hair follicle has been shown be a source of stem cells that contribute to skin 
wound healing in multiple studies.  It has been demonstrated that populations of hair 
follicle stem cells residing in the bulge, isthmus and infundibulum are able to contribute to 
wound repair in both the short- and long-term (Ito et al., 2005a; Levy et al., 2007; Plikus et 
al., 2012).  Recent studies have also shown that cells derived from the DP may improve 
skin wound healing (Sato et al., 2015).  In addition, wound re-epithelialisation has been 
shown to be improved when surrounding hair follicles are in anagen, with a correlation 
described between the genes upregulated during anagen and those that improve wound 
healing (Ansell et al., 2011).  Outside of the hair follicle, there is evidence suggesting that 
by inhibiting macrophages within the early stages of wound healing, scar tissue formation 
can be minimised (Lucas et al., 2010) 
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Much remains to be elucidated regarding the contributions of macrophages and the 
therapeutic potential of dermal cell populations in wound healing.  This chapter will 
investigate further the role of macrophages in modulating mesenchymal cells within the 
wound, and explore the potential of cultured dermal cells in the treatment of skin wounds.  
Given the findings of this thesis thus far, the overexpression of STAT5 within dermal 
populations used to treat skin wounds may further improve any potential effects. 
 
6.3. Wound-Associated Macrophages Control Collagen 1α2 Transcription during the 
Early Stages of Skin Wound Healing 
 
This section consists of one manuscript published by the PhD candidate in Experimental 
Dermatology 
 
6.3.1. Abstract 
Wound-associated fibrosis is important to provide tensile strength upon wound healing 
but at the same time is detrimental to proper tissue regeneration. To date, there is no clear 
evidence of the role of macrophages and their subpopulations in the control of the kinetics 
of collagen production during wound healing. To evaluate in vivo the contribution of 
macrophages in collagen transcription, we depleted macrophages after wounding 
luciferase reporter mice of the collagen 1 alpha 2 (Col1α2) promoter activity. Our data 
reveal that Col1α2 starts to be transcribed at D2 after wounding, reaching a plateau after 
7 days. Sustained macrophage depletion significantly reduced Col1α2 transcription from 
D4, indicating that the control of fibrosis by macrophages occurs during the early stages of 
the wound healing process. In conclusion, our results demonstrate an important role of 
wound macrophages in the control of collagen production during wound healing. 
 
6.3.2. Background 
Scarring results from extracellular matrix deposition during the new tissue formation 
and the remodelling phases of wound healing. The main source of collagen is believed to 
emanate from fibroblasts and myofibroblasts surrounding the wound site (Higashiyama et 
al., 2009). Previous findings suggest that macrophages may affect fibroblast recruitment to 
the wound site and collagen deposition (Kahari and Saarialho-Kere, 1997; Lucas et al., 
2010; Mori et al., 2008; Rodero and Khosrotehrani, 2010). In vitro, macrophages have 
been classified as M1 inflammatory macrophages or M2 tissue repair and pro-angiogenic 
macrophages (Mantovani et al., 2002). In vivo, however, wound-associated macrophages 
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(WAM) are heterogeneous bearing both classical M1 and M2 phenotypes and 
transcriptomic properties (Daley et al., 2010; Rodero et al., 2013a; Stables et al., 2011; 
Willenborg et al., 2012). Using both Ly6c and MHC class II (MHCII) levels of expression, 
we recently defined 4 WAM populations with distinct recruitment patterns to the 
granulation tissues and distinct transcriptomic profiles (Rodero et al., 2013a). We also 
identified the Ly6clo–MHChi macrophages as the population associated with wound healing 
across multiple genetic backgrounds. Despite previous reports of reduced scar tissue 
formation and myofibroblast differentiation upon macrophage depletion (Lucas et al., 
2010), the more direct role of macrophages in modulating collagen gene transcription has 
not been addressed properly. Besides, the relative contribution of distinctive macrophage 
populations in modulating skin fibrosis also remains elusive. 
 
6.3.3. Question Addressed 
Do macrophages or macrophage subpopulations modulate collagen I expression 
levels in vivo during skin wound healing? 
As macrophages are heterogeneous and dynamically change their phenotype and 
function during wound healing, we speculate that some populations play a greater role in 
the promotion of fibrosis than others. 
6.3.4. Experimental Design 
6.3.4.1. Animals 
Transgenic mice hemizygous for the luciferase and ß-galactosidase (β-gal) reporters 
driven under the collagen type 1 alpha 2 chain promoter (Bou-Gharios et al., 1996) 
(Col1α2-Luc) were used between 8-12 weeks of age. All mice were treated in accordance 
with institutional guidelines and ethical approvals for the care of experimental animals 
(AEC Approval Number: UQCCR/380/09/UQCCR). 
Large full thickness excisional wounds (1cm2) were performed on the back skin and 
mice were allocated in two groups receiving 30 μl of Clodronate or PBS filled liposomes 
intralesionally ever two days, as well as 200 μl intraperitoneally. Clodronate (Cl2MDP, a 
gift of Roche Diagnostics GmbH, Mannheim, Germany) was encapsulated in liposomes 
containing phosphatidylcholine (Lipoid GmbH, Ludwigshafen, Germany) and cholesterol 
(Sigma-Aldrich, MO, USA)  
Standardised digital photographs were taken at multiple time points to evaluate wound 
closure (Nassar et al., 2012). 
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6.3.4.2. Tissue Processing 
Six mice were sacrificed at D4 to evaluate macrophage depletion. Excess skin 
surrounding individual wounds was removed and wounds were minced through a 70µm 
cell strainer to generate single cell suspensions from wound granulation tissue. All cell 
suspensions were layered on Histopaque 1083 (Sigma Aldrich, MO, USA) for gradient 
density centrifugation. The mononuclear cell fraction was stained for flow cytometry 
analysis. 
 
6.3.4.3. Flow Cytometry 
Dissociated single cells were pre-blocked with anti-CD16/CD32 (Becton Dickinson, NJ, 
USA) to prevent non-specific Fc binding. Cell preparations were then incubated with either 
Rat anti-mouse CD11b PerCp-Cy5.5, MHCII FITC, Ly6g PE, NK1.1 PE, Ly6c V450 for 
multi-parameter flow acquisition and analysis. 
A Gallios™ flow cytometer was used for sample acquisition while unbiased data 
analyses were performed with Kaluza® analysis software (Beckman-Coulter, CA, USA). 
 
6.3.4.4. In vivo Bioluminescence Imaging: Image Capture 
Wounded mice were injected with 150 mg/kg D-luciferin firefly substrate (Regis 
Technologies, IL, USA). After 10 mins, mice were anaesthetised (3% isofluorane) and 
placed ventral-side down in the Xenogen IVIS® Spectrum (PerkinElmer, MA, USA). 
Images were acquired and light was captured using a CCD camera at -95°C. Acquisition 
parameters were as follows; 10 minutes exposure, F/stop 4, binning 4, field of view C. 
Luminescence was quantified in photons/sec/cm2 in order to normalise data to wound 
area. 
 
6.3.4.5. Masson’s Trichrome Staining and Quantification 
Paraffin sections were stained using Masson’s trichrome. The blue labelling of 
collagen bundles was quantified in the scar area.  The area covered by the staining was 
calculated and reported to the analysed area using ImageJ software.  
 
6.3.4.6. Statistical Analysis 
All statistical analyses were performed using GraphPad Prism v5c software 
(GraphPad Software, CA, USA). Data were analysed using Mann-Whitney tests. A p value 
of less than 0.05 was considered significant. 
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6.3.5. Results 
6.3.5.1. Macrophage Depletion 
Wound-associated macrophages were defined as CD11bhi Ly6glo cells, as previously 
described (see Figure 6.3.1 a). WAM were massively recruited to the granulation tissue at 
D4 in this large wound model. Also, as reported in small 6-mm diameter excisional 
wounds, WAM could be discriminated into four populations based on Ly6c and MHCII 
expression (Rodero et al., 2013a) (see Figure 6.3.1 b). We measured by flow cytometry 
the efficiency of the clodronate depletion strategy in blood and the granulation tissue at D4 
post-wounding (see Figure 6.3.1 a-c and Supplemental Figure 6.3.1). The clodronate-
treated group displayed a 60% reduction in the absolute number of WAM recruited to the 
granulation tissues (57605 ± 29992, 17030 ± 9081, p = 0.026, n = 7 per group), while 
neutrophils were not significantly affected (p = 0.18) (see Figure 6.3.1 d). The depletion 
significantly affected all subpopulations (see Figure 6.1 e), but at different relative levels. 
While the proportions of Ly6clo–MHCIIlo and Ly6chi–MHCIIlo were not significantly affected, 
Ly6clo–MHCIIhi and Ly6chi–MHCIIhi populations' frequencies decreased by 45% 
(11.34 ± 1.27, 6.28 ± 3.64, P = 0.015) and 78% (6.57 ± 1.45, 1.47 ± 1.87, p = 0.002, n = 7 
per group), respectively (see Figure 6.3.1 f). Therefore, in addition to the global number of 
macrophages, the balance between the distinct macrophage populations was also affected 
by the clodronate depletion. 
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Figure 6.3.1. Effect of clodronate treatment on wound-associated macrophages 
(WAM). (a) Flow cytometry dot plot representation of wound leucocytes. WAM were defined 
as Cd11bhi Ly6 g −/lo cells. Flow cytometry dot plot representation of Cd11bhi Ly6g −/lo-gated 
WAM subpopulation based on Ly6c and MHCII level of expression in (b) PBS- and (c) 
clodronate-treated mice. Histogram of the effect of clodronate depletion on (d) WAM 
absolute numbers, (e) WAM subpopulation number and (f) WAM subpopulation percentage; 
n = 7 mice from two distinct experiments with similar trend. Result shown as mean ± SEM. 
*<0.05. **<0.01 Mann–Whitney U-test. L−:Ly6c low, L+: Ly6c high, M−: MHCII low, M+: 
MHCII high. 
 
 
 
 
Supplemental Figure 6.3.1. Effect of clodronate treatment on circulating monocytes. 
a) Representation of the percentage of circulating monocytes in PBS and clodronate treated 
group. b) Representation of the percentage of circulating monocyte subpopulations based 
on Ly6c and MHCII level of expression in PBS and clodronate treated group. n=3mice per 
group. Results show as mean +/- SEM. 
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6.3.5.2. Wound Closure and Col1α2 Transcription 
Previous reports indicated that macrophage depletion altered normal wound closure in 
several wound healing models (Goren et al., 2009; Mirza et al., 2013). Here, we assessed 
the effect of macrophage depletion on large excisional wounds that leave significant scars 
in mouse back skin and therefore constitute an ideal model to study fibrosis and 
scarring (Ito et al., 2007). In accordance with previous models, we observed a defect in 
wound closure in macrophage-depleted mice. This defect of 18–20% reached significance 
only by D9 (69.36 ± 19.26%, 84.24 ± 8.68%, Mann–Whitney U-test p = 0.009, n = 9 to 16 
per group, depending on time point). 
We next examined the expression of collagen during healing using in vivo 
bioluminescence imaging.  Col1α2 transcription levels increased in both PBS- and 
clodronate-treated groups from D2 to D7 and then slightly decreased.  However, Col1α2 
level of transcription was significantly reduced in the clodronate-treated group compared 
with the PBS group at D4 and D7, by 26% (1.39 ± 0.62 x 107 vs. 1.03 ± 0.75 x 107 
photons/s/cm2, p = 0.026) and 31% (2.51 ± 0.13 x 107 vs. 1.74 ± 0.1 x 107 photons/s/cm2, 
p = 0.038, n = 8-16 per group, depending on time point), respectively.  This was further 
confirmed histologically on wound sections at D14 displaying reduced fibrosis in the scar 
tissue in the clodronate-treated group compared with controls (see Figure 6.3.2 g and 
Supplemental Figure 6.3.2). 
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Figure 6.3.2. Effect of clodronate treatment on wound closure and collagen 1alpha2 
transcription. (a) Representative digital pictures of wounds from PBS- and clodronate-
treated animals over time. (b) Wound closure percentage along healing. (c) Quantitative 
analysis of bioluminescence reflecting collagen 1alpha2 transcription in wounds of PBS- 
and clodronate-treated animals. (d) Representative bioluminescence image of wounded 
collagen 1alpha2–Luc mice treated with PBS or clodronate-filled liposomes; n = 9–16 mice 
per time point from two distinct experiments with similar trend. Representative picture of 
Sirius red staining of wound sections from mice treated with (e) PBS and (f) clodronate. (g) 
Quantitative analysis of the relative surface area of red (collagen) staining in mice treated 
with PBS (n = 8 sections from four mice) and clodronate (n = 3 sections from two mice). sa, 
scar area. Result shown as mean ± SEM. *<0.05. **<0.01. Mann–Whitney U-test. 
 
Supplemental Figure 6.3.2. Effect of macrophage depletion on wound fibrosis. 
Representative pictures of Masson’s Trichrome staining of wound sections from mice 
treated with a) PBS and b) Clodronate. c) Quantitative analysis of the relative surface area 
of blue (collagen) staining in mice treated with PBS (n=8 sections from 4 mice) and 
Clodronate (n=4 sections from 2 mice). Results show as mean +/- SD. *** <0.01 (Mann 
Whitney), sa: Scar Area. 
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6.3.6. Conclusions 
Production of extracellular matrix, mainly collagen, during the later stages of wound 
healing favours a fast restoration of skin integrity, protecting the body against further 
insults. However, fibrosis as a result of excessive collagen deposition is also responsible 
for poor regeneration of tissues after skin wound injury in the adult (Rhett et al., 2008). 
Fibrosis is dependent on inflammation, and more specifically on macrophage-associated 
inflammation (Werner and Grose, 2003). In this work, we demonstrate that besides what is 
commonly believed, control of collagen I transcription is an early event and starts within 
the two days following injury and is not restricted to the remodelling phase of healing. In 
this large wound model, we show that sustained macrophage depletion starting at the time 
of wounding significantly reduces Col1α2 transcription as early as D4. This could be 
possibly through their modulation of the activation and differentiation of fibroblasts into 
myofibroblasts. The direct depletion of fibrocytes, a myeloid population that could be 
closely related to macrophages that produce collagen in our experiments, cannot be 
excluded but is unlikely. Indeed, Higashiyama et al. (2009) have previously demonstrated 
that these bone marrow-derived cells were unlikely to be involved in spontaneous skin 
wound healing. 
Sustained systemic and local clodronate depletion affected both circulating monocytes 
and WAM. While the clodronate treatment resulted mainly in a defect of Ly6clo circulating 
monocytes regardless of their level of MHCII (see Supplemental Figure 6.1), it affected 
more drastically the MHCIIhi WAM populations, regardless of Ly6c level of expression. This 
dichotomy between circulating and infiltrating populations could be explained by the fact 
that recruited monocytes (especially Ly6chi) may significantly change their phenotype once 
exposed to the wound's complex environment (Geissmann et al., 2003; Rodero et al., 
2013a). The fact that the clodronate depletion reduced collagen transcription and affects to 
a larger extent the MHCIIhi WAM may suggest that MHCIIhi macrophages have a more 
prominent role in controlling collagen transcription during the early stages of healing, 
although this remains to be more specifically tested (Rodero et al., 2013a). The molecular 
mechanism of the control by macrophages of Col1α2 transcription in wounds needs to be 
further investigated. The direct or indirect production or promotion of TGF-beta could be 
incriminated for Col1α2 transcription by competent cells (Romana-Souza et al., 2010). 
However, other factors that may induce pro-fibrotic mediators by intermediate cell types 
could also be considered (Arima et al., 2012; Ontsuka et al., 2012; Poindexter et al., 2010; 
Rodero and Khosrotehrani, 2010). Naturally, because of the central role of macrophages 
in wound healing biology, these hypotheses are not mutually exclusive. 
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In conclusion, our data reveal that Col1α2 transcription starts early during the healing 
process, only two days after wounding. Moreover, our data indicate that this early 
transcription of Col1α2 can be controlled by macrophage depletion and more specifically 
by targeting MHCIIhi macrophages. Further studies need to elucidate the underlying 
molecular mechanisms driving the macrophage-mesenchyme crosstalk. 
 
6.4. Skin-Derived Precursors Expressing Constitutively-Active STAT5B Improve 
Wound Healing 
6.4.1. Background 
Treatment of full-thickness skin wounds with cultured DP cells have been shown to 
improve wound healing outcome (Leiros et al., 2014; Shin et al., 2011).  It has been shown 
that with the introduction of DP cells as part of a bioengineered scaffold, 
neovascularisation within the wound and graft-take was markedly improved compared to 
acellular and dermal fibroblast controls (Leiros et al., 2014).  Recent studies have also 
shown that DP-derived SKPs improve wound healing and it has been suggested that this 
occurs due to improved vascularisation of the wound (Sato et al., 2015). 
This thesis has shown so far that STAT5 plays an important role in DP signalling.  
Furthermore, the ability for SKPs to engraft and form DP in hair regeneration assays has 
been shown in this thesis to be significantly improved when transduced with constitutively-
active STAT5.  Therefore, the question arises whether DP cells with active STAT5 have a 
better wound healing capacity compared to those that have little or no STAT5 activity.  To 
investigate this hypothesis, SKPs transduced with constitutively-active STAT5B were used 
in wound healing assays to elucidate their effectiveness in improving wound healing 
outcome. 
 
6.4.2. Materials and Methods 
6.4.2.1. Animals 
Eight week old C57BL/6 mice were used for wound experiments.  To prepare animals 
for wounding, dorsal hair was removed under isofluorane anaesthesia using electric hair 
clippers, followed by application of Veet® hair removal cream (Reckitt Benckiser, Slough, 
UK).  The hair removal cream was allowed to stand for one minute and was then removed 
using water, and dried with paper towel. 
Under isofluorane anaesthesia, mouse back skin was sterilised with Betadine® 
povidone-iodine solution (Sanofi, Paris, France) and four 6mm diameter circular excisional 
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wounds were made using a sterile punch biopsy tool (Stiefel Laboratories, NC, USA).  All 
wounds were full skin thickness, extending down to the panniculus carnosus muscle.   
 
6.4.2.2. Cell Culture and Viral Transduction 
SKPs were cultured from neonatal C57BL/6 mice as described previously (Biernaskie 
et al., 2006) and plated in six-well plates.  STAT5B constitutively-active (STAT5B-CA) and 
GFP adenoviral constructs kindly provided by Dr. Andrew Brooks (UQ Diamantina 
Institute, Woolloongabba, Queensland, Australia) were added at 1:40 dilution in each well 
containing C57BL/6 SKPs in 3ml culture medium.  Viral constructs at this concentration 
were determined to successfully infect >97% of cells as determined by flow cytometry (see 
Supplemental Figure 6.4.1 A-B). Viral constructs were allowed to incubate for 48 hours at 
37oC and 5% CO2 before proceeding with wound experiments. 
 
6.4.2.3. SKP Treatment of Wounds 
Following SKP culture and viral transduction, SKPs were collected by centrifugation at 
380 x g for five minutes, resuspended in DMEM/F12 (3:1) (Gibco, NY, USA) and 
centrifuged once more.  Cells were then resuspended at 1 x 106 cells in 100μl DMEM/F12 
(3:1) (Gibco, NY, USA).  While animals were under anaesthesia, SKPs were injected into 
the hypodermis at four sites adjacent to each wound.  Each wound was treated with 1 x 
106 SKPs.  Wounds were treated at D0 and mice were humanely sacrificed and wounds 
collected at D7. 
 
6.4.2.4. Skin Wound Analyses 
Skin wounds were analysed using the Xenogen IVIS® Spectrum bioluminescence 
imaging system (PerkinElmer, MA, USA) and Living Image® 3.2 software (Caliper Life 
Sciences, MA, USA).  Mice were anaesthetised using isofluorane and placed dorsal side 
up in the Xenogen system, after which an image was captured using the photograph-only 
function of the imaging system. Wound images were analysed using ImageJ 1.44p 
software (Rasband, W.S, National Institute of Health, MD, USA). Percentage wound 
closure over time was measured for each condition, with eight wounds per condition. 
 
6.4.2.5. Immunohistochemistry 
Skin wounds were collected and prepared for immunohistochemistry as described in 
section 2.2 of this thesis.  Briefly, skin wounds were collected and fixed in 4% PFA for two 
hours at 4oC.  Wounds were collected and prepared for paraffin or frozen section 
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immunohistochemistry with sections cut at 5-7μm.  Immunofluorescence staining for CD31 
(BD Biosciences, CA, USA; 1:50; Rat IgG), F4/80 (AbD Serotec, Kidlington, UK; 1:200; 
Rat IgG) and GFP (Invitrogen, CA, USA; 1:200; Chicken IgY) was performed as described 
in section 2.2.3. Goat anti-rabbit Alexa® 488, Goat anti-rabbit Alexa® 568 and Goat anti-
chicken Alexa® 488 antibodies (all Invitrogen, CA, USA; all 1:500 dilution) were used as 
secondary antibodies. All sections were counterstained with DAPI (1:10000 dilution of 
1mg/ml stock). 
Haematoxylin and eosin and Masson’s trichrome staining were performed by 
colleagues at the UQ Diamantina Institute histology facility. 
 
6.4.2.6. Image Capture and Data Analysis 
All images were acquired using either the Zeiss LSM 710 confocal microscope and 
Zen 2009 software (Carl Zeiss, Oberkochen, Germany), or Axio Imager M1 fluorescence 
microscope and AxioVision 4.8 software (Carl Zeiss, Oberkochen, Germany). 
To analyse Masson’s trichrome staining, the blue labelling of collagen bundles within 
the scar area was quantified.  The area covered by the staining was calculated and 
reported to the analysed area using ImageJ 1.44p software (Rasband, W.S, National 
Institute of Health, MD, USA).  
Quantification of F4/80 staining was performed by determining the proportion of F4/80 
positive cells relative to the total number of cells present, which was determined by 
counting DAPI stained nuclei.  These analyses were performed using ImageJ 1.44p 
software (Rasband, W.S, National Institute of Health, MD, USA). 
All statistical analyses were performed using GraphPad Prism v6 software (GraphPad 
Software, CA, USA).  Non-parametric data was analysed using Mann-Whitney tests and 
statistical significance was accepted at a p-value less than 0.05. 
 
6.4.2.7. Microarray 
Microarray experiments were performed on Ad-GFP (n=4) and Ad-STAT5B-CA (n=4) 
transduced SKP samples. Biotin labeled cRNA was produced using Illumina® TotalPrep™ 
RNA Amplification (Life Technologies, CA, USA) as per the manufacturer’s instructions. 
50ng of starting total RNA was used and a 14 hour IVT reaction. cRNA samples were 
hybridized to Sentrix Illumina_MouseWG-6 v2.0 Expression BeadChip overnight for 18 
hours at 58oC then scanned on a BeadStation 500 System using Beadscan software 
v3.5.31 (Illumina, CA, USA). Raw data was then imported into GenomeStudio v2010.2 
(Illumina, CA, USA) for bead summarization and quality control assessment. For data 
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analysis, raw probe intensity data were imported into GeneSpring GX 11 (Agilent 
Technologies, CA, USA) and subsequent normalisation and significance analysis to 
identify differentially expressed probes were performed.  Microarray data was interpreted 
further using the Ingenuity Pathway Analysis platform (Qiagen, Limburg, Netherlands).  
 
6.4.3. Results 
6.4.3.1. SKPs Transduced with Constitutively-Active STAT5B Accelerate Wound Closure 
Recent evidence suggest that SKPs improve wound closure compared to an acellular 
control in diabetic mice (Sato et al., 2015). In this study, C57BL/6 mice were treated with 
either an acellular control, SKPs transduced with a GFP control construct (SKPs+GFP), or 
SKPs transduced with a constitutively-active STAT5B construct (SKPs+STAT5B-CA).  
Only STAT5B was chosen for this study as previous findings in this thesis show larger 
functional alterations through luciferase and patch assays with the STAT5B-CA construct.  
It was found that at D3 post-wounding, wounds treated with SKPs+STAT5B-CA 
(53.68±11.96%, n=8, p<0.05) and SKPs+GFP (51.15±14.25%, n=8, p<0.05) were 
significantly reduced in size compared to the control condition (26.63±25.75%, n=8).  This 
significant difference persisted at D4 (SKPs+STAT5B-CA: 67.15±5.76%, p<0.01; 
SKPs+GFP: 60.05±15.94%, p<0.05; control: 40.81±19.34%) and D5 (SKPs+STAT5B-CA: 
78.28±6.29%, p<0.001; SKPs+GFP: 72.12±14.33%, p<0.01; control: 48.13±22.25%).  By 
D7, there was no statistically significant difference observed between the control and 
SKPs+GFP (p=0.32), or SKPs+GFP and SKPs+STAT5B-CA (p=0.27) conditions.  
However, wounds treated with SKPs+STAT5B-CA (92.55±2.19%) were significantly 
reduced in size compared to control wounds (77.68±14.47%) (p<0.001) (see Figure 6.4.1 
A-B).  This suggests that treatment of wounds with SKPs accelerates wound closure 
during the early stages of wound healing, and this effect is increased later on during 
wound closure with the overexpression of STAT5B. 
Anti-GFP immunofluorescence staining was performed to detect the presence of SKPs 
within the wound area at D7.  GFP-positive cells and filamentous structures were detected 
within the wound in both the SKPs+GFP and SKPs+STAT5B-CA conditions, indicating the 
integration of SKPs and possible differentiation within the wound environment (see Figure 
6.4.1 C) 
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6.4.3.2. SKPs Transduced with Constitutively-Active STAT5B Reduce the Proportion of 
Macrophages within the Granulation Tissue 
Following wounding, macrophages within the granulation tissue are known to provide 
cytokines and growth factors necessary for re-epithelialisation, fibroblast recruitment and 
angiogenesis within the wound (Rodero and Khosrotehrani, 2010).  In addition, 
macrophages have been shown to control transcription of Col1α2 during the early stages 
of wound healing (Rodero et al., 2013b).  F4/80, a marker of mouse macrophages, can be 
used to visualise the presence of macrophages within the granulation tissue (Austyn and 
Gordon, 1981).  In this study, collagen deposition within the wound at D7 was analysed by 
quantifying Masson’s trichrome staining, which stains collagen in blue.  No statistically 
significant difference in the proportion of collagen within wounds between the control 
(43.79±9.23%, n=9 sections from 3 wounds), SKPs+GFP (42.93±10.87%, n=9 sections 
from 3 wounds) or SKPs+STAT5B-CA (37.20±6.22%, n=9 sections from 3 wounds) was 
observed (see Figure 6.4.1 D).  The proportion of macrophages within the granulation 
tissue at D7 was determined by quantification of F4/80 staining.  No significant difference 
was observed in the proportion of F4/80+ cells between the control (66.35±13.68%, n=3 
wounds) and SKPs+GFP (62.45±12.16%, n=3 wounds) conditions (p=0.68).  However, a 
significantly reduced proportion of F4/80+ cells was observed in the SKPs+STAT5B-CA 
condition (47.53±8.55%, n=3 wounds) compared to the control (p<0.05) and SKPs+GFP 
(p<0.01) conditions (see Figure 6.4.1 E and Supplemental Figure 6.4.1 C). 
Taken together, these results suggest that the transplant of SKPs does not affect the 
deposition of collagen within the wound; however, the recruitment or persistence of 
macrophages within the wound is inhibited in the presence of SKPs with constitutively-
active STAT5B. 
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Figure 6.4.1. Transplant of SKPs with constitutively-active STAT5B improves wound 
healing. (A) Wound closure percentage over time. Asterisks denote statistical significance 
compared to control (n=8 wounds).  All other differences are not significant; GFP: SKPs with 
GFP construct; STAT5B-CA: SKPs with STAT5 constitutively-active construct. (B) Anti-GFP 
immunofluorescence to detect persistence of SKPs within the wound area. Scale bar = 
50μm.  (C) Representative digital images of wound healing across the three conditions: 
control, SKPs transduced with GFP control construct, and SKPs transduced with STAT5B 
constitutively-active (CA) construct. (D) Percentage of collagen staining within granulation 
tissue determined by Masson’s trichrome staining. (n=3 wounds per group, 3 sections per 
wound). (E) Percentage of F4/80-positive cells within granulation tissue. (n=3 wounds per 
group). *: p<0.05; **: p<0.01, ***: p<0.001. 
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Supplemental Figure 6.4.1. SKPs transduced with constitutively-active STAT5B alter 
granulation tissue macrophage number at D7 (A) Neonatal C57BL/6J skin-derived 
precursors (SKPs) transduced with adenoviral GFP (Ad-GFP) constitutively-active STAT5B 
(Ad-STAT5B-CA) constructs, all containing a GFP label.  Flow cytometry analysis was 
performed 48 hours post-infection to determine the percentage of SKPs infected. (B) 
Representative digital images of SKPs transduced with GFP control (left), or STAT5B 
constitutively-active (right) constructs. (C) F4/80 staining (red) within granulation tissue of 
wounds treated with an acellular control (left), SKPs with GFP control construct (right) or 
SKPs with STAT5B constitutively-active construct (bottom). All scale bars denote 50μm. 
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6.4.3.3. Downregulation of Genes Associated with Inflammatory Pathways and 
Upregulation of Cytokine Signalling Inhibitors in STAT5B Constitutively-Active SKPs 
In order to gain further insight into how constitutively-active STAT5B affects the wound 
environment, we performed gene expression microarray on SKPs isolated from C57BL/6 
neonates transduced with an Ad-GFP or Ad-STAT5B-CA construct to produce control or 
STAT5B-CA SKPs, respectively. 327 genes were differentially expressed with a p-value 
less than 0.05 after correction for multiple testing. Among these, 266 showed over 1.5-fold 
difference between control and STAT5B-CA SKPs.   
Pathway analysis revealed that a number of genes related to pro-inflammatory 
signalling pathways were downregulated in STAT5B-CA SKPs compared to control.  This 
included those of TNF, interferon-γ (see Table 6.4.1) and numerous chemokines (see 
Table 6.4.2). 
The top two genes found to be upregulated in STAT5B-CA SKPs included expectedly 
CISH (8.15 fold, p=3.68x10-5) and SOCS2 (6.94 fold, p=4.43x10-5), both inhibitors of 
cytokine signalling serving as a negative retro-control of the pathway. 
This suggests that SKPs overexpressing STAT5B within the wound environment 
results in inhibition of inflammatory pathways, downregulating many of the chemokines 
required for the recruitment of circulating neutrophils and inflammatory monocytes, as well 
as TNF-α. 
 
Table 6.4.1. Downregulated genes related to inflammatory pathways. List of genes 
related to inflammatory pathways found in this study to be ≥1.5x downregulated in 
STAT5B-CA SKPs compared to control. 
Gene Symbol Gene Name Fold Change p-value 
CCL7 Chemokine (C-C motif) ligand 7 2.03 2.78x10
-6
 
CSF2 Colony stimulating factor 2 (granulocyte-macrophage) 2.52 7.83x10
-4
 
CXCL9 Chemokine (C-X-C motif) ligand 9 4.96 1.17x10
-4
 
CXCL10 Chemokine (C-X-C motif) ligand 9 2.74 3.14x10
-8
 
MAP3K8 Mitogen-activated protein kinase kinase kinase 8 1.87 3.36x10
-4
 
MMP9 Matrix metalloproteinase 9 7.92 1.08x10
-6
 
NFKBIA 
 
Nuclear factor of kappa  light polypeptide gene enhancer in 
B-cells inhibitor, alpha 
2.16 
 
8.94x10
-5
 
TNF Tumor necrosis factor 2.79 1.70x10
-5
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Table 6.4.2. Downregulated genes related to chemokine signalling. List of genes 
related to chemokine signalling found in this study to be ≥1.5x downregulated in STAT5B-
CA SKPs compared to control. 
Gene Symbol Gene Name Fold Change p-value 
CCL2 Chemokine (C-C motif) ligand 2 2.45 4.64x10
-5
 
CCL5 Chemokine (C-C motif) ligand 5 1.92 1.30x10
-4
 
CCL7 Chemokine (C-C motif) ligand 7 2.03 2.78x10
-6
 
CXCL1 Chemokine (C-X-C motif) ligand 1 9.18 1.11x10
-5
 
CXCL2 Chemokine (C-X-C motif) ligand 2 9.21 2.21x10
-6
 
CXCL9 Chemokine (C-X-C motif) ligand 9 4.96 1.17x10
-4
 
CXCL10 Chemokine (C-X-C motif) ligand 10 2.74 3.14x10
-8
 
CXCL16 Chemokine (C-X-C motif) ligand 16 3.32 2.70x10
-7
 
 
6.5. Discussion 
The essential barrier function of the skin is compromised upon wounding and therefore 
repair must occur quickly to restore function, generally at the expense of skin integrity.  
Facilitating the wound healing response are macrophages, which provide growth factors 
and cytokines necessary for keratinocyte proliferation, fibroblast recruitment and 
angiogenesis (Rodero and Khosrotehrani, 2010).  Following wound healing in the adult, 
the skin is left with a fibrotic scar owing to extracellular collagen matrix deposition during 
the latter stages of wound healing.  This collagen deposition is suggested to derive from 
fibroblasts and myofibroblasts surrounding the wound site (Higashiyama et al., 2009).  
Depletion of macrophages has been shown to reduce the formation of collagen-rich scar 
tissue, implicating macrophages in the control of collagen production (Lucas et al., 2010).   
The results of this study provide further evidence to support the role of macrophages 
in the control of collagen production.  It was found that by depleting macrophages with 
clodronate, both circulating monocytes and WAM were depleted, consequently reducing 
the transcription of Col1α2.  Although collagen production was inhibited, wound healing 
continued to progress, with no significant difference in wound size between the clodronate-
treated and control groups observed from D11.  Although these findings may have 
implications in improving the quality of repaired skin, the regeneration of skin and “scarless 
wound healing” is the ultimate therapeutic outcome.  One potential avenue to achieving 
skin regeneration is through the use of stem/progenitor cells. 
Sources of stem cells already present within the skin can be found in the hair follicle.  
These include populations residing in the bulge, infundibulum and isthmus, all of which 
have been shown to contribute to skin wound healing (Ito et al., 2005a; Levy et al., 2007; 
Plikus et al., 2012).  Less is known regarding the contribution of populations within the 
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dermal component of the hair follicle to wound healing.  It has been shown previously that 
most fibroblasts within the granulation tissue derive from Dlk1-positive pre-adipocytes 
(Driskell et al., 2013). It is therefore unlikely that the DP has any contribution to the healing 
of wounds spontaneously.  Studies investigating the use of cultured DP cells in wound 
healing report an improved outcome when introducing DP cells as part of an engineered 
skin graft or collagen scaffold (Leiros et al., 2014; Shin et al., 2011).  In this study, SKPs 
were cultured and delivered to the wound without the use of a bioengineered scaffold.  
Furthermore, based on the findings within this thesis so far, SKPs transduced with a 
constitutivey-active STAT5B construct (STAT5B-CA) were also transplanted into skin 
wounds in an effort to improve wound healing outcome.  It was found that both GFP 
control and STAT5B-CA SKPs significantly increased wound closure from D2 through to 
D5 compared to the acellular control condition. No difference in wound closure was 
observed between GFP and STAT5B-CA SKPs at these time points; however at D7, 
wound closure in the STAT5B-CA SKPs condition continued to be significantly increased 
compared to the acellular control, whereas no difference was observed between the 
control and GFP groups.  This suggests that during the early stages of wound healing, 
SKPs promote wound closure regardless of STAT5B expression.  However in the later 
stages of wound closure, the overexpression of STAT5B augments the contribution of 
SKPs to the wound healing process. 
Recent studies have found that SKPs promote wound healing in diabetic mice, with a 
significant reduction in time to closure and percentage closure observed at specified time 
points during wound healing.  The study observed a significant increase in capillary density 
within SKP-treated wounds compared to control wounds at D10 post-wounding, but not at 
any other time point. Neurofilament density within wounds treated with SKPs was also 
found to be significantly increased compared to control, but only at D28 post-wounding.  It 
was also found that transplanted SKPs differentiated into peripheral nerve fibres within the 
wounds by D28.  The authors of the study concluded that wound healing was improved as 
a result of increased neovascularisation promoted by SKPs (Sato et al., 2015).   
By analysis of F4/80+ cell staining within wounds at D7, this study found a significantly 
reduced proportion of F4/80+ cells in wounds treated with STAT5B-CA SKPs.  This 
suggests that the recruitment of macrophages to the wound site may be inhibited, or 
persistence of macrophages within the wound at later stages has been impaired.  Analysis 
of collagen within the wound did not determine significant differences between any of the 
experimental conditions, although a reduced overall mean within the STAT5B-CA 
condition was observed compared to the control and SKPs+GFP conditions. 
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Gene expression analysis within this study found a significant downregulation in 
STAT5B-CA SKPs of genes involved in pro-inflammatory pathways, including those 
involved in interferon-γ and TNF-α signalling, and those of chemokines.  Together with the 
upregulation of cytokine signalling inhibitors, this suggests that constitutive-activation of 
STAT5B results in the inhibition of inflammation. 
Excessive inflammation is known to exacerbate wound healing, as seen in cases of 
chronic diabetic ulcers (Baltzis et al., 2014).  Furthermore, this inflammation and 
impairment in wound healing has been shown to be perpetuated by pro-inflammatory 
macrophages through TNF-α (Sindrilaru et al., 2011).    This is in contrast to the role of a 
pro-tissue repair macrophage sub-population defined as a Ly6clowMHCIIhigh expressing 
population.  These macrophages have been described as non-inflammatory, and a larger 
proportion of these macrophages within wounds results in improved wound healing 
(Rodero et al., 2013a).  Given the downregulation of TNF and other pro-inflammatory 
genes, it is possible that the presence of STAT5B-CA SKPs promotes the recruitment or 
increases the proportion of Ly6clowMHCIIhigh macrophages within the wound environment.  
This may occur through inhibition of signals that stimulate the recruitment or differentiation 
of pro-inflammatory macrophages.  This is a possible explanation for the reduced number 
of macrophages observed in wounds treated with STAT5B-CA SKPs and its association 
with increased wound closure. 
Interestingly, a study examining epidermal gene expression during the proliferative 
phase of wound healing found a gene expression profile conducive to protection against 
the inflammatory environment.  The study found that amongst the most differentially 
expressed genes, a significant overrepresentation of STAT5 binding sites was observed 
(Roupe et al., 2010).  This suggests that STAT5 may play a role in the protection of 
keratinocytes against the detrimental effects of inflammation, thereby promoting 
keratinocyte proliferation. 
 
6.6. Conclusion 
This study provides further evidence that SKPs are beneficial to wound healing, and 
furthermore, constitutively-active STAT5B within SKPs enhances their wound closure-
promoting effects.  This study found that macrophages play an important role in Col1α2 
transcription during the early stages of wound healing, and that the presence of STAT5B-
CA SKPs within wounds reduces the number of macrophages. 
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Although transplantation of dermis-derived SKPs has not shown direct benefits in skin 
regeneration, their effects in improving skin repair during wound healing cannot be 
discredited. 
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Chapter Seven 
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
136 
 
7.1. Why Study Hair Follicles? 
Hair is a defining characteristic of all mammals, important for sensation, maintaining 
the lubrication of skin, defending against invading microbes, and protection against 
harmful environmental factors such as UV radiation and extreme temperatures.  Although 
the latter functions may not be as pronounced in humans, hair is of such cosmetic 
importance that a multi-billion dollar industry is dedicated to its care.  Within biomedical 
research, the hair follicle and its remarkable ability to completely regenerate itself 
throughout the life of a mammal is particularly interesting. 
The hair follicle contains multiple populations of cells derived from different 
developmental origins, including the ectoderm, mesoderm and neural crest (Al-Nuaimi et 
al., 2010).  Amongst these populations are reservoirs of stem cells within the epidermal 
component that enable the hair follicle to cycle indefinitely through periods of growth, 
regression and rest.  At the centre of this cycling process is a specialised mesenchymal 
component, the dermal papilla, without which the hair follicle cannot develop or survive 
(Jahoda et al., 1984; Schmidt-Ullrich and Paus, 2005).  It is this highly regulated reciprocal 
signalling between the mesenchymal and epidermal components that has lead to the hair 
follicle being described as a “dynamic mini-organ” and model system for investigating stem 
cell biology and signalling interactions during tissue regeneration (Al-Nuaimi et al., 2010; 
Schneider et al., 2009).  The implications of hair follicle research and in particular, the 
understanding of how the mesenchyme directs stem and progenitor cells, extend well 
beyond the treatment of skin and hair disorders.  However, signalling within the hair follicle 
is extremely complex and much remains to be understood before harnessing this 
knowledge within other fields. 
This thesis sought to contribute to the understanding of DP signalling pathways by 
investigating the role of STAT5, a transcription factor that has gone largely unnoticed in 
hair follicle biology, as well as elucidating further the role of Sox18, a transcription factor 
known to play a role in hair follicle type determination. 
 
7.2. Summary of Findings 
7.2.1. Maximal STAT5 Activation in the Dermal Papilla Is Associated with the 
Transition from the Resting to the Growth Phase of the Hair Follicle  
To date, a specific role for STAT5 in the DP has not been described, despite being 
found to be specifically expressed and upregulated within the DP in gene expression 
analyses (Driskell et al., 2009; Rendl et al., 2005).  In this thesis, it was found that STAT5 
is specifically expressed and activated in the DP following the initial period of postnatal 
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hair follicle development.  No STAT5 was detected in the embryonic or postnatal 
developing hair follicle.  STAT5 activation and expression was found to commence late in 
the first catagen phase and continue through telogen to early anagen, after which its 
expression was minimal or completely absent.  This pattern of STAT5 expression and 
activation in the DP continues throughout adult hair follicle cycling.  This suggested that 
STAT5 may play a role somewhere during the transition from catagen to telogen, or from 
telogen to anagen.  Quantification of staining intensity found that staining was most 
intense during competent telogen and early anagen, with expression of downstream 
STAT5 target, SOCS2, only observed during these phases.  This led to the suggestion that 
STAT5 is involved in the transition from telogen to anagen. 
Subsequently, patch assay experiments were performed using SKPs that had STAT5A 
or STAT5B constitutively-active constructs introduced through adenoviral transduction, as 
well as STAT5-/- SKPs that were obtained through adenoviral cre-mediated deletion in 
STAT5lox/lox SKPs.  It was found that constitutive-activation of both STAT5A or STAT5B 
independently resulted in a significantly improved ability for these cells to form DP 
compared to SKPs transduced with a control GFP construct.  On the other hand, deletion 
of STAT5 within SKPs and the subsequent use of these cells in patch assay experiments 
resulted in a significantly lower number of hair follicles, with fewer integrating and forming 
dermal papillae. This supported further the notion that STAT5 activation is involved in the 
DP’s control of anagen induction. RNA microarray comparison of STAT5-/- SKPs against 
control SKPs revealed a significant downregulation of genes involved in anagen induction 
including FGF7, FGF10, Wnt5a, Wnt6 and IGF-1, and upregulation of the Wnt and Notch 
inhibitors Dkk3 and Dlk1, respectively.  This suggested that STAT5 could be mediating its 
anagen-inducing effects by upregulation of known anagen signalling pathways.   
 In order to provide further evidence to support this hypothesis, in vivo investigation of 
the role of STAT5 was required.  This would be achieved through STAT5 conditional 
knockout studies; however, prior to conducting these studies, the role of Sox18 in the DP 
and its potential use to target the DP in conditional knockout studies was examined. 
 
7.2.2. Mesenchymal Sox18 Activity Is Essential for Dermal Papilla Development and 
Function in All Murine Hair Types 
Sox18 expression in the DP is known to be important for specification of the murine 
zigzag hair follicle type, whereas guard, awl and auchene hair follicles are specified by 
Sox2 expression within the DP (Driskell et al., 2009; Pennisi et al., 2000a). However, 
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Sox18 has been shown to be expressed in the DC as early as E14.5, a time point where 
only the guard hair follicle type is developing (Pennisi et al., 2000b). 
In this thesis, it was confirmed through labelling of Sox18 and lineage tracing 
experiments that Sox18 is expressed within the DCs of all developing hair follicle types 
starting at E14.5.  Sox18 was shown to be co-expressed with Sox2 in developing guard 
and awl/auchene hair type dermal papillae, albeit for a limited time at the beginning of their 
respective hair waves.  However, the dermal papillae of developing zigzag hair follicles 
displayed only Sox18 expression and not Sox2.  As Sox18 is part of the SoxF family of 
transcription factors that also includes Sox7 and Sox17, their presence within developing 
hair follicles was also examined (Dunn et al., 1995).  It was found that neither Sox7 nor 
Sox17 were expressed in any of the developing hair follicles.  Following characterisation of 
its expression during hair follicle development, the function of Sox18 in the DP was 
investigated using the Sox18+/Op mouse model, which carries a dominant negative Sox18 
mutation.  It was found that hair placodes developed during all hair follicle development 
waves in Sox18+/Op mice, however, all hair follicle types failed to develop normally.  
Primary hair follicles were shown to be altered in morphology and polarity, whereas 
secondary and tertiary hair follicles failed to develop at all, leaving behind epithelial strands 
within the dermis.  This suggested that dominant negative Sox18 mutation affects all hair 
follicle types following placode development and not just zigzag follicles.  This led to the 
suggestion that Sox18 was important for DC specification. 
It was found that Sox2+ DPs were present in primary hair follicles of Sox18+/Op mice at 
E18.5 and P0, however, the remnants of secondary and tertiary hair follicles were 
completely devoid of DP markers such as alkaline phosphatase, CD133 or α-SMA.  Wnt 
signalling responsible for DC specification was seen to be occurring normally in all hair 
follicle types, as Lef1+ DCs could be detected at all stages, leading to the suggestion that 
Sox18+/Op mutation was impairing DC differentiation into a DP. 
Within guard hair follicles, it was found that DP formation was not impaired, resulting in 
what appeared to be normal development of the hair follicle.  Upon further investigation it 
was observed that the morphology of Sox18+/Op guard hair shafts differed to those of wild-
type littermates, exhibiting a longer and more bent shape.  Ki67 staining revealed that 
Sox18+/Op guard hair follicles did not stop proliferating, explaining the longer hair shaft, and 
did not enter telogen.  Further analysis found that IRS differentiation was impaired in 
Sox18+/Op mice, and quiescence markers in bulge stem cells were significantly reduced 
compared to control hair follicles.  This suggested that Sox18+/Op mutation resulted in an 
excessive activation of bulge stem cells, ultimately leading to their exhaustion. This was 
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supported further by the observation that at 12 months, Sox18+/Op mice had lost all hair 
shafts. 
To support the notion that Sox18+/Op mutation was resulting in a mesenchymal defect, 
patch assays were formed by using combinations of wild-type and Sox18+/Op keratinocytes 
and dermal cells.  Appropriately, it was found that wild-type keratinocytes combined with 
wild-type dermal cells resulted in significant hair formation, whereas Sox18+/Op 
keratinocytes combined with Sox18+/Op dermal cells did not induce hair follicle formation.  
When Sox18+/Op keratinocytes were combined with wild-type dermal cells, hair formation 
was comparable to wild-type control patch assays.  However, when Sox18+/Op dermal cells 
were combined with wild-type keratinocytes, hair follicle formation did not occur.  This 
suggested that the impairment in hair follicle formation was due to a dermal defect. 
Patch assay experiments were then performed using wild-type and Sox18+/Op SKPs, 
and these were added to Sox18+/Op keratinocyte and Sox18+/Op dermal cell combinations.  
Sox18+/Op SKPs failed to alter the result of these patch assays, failing to induce hair follicle 
formation; however, wild-type SKPs added to the same combination of cells resulted in at 
least a partial restoration of hair follicle formation.  This suggested that the function of 
Sox18 is cell autonomous and that wild-type SKPs have intrinsic Sox18-dependent 
properties that are able to reverse the Sox18+/Op mutation.  Microarray comparison of wild-
type and Sox18+/Op SKPs revealed that several contributors to hair follicle development or 
cycling were downregulated in Sox18+/Op SKPs, as well as several genes previously 
identified as DP signature genes. 
Given the expression of Sox18 within the DP, this thesis sought to target the DP in 
conditional knockout studies using a mouse line expressing cre-recombinase under the 
control of a Sox18 promoter.  These mice, described as Sox18GCre/ER+, also expressed 
GFP driven by the Sox18 promoter.  Sox18GCre/ER+ mice were crossed with YFPlox-STOP-
lox reporter mice and it was found that Sox18 continued to be expressed within the DP at 
P3 and at P21.  Lineage tracing experiments performed by inducing recombination in 
Sox18GCre/ER+ YFPlox-STOP-lox mice at birth and at P21 found that labelling of the DP did 
occur and could still be detected at eight weeks of age.  This suggested that 
Sox18GCre/ER+ mice could be used to target the DP effectively within conditional 
knockout studies.  However, potential effects on vasculature and lymphatics needed to be 
considered, as Sox18-GFP-positive staining was observed to be co-localised with CD31- 
and LYVE1-positive cells. 
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7.2.3. Consequences of In vivo STAT5 Inhibition in the Dermal Papilla on Hair Follicle 
Cycling 
To investigate further the role of STAT5 in the DP control of hair cycling, a cre-lox 
conditional knockout model was developed.  Sox18GCre/ER+ mice were crossed with 
STAT5A/Blox/lox mice in order to conditionally ablate STAT5 within the DP.  Conditional 
deletion of STAT5 was confirmed by PCR and immunofluorescence.  Within the STAT5 
cKO group, activated STAT5 was still present in Sox2-positive DP, confirming that STAT5 
deletion was restricted to Sox18-positive DP. 
Quantification of hair follicle cycling was achieved through incorporation of the 
Topflash reporter line within the conditional knockout model breeding strategy.  With 
conditional knockout induced at birth, it was found that the STAT5 cKO group exhibited a 
delayed onset of the second postnatal anagen phase compared to the control group.  
Luminescence remained significantly lower within the STAT5 cKO group for at least six 
days, and anagen was delayed by at least three days compared to the control group.  This 
supported further the previous findings of this thesis and suggested that STAT5 activation 
plays a role in the transition to anagen from telogen in the adult cycling hair follicle. 
Pharmacological inhibition of STAT5 was attempted through the use of ruxolitinib, a 
JAK2 inhibitor that has shown promise in the treatment of alopecia areata.  It was found 
that in non-pathological hair cycling, ruxolitinib treatment did not inhibit STAT5 within the 
DP although it reduced STAT3 activation in the interfollicular epidermis, and thus has no 
effect on hair follicle cycling.   
 
7.2.4. Contributions of Dermal Populations to Skin Wound Healing 
Repair of cutaneous wounds must occur quickly in order to restore the skin’s essential 
barrier function.  Contributing to this process are macrophages, which play an essential 
role in stimulating several wound healing pathways, and epidermal stem cells that migrate 
to the wound and differentiate in order to facilitate rapid closure (Plikus et al., 2012; 
Rodero and Khosrotehrani, 2010). 
This thesis found that by depleting macrophages within the wound environment using 
clodronate, subpopulations of macrophages with high expression of MHCII were 
significantly reduced in proportion.  Through a large excisional wound model, it was found 
that depletion of macrophages resulted in defective wound closure, supporting the findings 
of previous studies.  Collagen expression during wound healing was then quantified 
through bioluminescence using Col1α2-Luc mice and it was found that Col1α2 
transcription was significantly reduced in the clodronate-treated condition compared to the 
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control group at D4 and D7.  This finding was supported by histological quantification of 
wound sections at D14, revealing significantly reduced fibrosis within the clodronate-
treated group compared to the control condition.  These findings suggested that 
macrophages control the transcription of Col1α2 early on in the wound healing process, 
and this transcription and subsequent collagen production can be modulated by 
macrophage depletion. 
To assess the potential for DP-derived cultured cell populations to provide a positive 
contribution to wound healing, SKPs were transplanted into mouse dorsal excisional 
wounds.  Furthermore, as the findings of this thesis indicated that STAT5 plays an 
important role in anagen induction and found STAT5B constitutively-active SKPs to be the 
most effective at generating DP and hair follicles, the effect of treating wounds with 
STAT5B-CA SKPs was investigated.   
It was found that in C57BL/6 mice, wounds treated with either GFP control SKPs 
(SKPs+GFP) or SKPs transduced with a STAT5B constitutively-active construct 
(SKPs+STAT5B-CA) were significantly reduced in size compared to wounds treated with 
an acellular control at D3 and D4.  By D5, no difference was observed between the 
SKPs+GFP and control conditions; however, SKPs+STAT5B-CA treated wound were still 
significantly reduced in size compared to control wounds.  This suggested that SKPs 
improve wound closure during the early stages of wound healing, and this effect was 
improved further with the constitutive-activation of STAT5B.  Immunofluorescence found 
that SKPs had persisted in the wound environment at D7. 
Quantification of collagen deposition within the wounds found no significant difference 
between conditions, although the overall mean within the SKPs+STAT5B-CA condition 
was lower compared to the other conditions.  Quantification of F4/80+ cells, indicative of 
macrophages, found that the proportion of macrophages within the granulation tissue of 
SKPs+STAT5B-CA treated wounds was significantly reduced compared to the SKPs+GFP 
and control conditions.  Microarray analysis comparing SKPs+GFP to SKPs+STAT5B-CA 
found a significant downregulation of genes involved in inflammatory pathways within the 
SKPs+STAT5B-CA condition.  This suggested that an overall reduction of inflammation 
and possibly impaired recruitment of pro-inflammatory macrophages induced by the 
presence of SKPs+STAT5B-CA was responsible for the improved wound closure that was 
observed. 
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7.3. Interpretation of Findings 
7.3.1. STAT5 and the Dermal Papilla Control of Hair Cycling  
This thesis found that maximal activation of STAT5 in the DP plays an important role in 
the transition from telogen to anagen phase in the adult cycling hair follicle. Deletion of 
STAT5 in the DP resulted in delayed entry into the second anagen phase. It was found 
that STAT5 was not expressed in the DP during hair follicle development, a finding that 
was later substantiated through the observation of unaffected hair follicle type proportions 
in STAT5 conditional knockout mice. 
A previous study investigating growth hormone signalling has shown that ubiquitous 
knockout of STAT5B results in a delayed anagen phase by up to two weeks (Udy et al., 
1997).  However, this is unlike the model used in this thesis, which performed targeted 
deletion of STAT5A and STAT5B in the DP. Although the findings of Udy et al. (1997) 
suggest STAT5B has a role in hair follicle cycling, it does not implicate STAT5 within the 
DP’s control of hair cycling specifically.  It is likely that the effects seen in the study by Udy 
et al. (1997) is the consequence of a combination of effects resulting in the inhibition of 
STAT5 signalling pathways within both components of the hair follicle and its 
macroenvironment.  Specific to the DP, few signalling pathways that mediate their effects 
through downstream activation of STAT5 have been implicated in the DP’s control of hair 
follicle cycling.  These include those of PRLR, EPOR and FGFR3. 
PRLR has long been known to mediate its effects through STAT5, with the 
transcription factor initially described as mammary gland factor (Wakao et al., 1994).  
Limited evidence has demonstrated the expression of PRLR in the DP, with a study 
investigating the distribution of PRLR immunoreactivity within ovine skin describing the 
presence of PRLR within the DP of telogen and anagen hair follicles.  However, the 
consequences of activation of these receptors were not examined and therefore their role 
in hair cycling was not determined (Choy et al., 1997).  Conversely, multiple studies 
describe PRLR expression within the hair follicle epidermal compartment, as well as the 
effects of prolactin on hair cycling.  A recent study has described STAT5 as part of a PRLR 
signalling pathway that is responsible for quiescence of hair follicle stem cells during 
pregnancy and lactation (Goldstein et al., 2014).  Furthermore, earlier studies have 
provided evidence to suggest that PRLR activation results in catagen induction or a 
significant delay in anagen entry (Craven et al., 2006; Foitzik et al., 2006; Foitzik et al., 
2003).  Characterisation of PRLR expression throughout the hair follicle cycle has shown 
strongest expression within the epidermal compartment during the later stages of anagen 
and in early catagen (Foitzik et al., 2003).  Furthermore, the lack of effect of JAK1/2 
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inhibitors on STAT5 phosphorylation in the DP casts doubt on the role of PRLR.  Given the 
findings of this thesis regarding STAT5, which are in contrast to the previously described 
effects in the hair follicle epidermal compartment, it is unlikely that PRLR is the upstream 
activator of STAT5 within the DP. 
EPOR is known to mediate its effects through the JAK-STAT signalling pathway, with 
activation of STAT5 specifically described (Yoshimura and Arai, 1996).  Previous studies 
exist that demonstrate EPOR presence within the DP and note STAT5 activation in DP 
cells in response to EPO (Kang et al., 2010; LeBaron et al., 2007).  In vitro, EPO has been 
shown to promote hair shaft growth in cultured human hair follicles and in vivo experiments 
in mice have shown that EPO treatment in telogen skin induces anagen phase (Kang et 
al., 2010).  In humans, recombinant EPO given for the treatment of chronic kidney failure 
was demonstrated to induce hypertrichosis in a modest proportion of patients (Kleiner et 
al., 1991; Tosi et al., 1994).  These reported effects of EPO and the expression of EPOR 
within the DP suggest that EPOR may be an upstream activator of STAT5 in the DP. 
FGFR1 is known to be expressed within the DP and has been described as part of the 
DP’s genetic signature (Driskell et al., 2009; Rendl et al., 2005).  FGFR3 has also been 
shown to be expressed within the hair follicle ORS, bulge and DP during telogen phase 
(Kimura-Ueki et al., 2012).  FGF18 is known to interact with FGFR3; however, 
contradictory studies exist regarding its role in hair follicle cycling.  An earlier study found 
that subcutaneous administration of FGF18 into telogen skin resulted in the induction of 
anagen and vigorous hair growth (Kawano et al., 2005).  A later study found that FGF18 
knockout mice display a shortened telogen phase and that treatment with FGF18 during 
anagen phase inhibited matrix cell proliferation.  However, the same study replicated the 
findings of the earlier study, and again found that FGF18 delivery during telogen resulted 
in earlier anagen induction compared to control treated mice (Kimura-Ueki et al., 2012).  
Assuming these effects are mediated by FGFR3 activation, this suggests that FGF18-
induced FGFR3 signalling may play a role in the transition from telogen to anagen.  FGF 
receptors are known to signal through a variety of pathways, including those of MAPK, 
PI3K and STATs (Coleman et al., 2014).  In particular, FGFR3 activation has been shown 
to result in phosphorylation and nuclear translocation of STAT5, independently of JAKs 
(Kong et al., 2002).  Together, these studies lead to the suggestion that upstream 
activation of FGFR3 within the DP by FGF18 may result in STAT5 activation and 
subsequent anagen induction.  Given that FGF receptors are known to signal through 
STAT transcription factors, STAT5 may also play a currently undescribed role in the 
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signalling of FGFR1, a receptor known to be expressed in the DP (Coleman et al., 2014; 
Driskell et al., 2009; Rendl et al., 2005). 
In this thesis, microarray comparisons of STAT5-/- SKPs with wild-type SKPs revealed 
a number of gene expression alterations involving genes implicated in hair follicle cycling. 
Amongst these alterations was the downregulation of Wnt5a and Wnt6.  It is well 
established that Wnt/β-catenin signalling is pivotal to hair follicle morphogenesis and the 
anagen phase of the hair cycle (Andl et al., 2002; Schneider et al., 2009).  During hair 
follicle morphogenesis, Wnt6 is suggested to induce expression of Eda in the ectoderm 
(Laurikkala et al., 2002).  Eda/Edar signalling has been demonstrated to be an important 
effector of Wnt/β-catenin signalling and subsequent hair follicle patterning and 
development (Kowalczyk-Quintas and Schneider, 2014; Zhang et al., 2009).  Less is 
known regarding the role of Wnt6 in adult hair follicle cycling; however, as many signalling 
pathways involved in morphogenesis are conserved in adult hair cycling, its potential role 
in anagen induction cannot be dismissed.   
Wnt5a has been described as a target of Shh signalling, which is known to be 
essential during hair follicle development.  Maturation of the DC into a functioning DP has 
been shown to be inhibited in the absence of Shh, consequently inhibiting hair follicle 
morphogenesis (Huelsken et al., 2001; Millar, 2002; Reddy et al., 2001; Woo et al., 2012).  
In contrast, a study investigating the role of Wnt5a during adult hair cycling found that 
overexpression of Wnt5a results in the inhibition of anagen entry, and an in vitro study has 
shown attenuation of Wnt/β-catenin signalling in human DP cells with Wnt5a treatment 
(Kwack et al., 2013; Xing et al., 2013).  The findings of this thesis support a role for Wnt5a 
in anagen induction, as gene expression analyses found this gene to be downregulated in 
cells that are less likely to induce hair follicle formation. 
Dkk1 is a known inhibitor of Wnt signalling, with previous studies demonstrating that 
ectopic expression of Dkk1 resulted in complete inhibition of hair placode formation (Andl 
et al., 2002).  This thesis found that Dkk3 was upregulated in STAT5-/- SKPs compared to 
control SKPs, and although Dkk3 has not been directly implicated in hair follicle 
development or cycling in the past, it is known to be a negative regulator of β-catenin 
signalling in other tissues (Lee et al., 2009).  Also discovered to be upregulated in STAT5-/- 
SKPs was an inhibitor of Notch signalling, Dlk1.   
Notch signalling is known to be important for differentiation of matrix cells, and Notch1 
has been shown to be essential for postnatal hair follicle homeostasis.  Conditional 
knockout of Notch1 was found to result in premature catagen induction and loss of hair 
follicles coupled with cyst formation (Aubin-Houzelstein, 2012; Vauclair et al., 2005).  Dlk1 
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is a known inhibitor of Notch signalling, and therefore upregulation of Dlk1 can be 
predicted to impair hair follicle differentiation and cycling (Baladron et al., 2005; Falix et al., 
2012).   
FGFs, particularly FGF7 and FGF10, are described to play an important role in DP 
signalling during transition from telogen to anagen.  Greco et al. (2009) described a 
significant upregulation of FGF7 and FGF10 during late telogen and ultimately determined 
that their proteins instruct cells within the hair germ to proliferate and enter a new anagen 
phase.  The results of this thesis found that FGF7 and FGF10 were significantly 
downregulated in STAT5-/- SKPs compared to control SKPs, implicating a role for STAT5 
in the control of their transcription. 
Interestingly, follistatin was found in this thesis to be significantly downregulated in 
STAT5-/- SKPs compared to control SKPs.  Follistatin has been described previously as 
part of the DP genetic signature; however, its specific role within the DP has not been 
elucidated (Rendl et al., 2005).  Extra-follicular follistatin has been shown to stimulate 
anagen propagation, with high levels described during competent telogen and early 
anagen (Chen et al., 2014).  The findings of this thesis implicate further the role of 
follistatin in anagen induction and suggest a specific role within DP signalling. 
Notably, VEGF-A and VEGF-C, genes encoding for the well-known pro-angiogenic 
growth factor, were both shown to be downregulated within STAT5-/- SKPs.  Previous 
studies have shown that in order to meet the increased nutritional demand of the highly 
proliferative anagen hair follicle, increased vascularisation is required within the hair 
follicle’s macroenvironment.  This increase in vascularisation has been shown to be 
mediated by the upregulation of VEGF within the ORS (Yano et al., 2001).  However, this 
thesis has shown that in STAT5-/- SKPs, which are less likely to generate hair follicles, a 
downregulation of VEGF is observed.  Recent evidence has also demonstrated that 
cultured DP cells release VEGF and promote survival, proliferation and tubulogenesis of 
endothelial cells (Bassino et al., 2015).  Together, these findings suggest that the DP plays 
an important role in mediating anagen-induced angiogenesis within the surrounding 
dermis. 
Taken together, STAT5-/- SKPs showed downregulation of canonical and non-
canonical Wnt and FGF signalling pathways, coupled with upregulation of hair follicle 
development and differentiation inhibitors.  Downregulation of less described anagen 
mediators such as follistatin was also observed.  As well as pathways implicated in DP to 
epidermal signalling, inhibition of potential DP to macroenvironment signals such as VEGF 
were also found to be downregulated in STAT5-/- SKPs.  This suggests that STAT5 
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activation within SKPs results in combined upregulation of several anagen signalling 
pathways and suppresses the transcription of anagen inhibitors.  SKPs are known to 
derive from the DP and previous studies combined with the findings of this thesis have 
demonstrated their ability to act as a surrogate DP (Biernaskie et al., 2009; Driskell et al., 
2009).  Therefore, it is likely that the signalling pathways implicated in anagen induction by 
comparison of STAT5-/- and control SKPs are conserved in the adult cycling hair follicle DP 
and represent possible mechanisms through which STAT5 activation is mediating its 
anagen-inducing effects in vivo.  However, it is important to consider that SKPs may 
exhibit a small degree of heterogeneity and do not represent a pure DP population.  In 
future, cell sorting based on DP surface markers and subsequent analysis of the sorted 
population may eliminate the influence of non-DP cells on in vitro assays and gene 
expression data. 
This thesis also found that pharmacological inhibition of STAT5 using the JAK1/2 
inhibitor, ruxolitinib, did not result in an altered hair follicle cycling phenotype.  No inhibition 
of STAT5 phosphorylation was observed within the DP during competent telogen/early 
anagen, a time point where maximum STAT5 activation was previously described.  
Ruxolitinib has recently shown promise as a treatment for alopecia areata, with oral and 
topical administration able to prevent and reverse development of the condition (Xing et 
al., 2014).  Inhibition of STAT5 resulting in the induction of hair growth appears to 
contradict the findings of this thesis; however, the mechanism through which ruxolitinib is 
suggested to exert its effects is by inhibition of the pathological immune response 
surrounding the hair follicle (Xing et al., 2014).  This suggests that inhibition of JAK-
mediated STAT5 activation by ruxolitinib does not occur in non-pathological conditions.  
Alternatively, it is conceivable that the STAT5-mediated effects on hair cycling observed in 
this thesis do not occur as a result of conventional JAK-STAT signalling.  There is 
evidence indicating that EGF receptor and FGF receptor are able to activate STAT5 
resulting in downstream effects, independent of JAK activity (David et al., 1996; Kong et 
al., 2002).  This notion is supported by the findings of this thesis that showed unaltered DP 
STAT5 activation, yet significantly reduced STAT3 activation within the interfollicular 
epidermis with ruxolitinib treatment compared to vehicle-treated controls.  
 
7.3.2. Sox18 and the Dermal Papilla  
This thesis found that expression of Sox18 is not restricted to the DP of zigzag hair 
follicles as believed previously, but is expressed and functionally important within the 
developing DP of all hair follicle types at some stage during development.  It was 
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suggested that Sox18 is required for proper differentiation of the DP and regulation of hair 
follicle cycling.  Microarray gene expression analysis of Sox18+/Op SKPs compared to 
control SKPs found a significant downregulation of Wnt5a and FGF7, whose function in 
the DP control of anagen-induction were described earlier. Additionally, Wnt7b, previously 
implicated as an anagen-inducer by Kandyba and Kobielak (2014), was shown to be 
downregulated in Sox18+/Op SKPs.  This suggests that Sox18 mediates at least some of its 
effects within the DP through downstream inhibition of Wnt signalling. 
MMP9 was found to be significantly downregulated within Sox18+/Op SKPs (18.11 fold), 
as well as STAT5-/- SKPs (11.57 fold) compared to their respective controls.  MMP9 
belongs to the matrix metalloproteinase family, which are known for their importance in 
extracellular matrix remodelling.  Within hair follicle biology, MMP9 has been suggested to 
be important in formation of the hair canal.  It is suggested that through extracellular matrix 
remodelling, MMP9 prompts formation of the hair canal lumen.  MMP9-/- mice displayed 
prolonged retention of the hair shaft within the hair canal and, as a consequence, a 
significant delay in hair shaft appearance at the skin surface compared to wild-type mice. 
However, the presence of MMP9 was noted only in the hair canal and was not explored 
beyond the hair follicle developmental stages (Sharov et al., 2011).  Speculatively, MMP9 
within the DP may be important for degradation of the extracellular matrix in order for the 
proliferating hair follicle to penetrate the dermis.  To date, the signalling mechanisms by 
which MMP9 is activated within the hair follicle remains unclear; however, the findings of 
this thesis suggest that its expression is regulated through a mechanism involving Sox18 
and STAT5. 
Tenascin-C is an extracellular matrix protein that is a known marker of the DP in both 
mice and human hair follicles (Chuong et al., 1993; Kaplan and Holbrook, 1994).  
Recently, tenascin-C has been found to be required for Wnt/β-catenin signalling in mouse 
vibrissae, and suggested to play a role in maintenance of their stem cell populations.  It 
was found that within vibrissae of tenascin-C knockout mice, both adipocyte and mast cell 
number were increased compared to control mice, a likely consequence of impaired 
Wnt/β-catenin signalling (Hendaoui et al., 2014). In this thesis, Tnc was again found to be 
downregulated in Sox18+/Op and STAT5-/- SKPs compared to their respective controls by 
approximately two-fold.  Furthermore, it was found that the quiescent population of stem 
cells within the hair follicle epidermal compartment was lost in guard hairs, a possible side 
effect of Tnc downregulation given recent findings regarding its role in stem cell 
maintenance. 
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It is important to note that the mouse model used to investigate the function of Sox18 
in this thesis carries a dominant negative mutation and not ubiquitous knockout of Sox18 
(Pennisi et al., 2000b).  Although Sox7 and Sox17 were not found to be expressed in the 
DP, it is plausible that other Sox genes are affected by the nature of the genetic mutation 
and may be partly responsible for the observed effects.  This may be construed as a 
limitation of the study, and further investigation is required to definitively conclude that the 
findings are due to the function of Sox18 alone.  As Sox18 is also known to be an 
important mediator of vascular and lymphatic development, it is possible that the nature of 
the mutation within Sox18+/Op mice may be affecting factors within the dermal 
macroenvironment that further perturb hair follicle formation and cycling.  Again, this 
requires further investigation. 
 
7.3.3. SKPs, STAT5 and Skin Wound Healing 
This thesis provided evidence to support the findings of previous studies 
demonstrating that SKPs accelerate wound closure (Sato et al., 2015).  In addition to this 
finding, this thesis reported that when SKPs express constitutively-active STAT5B, their 
ability to accelerate wound closure was augmented.  It was found that the overall number 
of macrophages was reduced within the granulation tissue of wounds treated with SKPs 
transduced with a STAT5B-CA construct.  Gene expression analyses comparing STAT5B-
CA SKPs and GFP control SKPs found significant downregulation of pro-inflammatory 
genes and upregulation of cytokine signalling inhibitors within the STAT5B-CA condition. 
Pathway analysis of microarray data revealed that several genes involved in 
interferon-γ signalling were downregulated in STAT5B-CA SKPs.  Interferon-γ signalling is 
a well-established inflammatory mechanism, playing an essential role in antimicrobial 
defense upon wounding (Farrar and Schreiber, 1993; Toliver-Kinsky et al., 2002).  
However, prolonged activation of interferon-γ has been shown to inhibit the proliferative 
phase of wound healing, resulting in reduced wound contraction, collagen deposition and 
re-epithelialisation (Cornelissen et al., 2000; Shen et al., 2012).  TNF-α is also known to be 
a critical mediator of the inflammatory response, with elevated levels shown to inhibit cell 
migration and stimulate apoptosis of keratinocytes and fibroblasts (Corredor et al., 2003; 
Petrache et al., 2000; Ruckert et al., 2000).  Significant downregulation of TNF and TNF 
signalling-related genes was seen to be downregulated in STAT5B-CA SKPs compared to 
GFP control SKPs in this thesis.  These findings may suggest that SKPs expressing 
constitutively-active STAT5B create an environment within the wound that is less 
inflammatory as a result of interferon-γ and TNF-α signalling inhibition, ultimately 
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accelerating wound closure.  However, it is important to note that microarray analyses 
within this study compared SKPs transduced with GFP or STAT5B-CA constructs against 
each other.  Therefore, the proposed effects on inflammation are suggestive and need to 
be validated through analysis of whole wounds.  Consequently, further investigation of 
wound granulation tissue is required to elucidate the impact of SKPs on inflammatory 
pathways. 
Macrophage number within SKPs+STAT5B-CA treated wounds was found to be 
significantly reduced compared to the SKPs+GFP and control conditions.  This may be a 
result of the significantly downregulated chemokine genes observed within STAT5B-CA 
SKPs.  Chemokines belonging to the CXC and CC family are known for their role in 
recruiting leukocytes during the wound healing inflammatory response.  In particular, CCL2 
and CCL5, significantly downregulated in STAT5B-CA SKPs, are known to be involved in 
macrophage recruitment (Gillitzer and Goebeler, 2001).  Therefore, it may be possible that 
the presence of STAT5B-CA SKPs within the wound environment inhibits macrophage 
recruitment by downregulating the expression of chemokines.  However, macrophages are 
known to be important for wound healing as they provide growth factors that stimulate 
keratinocyte proliferation, fibroblast recruitment and angiogenesis (Rodero and 
Khosrotehrani, 2010).  Therefore, a reduction in their number within the wound would be 
expected to impair wound healing.  Indeed, this thesis found that macrophages control the 
transcription of collagen during the early stages of wound healing, and their depletion 
results in reduced wound closure.  However, previous studies by Rodero et al. (2013) 
suggest that a larger proportion of Ly6clowMHCIIhigh pro-tissue repair macrophages within 
the wound improves healing outcome.  Given that macrophage number in SKPs+STAT5B-
CA treated wounds is reduced, yet collagen deposition is not significantly affected, it is 
possible that the gene expression profile of STAT5B-CA SKPs may be creating an 
environment that promotes differentiation of Ly6clowMHCIIhigh macrophages.  However, 
further investigation of macrophage subpopulations in SKPs+STAT5B-CA treated wounds 
is required before this can be concluded. 
Overall, SKPs expressing constitutively-active STAT5B are suggested to promote 
wound healing by modulation of the wound environment, reducing inflammation and 
promoting pro-tissue repair pathways. 
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7.4. Potential Implications 
7.4.1. Hair Follicle Disorders 
Conditions affecting the hair follicle may be a significant source of psychological stress 
amongst humans as pathological hair loss or growth causes obvious alterations in physical 
appearance.  Such pathological conditions include telogen effluvium, alopecia areata and 
hypertrichosis. 
Telogen effluvium is a hair follicle cycling disorder characterised by excessive 
shedding of hair follicles that are within telogen phase.  The exact mechanisms resulting in 
the onset and progression of chronic telogen effluvium remain largely unknown, although  
five functional types have been described (Harrison and Sinclair, 2002).  These types of 
telogen effluvium include the immediate anagen release, delayed anagen release, short 
anagen, immediate telogen release and delayed telogen release types (Headington, 
1993).  In essence, regulation of anagen and telogen phases is perturbed in all types of 
telogen effluvium due to an unknown mechanism.  The findings of this thesis implicating 
DP STAT5 activation in downstream upregulation of anagen-inducing pathways may offer 
a new mechanism through which manipulation of dysfunctional hair cycling can be 
achieved. 
Alopecia areata is described as an autoimmune condition where cytotoxic T 
lymphocytes damage the hair follicle bulb, resulting in premature catagen induction and 
loss of the hair shaft (Gilhar et al., 2012; Xing et al., 2014).  Treatment of alopecia areata 
is generally aimed at inhibiting the inflammatory response responsible the condition, and 
has yielded promising results in recent times (Xing et al., 2014).    However, it was noted in 
early investigations into alopecia areata that only hair follicles in anagen phase are 
affected by the condition and those in telogen phase appear to be protected (Messenger et 
al., 1986b).  Later studies found that the hair follicle is a site of immune privilege, and is 
therefore protected from an immune response under normal conditions (Ito et al., 2008).  
In alopecia areata, collapse of this immune privilege occurs during anagen phase, leading 
to the pathological immune response against the hair follicle (Xing et al., 2014).  As this 
thesis has suggested that STAT5 ablation in the DP results in delayed transition to anagen 
from telogen, inhibition of STAT5 activation in the DP may be a potential method of 
arresting hair follicles in telogen phase.  This arrest in telogen may be sufficient to protect 
hair follicles from a pathological immune reaction, preventing the cosmetic and potential 
psychological impacts of alopecia areata.  Of course, this presents only a temporary 
solution, but may be of benefit while addressing environmental factors that may have 
contributed to alopecia areata onset. 
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Hypertrichosis is a generalised term to describe abnormal and excessive hair growth 
for a person’s age, gender and ethnicity.  Hypertrichosis may be defined as primary, 
occurring as a result of a congenital defect; or secondary, caused by an underlying 
pathological condition or pharmacological treatment (Trueb, 2002; Wendelin et al., 2003).  
By definition, hypertrichosis is distinct from hirsutism, as the latter refers to abnormal hair 
growth that occurs in a male pattern distribution and caused by elevated levels of 
androgens (Mofid et al., 2008).  Currently, treatment options for hypertrichosis are limited, 
and generally involve commonly used cosmetic hair removal methods.  Treatment with 
topical eflornithine, an inhibitor of ornithine decarboxylase, has shown some success in 
slowing hair growth (Balfour and McClellan, 2001; Mofid et al., 2008).  As excessive hair 
growth is indicative of a prolonged anagen phase, manipulation of pathways that are 
known to be important for anagen and its induction may present novel therapeutic options.  
Inhibition of STAT5 may provide a method of inhibiting further hair growth in hypertrichosis 
cases, particularly following cosmetic hair removal procedures. 
Although not specifically a hair follicle disorder, the human condition, hypotrichosis-
lymphedema-telangiectasia (HLT) is characterised genetically by a dominant negative 
mutation of Sox18 found in mice described by Irrthum et al. (2003).  The insight into Sox18 
function gained from this thesis has the potential to open new avenues for treatment of the 
condition. Understanding the downstream genetic disruptions caused by impaired Sox18 
function is essential to develop therapies to manage HLT. 
 
7.4.2. Regenerative Medicine 
The therapeutic potential of stem cell populations within the hair follicle is well-
described.  Hair follicle stem cells are known to be multipotent, with the ability to 
differentiate into several lineages including neurons, adipocytes, chondrocytes and 
osteocytes (Mistriotis and Andreadis, 2013).  Additionally, DP cells have been shown to 
require only Oct4 and Klf4 in order to be reprogrammed into induced pluripotent stem cells 
(Tsai et al., 2010).  However, the mechanisms that drive activation and differentiation of 
these cell populations are less understood.  The hair follicle is well-established as a model 
system to investigate mesenchymal-epithelial interactions, owing to the reciprocal 
signalling between the DP and stem cell populations within the epidermal compartment.  A 
further understanding of the DP signals that induce and control differentiation of stem cells 
has potential implications within multiple organ systems and pathological processes that 
involve reciprocal mesenchymal-epithelial signalling.  For example, signalling pathways 
involved in hair follicle morphogenesis are virtually identical in tooth development with 
152 
 
BMP, Wnt/β-catenin, Notch, FGF and Shh signalling all required for normal odontogenesis 
(Li et al., 2013).  The findings of this thesis, namely identification and elucidation of the 
roles of STAT5 and Sox18, offer potential mechanisms through which stem cell activation 
and subsequent tooth regeneration may be achieved. 
The findings of this thesis regarding SKPs and STAT5 in wound healing have obvious 
implications in skin repair and regeneration. These findings could be applied in an effort to 
reduce scarring following wound healing, or even inhibit pathological wound healing 
processes such as hypertrophic scarring.  Furthermore, these findings may benefit cases 
where excessive inflammation contributes to poor wound healing outcome, as is the case 
with diabetic ulcers. 
 
7.5. Future Directions 
This thesis has described a novel role for STAT5 in the DP control of hair follicle 
cycling, provided further insight into Sox18 function within the DP and described a 
potential role for STAT5 activation in improving wound healing outcome.  Further studies 
regarding STAT5 function in the DP are required to validate downstream transcriptional 
targets and offer a more detailed mechanism of action.  In addition to downstream targets, 
elucidation of upstream activators of STAT5 signalling is also required.  Understanding of 
the mechanisms through which STAT5 is activated within the DP would be beneficial in 
attempting to modulate hair follicle cycling in potential therapeutic settings.  On that note, 
in vivo modulation of STAT5 should be examined within models of hair follicle disorders in 
order to elucidate a potential clinical implication.  This could be attempted with direct 
inhibitors of STAT5 and its phosphorylation, and not its upstream activators such as JAK2.  
One potential candidate for more specific STAT5 inhibition in vivo is N'-(11H-indolo[3,2-
c]quinolin-6-yl)-N,N-dimethylethane-1,2-dia-mine (IQDMA), an indoloquinoline derivative 
that has been shown to inhibit STAT5 activity by suppressing its phosphorylation (Chien et 
al., 2008). 
Further investigation of Sox18 function within the DP is required to confirm that the 
effects observed within this thesis are specifically a consequence of Sox18 loss of function 
and not due to an impairment of other Sox genes.  Investigation of potential therapeutic 
applications of these findings should begin with attempting to restore Sox18 function and 
thus normal hair cycling in the Sox18+/Op model. 
Further studies of SKPs within the wound environment should first address the fate of 
SKPs that integrate into the wound site.  Elucidation of their differentiation pathway would 
provide further insight into the possible mechanism through which they improve wound 
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healing.  Given the findings regarding SKPs+STAT5B-CA treated wounds and 
macrophage numbers, investigation of macrophage subpopulations at least by flow 
cytometry should be performed to determine whether the proportion of pro-inflammatory 
and pro-tissue repair macrophages has been affected.  Modulation of STAT5 within the 
wound in the absence of SKPs should also be performed to determine whether the same 
wound healing effects can be replicated without the need for cell transplantation. 
 
7.6. Conclusion 
This thesis found that activation of STAT5 within the DP plays a previously 
undescribed role in the hair follicle’s transition from telogen to anagen phase.  It was found 
that maximal activation of STAT5 is required for normal transition from telogen to anagen 
in the adult cycling hair follicle, and without STAT5, the natural entry into anagen is 
delayed.  STAT5 was suggested to exert its effects within the DP through downstream 
activation of well-known anagen pathways, including Wnt and FGF signalling.  This thesis 
also found that Sox18 is expressed during the development of all hair follicle types, and 
acts as a mesenchymal molecular switch necessary for the formation and function of the 
DP.  It was also discovered that collagen transcription begins during the early stages of 
wound healing and is controlled by macrophages expressing high levels of MHCII.  Finally, 
this thesis also found that SKPs expressing constitutively-active STAT5B improve wound 
healing to a greater extent than control SKPs and acellular control conditions, and was 
suggested to occur through inhibition of inflammatory pathways.   
This thesis provides novel insight into mechanisms of DP signalling and wound healing 
processes that have implications in skin biology and regenerative medicine as a whole. 
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